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Abstract 
Background: Gestational diabetes mellitus (GDM) is defined as carbohydrate 
intolerance resulting in hyperglycaemia of variable severity with onset or first 
recognition during pregnancy. Women with GDM are at increased risk for 
preeclampsia during pregnancy and for delivery complications. In most cases GDM 
ends after pregnancy, but it increases the risk for future type 2 diabetes, and 
cardiovascular diseases, to both the mother and the child. With the current 
increase in prevalence of overweight/obesity and type 2 diabetes in Tanzania and 
other Sub Saharan African countries, it is possible that GDM may exist and may be 
on the rise.  
Methods: A cross-sectional survey was done in 2011 through 2013 where 910 
women in Tanzania (609 from urban, 301 from rural areas) were studied during 
their usual antenatal clinic visits. Weight, height, mid upper arm circumference 
(MUAC), blood pressure and haemoglobin levels were measured by a trained 
technician. Blood glucose was measured at fasting and at two hours after 75 g oral 
glucose tolerance test. Women were classified as having GDM using WHO 1999 
criteria. Sociodemographic information was collected through face-to-face 
interviews using structured questionnaire or retrieved from the antenatal clinic 
card. Dietary intake data was collected using 24-hour recall interview and foods 
were categorised into groups based on dietary diversity. The international physical 
activity questionnaire (IPAQ) was used to assess activities in the past one week. 
Information on birth outcome was obtained from 466 urban mothers (response 
rate 77%) through telephone interviews. To estimate the burden of GDM in the 
region, we additionally conducted a systematic search of published literature on 
the prevalence and risk factors of GDM in Sub Saharan Africa. Out of the 22 
reviewed studies, 15 studies graded as having low or moderate risk of bias were 
included in a meta-regression analysis. Finally, a review of literature regarding the 
health system and antenatal care was done and supported by a survey to assess 
antenatal care services in 24 health facilities that provide maternal and childcare 
services in Dar es Salaam region. 
Results: The prevalence of GDM was much higher among women residing in the 
urban (8.4%) compared to those in the rural areas (1.0%), which was much higher 
compared to 0%  reported in the 1990s. Prevalence of GDM was higher for women 
who had a previous stillbirth, family history of type 2 diabetes and MUAC ≥28 cm, 
and lower for women with normal haemoglobin concentrations compared to those 
with anaemia. Likewise, the prevalence of hypertension disorders of pregnancy 
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(HDP) was higher in urban (8.9%) compared to rural areas (5.3%). Risk factors for 
HDP in urban women were advanced maternal age, high MUAC, gestional age and 
being HIV positive, and in rural women age and gestational age.  
We reviewed 22 studies conducted in six out of the 47 Sub saharan African 
countries. Heterogeneity between the studies was high and it could not be 
significantly explained by study setting, population, diagnostic criteria, or the year 
the study was done. Nevertheless, a relatively higher prevalence was observed in 
studies done after the year 2000, when women at risk were selected and when 
more current diagnostic criteria were used. The prevalence was up to about 14.0% 
when women with at least one risk factor were studied. In Dar es Salaam women, 
despite a high prevalence of anemia and HIV, the prevalence of macrosomia was 
higher (5.9%) compared to the prevalence of low birth weight (3.6%). Presence of 
GDM (OR 3.46, 95% CI 1.01-11.85) and birth weight of the previous child (OR 2.42, 
95% CI 1.17-4.99) were the main predictors of macrosomia and HDP (OR 3.75, 95% 
CI 1.11-12.68) was the main predictor of low birth weight. Although glucose testing 
in urine appeared to be universally done in the urban setting, the sensitivity of this 
test for detection of GDM is low. Therefore selective blood glucose testing should 
be implemented and HIV testing and counselling may be used as an entry point.  
Conclusions: The prevalence of GDM and HDP was higher in the urban compared 
to the rural areas in Tanzania, indicating an increasing in women who are at risk for 
delivery complications, poor pregnancy outcomes, type 2 diabetes and 
cardiovascular diseases in later life. The risk factors observed can be used to 
identify risk groups for screening and as target for prevention interventions. To 
inform policy makers and for better health care planning, further studies on the 
costs for blood glucose testing during the usual antenatal clinic visits and on the 
management of women with GDM are warranted. 
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Background  
The prevalence of type 2 diabetes mellitus is increasing globally, and it is estimated 
that the highest increase between now and 2035 will be in Africa (109%) [1].The 
increasing prevalence of type 2 diabetes in the African population is linked to an 
increase in obesity. Most studies have observed a higher prevalence of obesity in 
women than in men, and significant increases are noted in rural areas [2-5]. This 
evidence of the increasing prevalence of type 2 diabetes mellitus and obesity begs 
the question of whether there are more women with hyperglycaemia in pregnancy 
– a condition that has been shown to result in diabetes and its complications at a 
later life stage [1].  
 
Gestational diabetes mellitus is defined as carbohydrate intolerance resulting in 
hyperglycaemia of variable severity, with onset or first recognition during 
pregnancy. The former WHO definition included previously unrecognized type 2 
diabetes mellitus [6]. According to the new WHO recommendation, hyperglycaemia 
first detected at any time during pregnancy is classified as either diabetes in 
pregnancy or gestational diabetes [7].  
The underlying pathophysiology of gestational diabetes is decreased maternal 
insulin sensitivity, or increased insulin resistance, which begins near mid pregnancy 
and progresses in the third trimester to the levels similar to those seen with type 2 
diabetes [8, 9]. Insulin resistance is defined as the inability of a defined 
concentration of insulin to affect a predictable biological response of nutrient 
metabolism at the level of the target tissue [10]. Insulin resistance appears to result 
from a combination of increased maternal adiposity and the insulin-desensitizing 
effects of hormonal products of the placenta [9]. Most cases of GDM result from 
beta cell dysfunction that occurs from secretions that arise in women with chronic 
insulin resistance and therefore seem to be related to type 2 diabetes [8, 9]. Insulin 
resistance is the key to the development of GDM: the main biological difference 
between women with and without GDM is a failure of insulin to rise in response to 
insulin resistance resulting from pregnancy. The strong family association between 
GDM and type 2 diabetes mellitus supports the notion that GDM is an inherent 
abnormality of the beta cell uncovered by the insulin-resistant state of pregnancy 
[11]. 
 
Usually GDM goes away after the baby is born [8]. Nevertheless, it makes a woman 
prone to GDM in her next pregnancy and is associated with long-term health risks 
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to the mother as well as the child, such as a predisposition to obesity, metabolic 
syndrome, and diabetes later in life [12-15]. A systematic review of 28 studies 
reported a cumulative incidence of diabetes ranging from 2.6% to over 70% in 
studies that examined women 6 weeks postpartum to 28 years postpartum 
[16].The risk was higher in women who required insulin and in those with a high 
body mass index (BMI) compared to those who did not require insulin or had a low 
BMI [16, 17]. As proper management and treatment of GDM prevents future 
complications, early diagnosis and identification of women at risk is essential. 
Trends and prevalence of GDM 
The prevalence of GDM may range from one to 23% of pregnancies depending on 
the population studied and diagnosis criteria used [18-21]. Ferrara reported that 
GDM prevalence has increased by 10 to 100% in several ethnic groups during the 
past 20 years. A significant increase in GDM prevalence was noted in the US and 
Australia, where a higher relative increase was observed in young women [22, 23]. 
In urban China, the adjusted prevalence of GDM was reported to have increased by 
2.8 times during the years 1999–2008 from 2.4% to 6.8% [24]. 
Gestational diabetes is also becoming a public health concern in Sub-Saharan Africa 
(SSA), although there are limited data available on the general population. A study 
in rural South Africa reported a prevalence of GDM of 1.5% and impaired glucose 
tolerance (IGT) of 7.3% [25]. In an Ethiopian rural community, GDM prevalence was 
3.7% [26].  In Tanzania, there is a paucity of current data on GDM prevalence in 
rural and urban areas, but about two decades ago, GDM was not detected [27]. 
More recently, however, it has been suggested that GDM may exist in rural East 
Africa because 3.1% of children are large for their gestational age [28]. Unlike in 
most developed countries where blood glucose level is assessed during routine 
antenatal clinic (ANC) visits, in Tanzania, and probably other SSA countries, priority 
is given to screening for anaemia, malaria, and HIV. In some clinics, glucose in urine 
is sometimes assessed. However, due to its low sensitivity and negative predictive 
value, it is not recommended for diagnostic purposes [29, 30]. If a patient has signs 
and symptoms of GDM, diagnosis and management may vary from one clinic to 
another depending on whether the clinic is in an urban or in a rural area, or in a 
private or a government hospital. 
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Risk factors for GDM 
Risk factors for GDM were summarized by Hayoush et al in 2004 and Petry in 2010 
as shown in Table 1.1. The most recognized risk factors include overweight or 
obesity, advanced maternal age, family history of type 2 diabetes, and history of 
GDM [19, 31-34].  
 
Table 1.1: Summary of risk factors for GDM 
 Obesity 
 Advanced maternal age 
 Excess weight gain in pregnancy 
 Family history of type 2 diabetes or GDM 
 Previous history of GDM 
 Previous congenital malformation, stillbirth, macrosomic baby, or caesarean 
section 
 Pregnancy-induced or pre-existing hypertension 
 Multiple pregnancy 
 Birth weight of the mother (high or low) 
 Increased iron store 
 Polycystic ovarian syndrome 
 Glycosuria 
 Smoking during pregnancy 
 High parity 
 Short stature 
 High intake of saturated fat 
 α-Thalassemia trait 
Adapted from Ben-Hayoush et al (2004) and Petry (2010) [35, 36] 
 
Other risk factors include previous macrosomia [13], previous still birth [37, 38], 
short stature [39, 40], physical inactivity [41], cigarette smoking [42], and dietary 
factors [43, 44]. In addition, infertility [45] and history of depression [46] have 
recently been reported as risk factors. There is growing evidence from systematic 
reviews that maternal birth weight, low or high, is also a risk factor for GDM [39, 
47]. A retrospective cohort study in Canada found that alcohol intake was 
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protective against GDM, although other confounding factors were not taken into 
account [48].  
GDM can vary according to ethnicity/racial differences, with some ethnic or racial 
groups being at relatively higher risk than others, irrespective of their BMI [49]. A 
large cohort study on Northern California from 1995 to 2006 examined 
racial/ethnic disparities in the prevalence of GDM by BMI. The authors reported 
that age-adjusted prevalence increased with increasing BMI category, but Asian and 
Filipino women had a GDM prevalence of 9.9% and 8.5%, respectively, at a 
relatively lower BMI of 22.0–24.9 kg/m2, whereas other ethnic groups had a high 
prevalence at a higher BMI category (>28 kg/m2) [50]. Furthermore, the risk of 
developing type 2 diabetes also varies according to ethnicity, and in the United 
States black women have the highest risk, even after adjusting for confounders 
[51].  
 
Overweight and obesity as a risk for GDM 
In several meta-analyses of primarily non-Asian populations, pre-pregnancy BMI 
has been shown to be the most important risk factor for GDM [52, 53]. Kim (2010) 
calculated the percentage of GDM attributable to overweight (15.4%), obesity 
(9.7%), and extreme obesity (21.1%) where the overall population attributable 
fraction was 46.2% [54]. In a recent meta-analyses of 20 relevant studies published 
between 1980 and 2006 [53],the risk of developing GDM was approximately 2, 3, 
and 6 times higher among overweight, obese, and severely obese women, 
respectively, as compared with normal-weight pregnant women, irrespective of the 
study characteristics. However, some studies in SSA did not find any association 
between BMI and GDM [25, 26, 55], probably due to genetics/ethnicity and/or 
differences in fat distribution [56, 57].  
 
In Tanzania, the prevalence of obesity is increasing, especially in urban areas. For 
example, the prevalence of overweight and obesity among women attending ANCs 
in Dar es Salaam increased from 3.6% in 1995 to 9.1% in 2004 [58]. Another cross-
sectional study in the urban area (Temeke district) in Dar es Salaam reported that 
the age-adjusted prevalence of obesity was 13% for men and 35% for women. 
Likewise, abdominal obesity was much higher in women (58%) compared to men 
(11%), and women had greater odds of having metabolic syndrome compared to 
male participants [59]. In Kinondoni district, also in Dar es Salaam, a community 
survey showed similar results; the overall prevalence of obesity was 19.2%, with 
more women being obese (24.7%) than men (9.0%) [60].  
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Obesity is thought to be a problem of affluence, and a higher prevalence is 
expected in urban compared to rural area. However, recent data show that rural 
areas are equally affected. A cross-sectional survey in three different seasons in 
rural Tanzania reported the prevalence of overweight and obesity in women to be 
16% and 6%, respectively, which was higher than the prevalence of underweight 
(7%) [61]. The link between obesity and GDM shows that, with this trend in obesity 
and overweight in Tanzania, GDM could also exist, contrary to what was reported 
20 years ago.  
 
Dietary intake 
Several studies have related dietary intake to the development of glucose 
intolerance in both the general population and pregnant women. In pregnant 
women, the diet before and/or during pregnancy may be protective or increase the 
risk for GDM. Large prospective cohort studies reported that pre-pregnancy diet – 
in particularly a diet low in fibre and high in glycaemic load [62], a high intake of 
protein, particular red meat[44, 63], or high intake of animal fat and cholesterol 
[64] – was associated with increased risk for GDM. On the other hand, higher intake 
of vegetable protein, specifically nuts, was associated with a significantly lower risk 
[63]. Interventional studies suggest that an increase in both fibre and low glycaemic 
carbohydrate sources in the diet decreases the pregnancy-associated progression 
of insulin resistance [65, 66].  
There is also growing evidence of an association between micronutrient status and 
GDM. For example, two studies reported that low maternal dietary vitamin C and 
low plasma ascorbic acid concentration increased the risk of gestational diabetes 
[67, 68]. Several studies associated vitamin D deficiency with increased risk of GDM 
[69-71]. Cho and co-workers reported only severe vitamin D deficiency to be 
associated with risk for GDM [71], and Parlea et al. found that lower vitamin D 
status in early pregnancy increased the risk for GDM independent of race, age, 
season, and maternal weight  [70]. However, in a nested case-control study, 
vitamin D deficiency was not found to be associated with GDM [72]. A case-control 
study in Sudan compared zinc and selenium levels among women with and without 
GDM, where the groups were matched in age parity, gestational age, haemoglobin, 
and BMI. This study reported no correlation between zinc or selenium and blood 
glucose levels [73].  
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Observational studies suggest that high iron intake during pregnancy is associated 
with the risk of GDM. The adjusted relative risk (RR) for GDM associated with a 
0.5mg per day increase in iron intake was 1.22 (95%CI; 1.10-1.36). No significant 
associations were observed between total dietary, non-theme, or supplemental 
iron intake and GDM risk[74]. 
There is a growing interest in considering the association between dietary pattern 
or food group consumption rather than individual food or single nutrient intake 
[75]. However, there are few studies on the association of dietary intake or dietary 
diversity with GDM. 
Anaemia in relation to GDM 
The prevalence of anaemia in pregnant women is estimated to be 38% worldwide. 
In Tanzania, a study conducted at Muhimbili National Hospital in 2009 reported 
that 68% of women attending ANCs were anaemic [76]. Maternal high or low 
haemoglobin concentration during pregnancy has been reported to increase the 
chance of unfavourable pregnancy outcomes such as low birth weight, preterm 
birth, and perinatal death [77-79]. Maternal death due to anaemia in Africa is about 
3.7% [80]. In Tanzania, maternal death due to anaemia is approximated to scale up 
to 15% because of malaria [81]. Anaemia is routinely assessed by measurement of 
haemoglobin (Hb) values during ANC visits, and women with Hb less than 8.5 mg/dl 
are usually referred to a clinician for further investigation and treatment. Although 
a low Hb level does not necessarily mean low iron levels, it is general practice to 
assess Hb levels for anaemia during pregnancy, and in rare cases, just the palms 
and the eyes are observed. The main cause of anaemia in most SSA countries is iron 
deficiency, but infections such as malaria, HIV, and parasites also contribute to 
anaemia during pregnancy [82]. 
A large body of evidence supports the hypothesis that excess iron contributes to 
chronic diseases by fostering excess production of free radicals. Elevated body iron 
stores are associated with increased risk of type 2 diabetes [83], insulin resistance 
[84], and GDM [85, 86]. Several case-control studies reported high serum ferritin in 
women with GDM compared to normal women [87, 88]. A case-control study 
assessing iron status in 34 women with GDM and 34 with normal glucose levels 
found that all biomarkers of iron status were higher in women with GDM than in 
their matched controls [89]. Although some studies have attempted to assess 
whether iron supplementation is linked to disease risk, particularly diabetes in 
women, the results have been inconsistent [90-92]. The effect of GDM on birth 
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outcome in Tanzania, where there is a high prevalence of anaemia and HIV 
infections during pregnancy, is rarely studied.  
 
GDM and birth outcome 
The common consequence of uncontrolled hyperglycaemia during the second 
and/or third trimesters of pregnancy is a high chance of delivery of a macrosomic 
baby, posing a risk to the mother and the child [93, 94]. Even when birth weights 
are similar in women with and without GDM, children born to women with GDM 
have increased body fat compared with infants of women with normal glucose 
tolerance [95, 96]. These babies are also at increased risk of future type 2 diabetes 
and other metabolic syndromes during childhood, adolescence, and adulthood; 
hence the lifecycle of diseases [97, 98]. Maternal outcomes associated with GDM 
are pregnancy-induced hypertension, preeclampsia, ante-partum haemorrhage, 
and caesarean section, and other neonatal complications include preterm birth, 
birth trauma, and congenital anomalies [99]. There is also at least a seven-fold 
increased risk of developing type 2 diabetes in women with GDM compared to 
those with normoglycemia[100]. There is a high chance of decreasing these risks if 
GDM is diagnosed and treated early enough. Randomized trials of glycaemic control 
in pregnancies complicated by GDM reveal decreased rates of macrosomia and 
shoulder dystocia among those treated [101, 102]. Early diagnosis and 
management would therefore reduce the risk of future complications related to 
GDM, as illustrated in Figure 1.1. 
 
Pregnancy, therefore, provides an important window of opportunity for early 
identification of high-risk women; thus, there is a need for better planning for 
prevention interventions at an early stage and for management of GDM.  
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Figure 1.1: Summary of potential lifetime intervention in the mother and/or infant for 
preventing later adverse outcomes (adapted from Symonds et al 2013) [103] 
 
Hypertensive disorders during pregnancy 
Hypertensive disorders during pregnancy (HDP) can be chronic when diagnosed 
before 20 weeks of pregnancy and persisting for more than two weeks after 
delivery, pregnancy induced, with or without preeclampsia, or preeclampsia. They 
usually occur late in pregnancy and are among the main contributors to maternal 
death in both developed and developing countries [104, 105]. GDM is one of the 
disorders associated with HDP and it increases the risk for chronic hypertension 
[106]. Other risk factors such as obesity, advanced maternal age, and multi-foetal 
pregnancy are common for both GDM and HDP. Like GDM, although non-chronic 
HDPs can resolve after delivery, they cause significant risk to the mother as well as 
the foetus and are a determinant of long-term diabetes development especially 
when they co-exist with GDM. In a population-based Canadian retrospective cohort 
study where women were followed up for 16.5 years, GDM led to a 12-fold risk 
increase for type 2 diabetes (hazard ratio (HR) 12.77; 95% CI, 12.44-13.10), but this 
risk increased further when GDM co-existed with preeclampsia (HR 15.75; 95% CI, 
14.52-17.07) or with gestational hypertension (HR 18.49; 95% CI, 17.12-19.96). The 
risk for diabetes with preeclampsia alone increased 2-fold (HR 2.08; 95% CI, 1.97-
2.19), similar to the risk increase with gestational hypertension alone (HR 1.95; 95% 
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CI, 1.83-2.07) [107]. In Tanzania, it is a requirement to take blood pressure 
measurements and to assess urine for protein during ANC visits. However, 
epidemiological studies on HDP and their determinants have rarely been reported.  
 
Screening and diagnosis of GDM 
Although the burden of GDM is acknowledged in most parts of the world, to date 
there are no agreed criteria for GDM screening and diagnosis. Some researchers 
recommend screening to start as early as 16 weeks of pregnancy [108], with a 
majority recommending screening at 24 to 28 weeks. Some organizations like the 
American College of Obstetricians and Gynaecologists (ACOG) and the UK National 
Institute for Health and Care Excellence (NICE) recommend selective screening 
based on risk factors [109, 110], whereas others like IADPSG, the Australasian 
Diabetes In Pregnancy Society (ADIPSI), the American Diabetes Association (ADA), 
and the Diabetes in Pregnancy Study Group India (DIPSI) recommend universal 
screening of all women [111-113]. 
The ‘how’ aspect is even more challenging, because recommendations for 
screening and diagnosis vary between medical organizations, and practice varies 
between health facilities even within the same country [114, 115]. The primary 
debate revolves around whether screening should consist of only fasting glucose, 
random glucose, or glucose challenge with 50 grams regardless of the last meal. 
Diagnostic criteria also vary, from using 100 g glucose or 75g glucose load, to 
whether to consider one reading or two readings [116]. An overview of the various 
diagnosis criteria is presented in Table 1.2. The simplest is the Indian guideline, 
which recommends a single glucose challenge test using 75g glucose load 
regardless of the last meal. It is reported to be cost effective, patient friendly, and 
an evidence-based approach to diagnosis of GDM [117]. The new ADA criteria 
propose either a one-step approach using 75 g of glucose, with plasma glucose 
measured at fasting and after two hours, or a two-step approach, where 50 g of 
glucose is given in a non-fasting state followed by 3-hour 100 g glucose for those 
with blood glucose ≥7.8 mmol/L [118]. In 2013, the WHO reviewed their 1999 
recommendation, and the new guideline distinguishes women with  previously 
undiagnosed type 2 diabetes opposed to GDM by setting a different cut-off for 
fasting and blood glucose levels after a 75 g glucose tolerance test (OGTT) [7]. This 
means that diabetes in pregnancy is defined as women with previously 
undiagnosed diabetes or fasting plasma glucose ≥7.0 mmol/L, 2-hour plasma 
glucose ≥11.1 mmol/L following 75 g OGTT, or random plasma glucose ≥11.1 
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mmol/L and diabetes symptoms, while lower cut-offs for fasting glucose levels and 
2-hour OGTT are used for diagnosis of GDM.  
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Table 1.2: Different diagnostic criteria used for GDM diagnosis  
Organization Screening test Blood glucose thresholds Diagnostic criteria 
WHO 1985 [119] 2 hr 75g OGTT Fasting ≥7.8 mmol/L  
2 hr ≥11.1 mmol/L  
 
At least one 
WHO 1999 [6] 2 hr 75g OGTT Fasting ≥7.0 mmol/L  
2 hr ≥7.8 mmol/L  
 
At least one 
WHO 2013 [7] 2 hr 75g OGTT Fasting: 5.1-6.9 mmol/L 
1 hr ≥10 mmol/L 
2 hrs ≥8.5 – 11.0 mmol/L 
At least one 
 
 
 
 
IADPSG[112] 75g OGTT Fasting 5.1-6.9 mmol/L  
1 hr ≥ 10 mmol/L 
2 hr ≥ 8.5-11.0 mmol/L 
 
At least one 
ADA [118] Two steps  
Step 1:  
50 g (1 hr ≥ 7.8 
mmol/L)  
 
Step 2 
100g OGTT 
Fasting 5.3 mmol/L 
1 hr ≥ 10.0 mmol/L 
2 hrs ≥ 8.6 mmol/L 
3 hr ≥ 7.8 mmol/L 
 
OR 
 
Fasting ≥5.8 mmol/L  
1 hr ≥ 10.6 mmol/L 
2 hr ≥ 9.2 mmol/L 
3 hr ≥ 8.0 mmol/L 
 
Two or more 
One step: 
75g OGTT 
Fasting ≥5.3 mmol/L 
1 hr ≥ 10 mmol/L 
2 hrs ≥8.6 mmol/L 
At least one 
ADIPSI [120] 75g OGTT Fasting ≥5.1 mmol/L  
1 hr ≥ 10 mmol/L 
2 hr ≥ 8.5-11.0 mmol/L 
 
At least one 
DIPSI [121] 
 
75g OGTT 2 hr ≥7.8  mmol/L   
 
Only one 
DPSG/EASD [122] 75g OGTT Fasting >5.2 mmol/L  
2 hr ≥ 9.0 mmol/L 
 
At least one 
 
 
 
Carpenter and 
Coustan[123] 
3 hr 100g OGTT Fasting ≥5.3 mmol/L  
1 hr ≥10 mmol/L 
2 hr ≥ 8.6 mmol/L 
3 hr ≥ 7.8 
At least two 
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NDDG [124] 3 hr 100g OGTT Fasting ≥5.8 mmol/L 
1 hr ≥10.6 mmol/L 
2 hrs ≥9.2 mmol/L 
3 hrs ≥ 8.0 mmol/L 
 
At least two 
WHO: World Health Organization; IADPSG: International Association of Diabetes and 
Pregnancy Study Group; ADA: American Diabetes Association; DIPSI: Diabetes in Pregnancy 
Study Group India; ADIPSI: Australian Diabetes Association in Pregnancy Society; DPSG: 
Diabetes Pregnancy Study Group; EASD: European Association for the Study of Diabetes; 
NDDG: National Diabetes Data Group 
 
 
Rationale  
About 20 years ago, GDM was not detected in rural and urban Tanzanian 
communities [27, 125]. Recently, an increase in the prevalence of type 2 diabetes, 
overweight, and obesity has been reported, with more women being overweight 
and obese than men [59, 60]. Although this is especially clear for the urban areas, 
the majority who reside in the rural areas may also be affected because the rural 
population is also under nutrition transition, i.e. there is increased intake of dietary 
fats and carbohydrate-rich foods as the main source of energy [61]. Since dietary 
energy intake, obesity, and diabetes are interlinked, GDM is therefore expected to 
exist in the Tanzanian community, although rarely studied.  
 
With the current prediction of increasing type 2 diabetes cases, even at a younger 
age, which could be related to GDM, controlling GDM would be of potential benefit 
to reduce the health care burden for treating people with type 2 diabetes, which is 
a costly lifetime condition. Diabetes testing is not a usual practice in Tanzania; 
priority is given to HIV/AIDS, malaria, and tuberculosis. GDM screening is not 
conducted in most health centres unless a patient has signs or symptoms of 
diabetes. Generally, there is limited up-to-date information on the prevalence of 
GDM, on its risk factors, and on related birth outcomes in Tanzania. 
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Research questions and thesis outline  
Overall objective  
The general objective of this study is to determine the prevalence of GDM and its 
determinants in urban and rural areas in Tanzania and in SSA. To achieve the 
overall objective, five research questions were formulated: 
 
1. Is gestational diabetes mellitus present in Tanzania? If yes, what are the 
determinants? 
As reported in chapter 2, 910 pregnant women attending ANCs in Dar es Salaam 
region representing the urban area (n=609) and in Morogoro region representing 
the rural area (n=301) area were assessed. Blood glucose levels were checked at 
fasting state and after a 75gr glucose challenge test. 
 
2. What is the burden and risk factors for gestational diabetes mellitus in Sub-
Saharan Africa? 
As reported in chapter 3, a systematic review and meta-regression was conducted 
by searching published articles from PubMed with a specific search in Google 
Scholar on the prevalence of, and/or risk factors for, GDM in any of the SSA 
countries. 
3. What is the prevalence and potential risk factor(s) for hypertension during 
pregnancy in women attending antenatal clinics in Tanzania? 
The prevalence of hypertension during pregnancy was determined and multiple 
logistic regression analysis was done to identify potential risk factors for 
hypertension during pregnancy (chapter 4). 
 
4. What are the maternal risk factors for macrosomia and low birth weight in 
Tanzania? 
This question is answered in chapter 5 where, after follow up of 609 urban women 
after delivery, birth outcome data for 466 women were available.  
5.  How is the Tanzania antenatal care system prepared to handle the rising 
challenge of diabetes in pregnancy? 
This question is answered in chapter 6. We reviewed published journal articles and 
other documents that discussed the quality of ANC in Tanzania and the strategies in 
place to improve maternal and child health. In addition, we conducted a survey in 
12 private and 12 government health facilities located in Dar es Salaam to assess 
 General introduction  
23 
 
the current screening practices and views of health care providers with regard to 
inclusion of blood glucose testing during maternal and childcare services.  
Finally, in chapter 7, the results of different studies are discussed in a broader 
context with an emphasis on methodological aspects and public health 
implications; recommendations and directions for future research are given. 
 
Study site and population 
The study was conducted in Dar es Salaam city, representing an urbanized 
population, and in the Kilombero district in Morogoro region representing a rural 
area (Figure 1.2).  
 
Location of the study area 
 
 
Figure 1.2: Map showing location of the study area, Tanzania 
 
Dar es Salaam is the largest city in the country with a population of about 4.3 
million, with the highest annual population growth rate of 6.5%, accounting for 10% 
of the Tanzania mainland population [126, 127]. The city is situated along the east 
coast bordering the western side of the Indian Ocean. Administratively, the city has 
three districts, namely, Ilala, Kinondoni, and Temeke. The districts are divided into 
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10 divisions, which are subdivided into 93 wards, 448 streets (mitaa), and 8 
constituencies. The health sector in the region provides health care services 
through hospitals, health centres, dispensaries, mobile health services, and 
referrals. The region has 449 health facilities (HFs), of which 28 are hospitals, 29 are 
health centres, and 392 are dispensaries.  
 
Kilombero is one of the seven districts of Morogoro region, located in South-
eastern Tanzania, about 230 km from Morogoro town and 420 km from Dar es 
Salaam. According to the 2012 population census, it had a total population of 
407,880, with an almost equal number of males and females, with a population 
growth rate of 2.4%,and an average household size of 4.3 [126]. The district has 58 
HFs, two of which are hospitals, six are health centres, and fifty are dispensaries. 
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Abstract 
Aim: To estimate prevalence of gestational diabetes mellitus (GDM) and associated 
determinants in urban and rural Tanzania. 
Methods: A cross-sectional study was conducted from 2011 through 2012 in 
selected urban and rural communities. Pregnant women (609 urban, 301 rural), 
who were not previously known to have diabetes, participated during usual ante-
natal clinic visits. Capillary blood samples were collected at fasting and two hours 
after 75gm glucose load and were measured using HemoCue. Diagnosis of GDM 
was made using World Health Organization (WHO) criteria.  
Results: Women in rural areas were younger (26.6 years) than in urban areas (27.5 
years). Mean gestational age, height, and mid-upper arm circumference (MUAC) 
were similar for the two areas. Overall prevalence of GDM averaged 5.9%, with 
8.4% in urban area and 1.0% in rural area. Prevalence of GDM was higher for 
women who had a previous stillbirth (OR 2.8, 95% CI 1.5-5.4), family history of type 
2 diabetes (OR 2.1, 95% CI 1.1-4.2), and MUAC above 28 cm (OR 1.9, 95% CI 1.1-
3.3), and lower for women with normal haemoglobin compared with anemia (OR 
0.45, 95% CI 0.22-0.93).  
Conclusions: Prevalence of GDM is higher than expected in urban areas in 
Tanzania, indicating an increasing population who are at risk for delivery 
complications and type 2 diabetes in Sub-Saharan Africa.  
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Introduction 
WHO defines GDM as carbohydrate intolerance resulting in hyperglycemia of 
variable severity with onset or first recognition during pregnancy [1]. The definition 
applies irrespective of whether or not insulin is used for treatment or the condition 
persists after pregnancy. Hyperglycemia usually disappears after the baby is born, 
but is associated with long term health risks to the mother and the child, such as 
predisposition to obesity, metabolic syndrome and diabetes later in life [2, 3]. 
Studies have shown that women with GDM had a 17 to 63% risk to develop 
postpartum diabetes within 16 years, and the risk is higher in women who required 
insulin and those with high body mass index (BMI) [4-6].  
 
Prevalence of GDM may range from 1% to 20% of pregnancies depending on the 
population studied [7-11]. A review by Ferrara showed that GDM prevalence has 
increased by 10 to 100% in several race groups during the past 20 years [12]. 
Higher prevalence was observed among US women from Asian and Philippino 
origin even at a lower BMI [13]. Community based studies have shown that the 
prevalence of GDM varies across urban, peri-urban and rural areas [9,14]. Factors 
contributing to GDM include family history of diabetes, age above 25 years and BMI 
above 25 [15,16]. Other factors include sedentary life style, pregnancy weight gain, 
maternal height, dietary factors and cigarette smoking [17,18] 
 
Studies on GDM in Sub-Saharan Africa are generally few. In a South African rural 
community a prevalence of 8.8% was reported and in rural Ethiopia the prevalence 
was 3.7% [7,19]. In Tanzania, data on the prevalence of GDM in rural and urban 
areas are scarce. About two decades ago, GDM was not detected in either rural or 
urban areas [20,21]. Ten years later, however, an increased prevalence of 
overweight and obesity was reported [22-24]. This implies that the prevalence of 
GDM may have increased as well, with accompanying increases in delivery 
complications and risk for type 2 diabetes later in life for the mother and the child. 
This cross-sectional study was done to estimate and compare prevalence of GDM in 
urban and rural communities. It is envisaged that the results of this study will 
provide essential information regarding the need to treat and prevent GDM in a 
country where there is also a challenge of combatting communicable infections and 
other forms of malnutrition as well as changing dietary and lifestyle practices which 
are risk factors for GDM. 
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Methods 
A cross-sectional study was conducted in Dar es Salaam city and Morogoro region 
from August 2011 through March, 2012. The study subjects were pregnant women 
aged 20 years or more and 20 gestational weeks or more, attending antenatal clinic 
(ANC) at selected six health facilities in Dar es Salaam city (urban) and two centers 
in Kilombero district in Morogoro region (rural).  
Six health facilities in the urban area and two health facilities in the rural area 
where chosen based on their high number of pregnant women attending ANC. All 
women aged above 20 years and with gestational age of 20 weeks or more, 
attending ANC during the survey period, were eligible to participate. Women with 
previously diagnosed diabetes and women from ethnic groups other than African 
were excluded. Other exclusion criteria included having chronic disease(s), such as 
sickle-cell anaemia or cancer, and having conditions that limit activities or normal 
dietary intake, such as bed-rest since conception. In two health facilities, on some 
days more women were attending ANC than researchers could handle and on these 
days, the first 15 women attending that day were included.  
During their normal ANC visit, the aim of the study, the procedure and the possible 
effects of oral glucose tolerance test (OGTT) were explained to the women, 
emphasizing that participation was voluntary. Tanzanian National Medical Research 
Institute (NIMRI) approved the study. Informed consent was sought from the study 
subjects before commencing of the study.  
With the assistance from reproductive, child health clinical officer, and the nurse in 
charge, eligible mothers were selected and invited to participate. In the urban area, 
715 mothers were invited, 637 qualified for the examination and 599 completed 
the OGTT. In the rural area, 400 eligible mothers were invited, 315 qualified for the 
examination and 301 completed an OGTT. Overall response rates were 89% and 
79% in the urban and rural area, respectively. 
 
Laboratory assessment 
Blood samples were taken using finger prick with a sterile lancet after cleaning the 
site with antiseptic alcohol swaps. Blood glucose was measured in capillary whole 
blood using HemoCue Glucose B-201 (Ängelholm AB, Sweden). On the first visit, 
mothers were asked to remain fasting overnight and return to the center for 
fasting blood glucose measurement, after a period of three days with usual eating 
habits and unrestricted activities. When a women’s fasting blood glucose exceeded 
the WHO limit for diabetes (n=12), they were asked to return a second time for a 
second fasting glucose measurement. When the fasting level was non-diabetic an 
Prevalence of gestational diabetes in Tanzania 
39 
 
OGTT was carried out. An anhydrous glucose (75 g) in 300 mls of water was given 
and blood glucose was assessed after two hours. Categorization of the women into 
GDM and normal was made using WHO diagnosis criteria for GDM (fasting and 2-
hour capillary whole blood). All those who met criteria for diabetes mellitus and 
impaired glucose tolerance (fasting ≥6.1 mmol/L or ≥2-hr 7.8 mmol/L) were 
classified as having GDM [1]. Women diagnosed with GDM were referred to the 
physician for further investigation, treatment and counseling. 
After taking the capillary blood sample for glucose measurement, another drop was 
taken for testing haemoglobin (Hb) levels. Hb concentrations were measured using 
HemoCueHb 201+ Haemoglobin photometer (HemoCue AB, Ängelholm, Sweden) 
and recorded to the nearest 0.1 g/dl.  Women were classified as anemic (<11 g/dl)  
or normal (≥11 g/dl) using Hb cut-off points suggested by WHO [25]. Further 
classification was in severe (<7 g/dl), moderate (7 to 9.9 g/dl), mild (10.0 to 10.9 
g/dl) and normal (≥11 g/dl).  
Women were asked to collect urine on the spot in a provided disposable plastic 
container. Urine samples were tested within one hour for glucose, ketones, 
leucocytes and protein using multistix made with color sensitive pads (urine strip 
10 C, Dialeb GmbH, Austria).  
 
Anthropometric assessment 
Systolic and diastolic blood pressure (BP) was measured from mid-upper-arm of the 
left side while the respondent was sitting and relaxed  for 10 minutes before the 
actual measurement, using a digital BP device (Microlife BPA100, Widnau, 
Switzerland). Two readings were taken with an interval of five to ten minutes, and 
the average systolic and diastolic BP was recorded in mmHg. Mothers with high 
blood pressure (defined as systolic ≥140 mmHg and diastolic ≥90 mmHg) were 
referred to see the doctor for further investigations and treatment. 
 
Height was measured without shoes and recorded to the nearest 0.1 cm, using 
height measuring board (Shorr productions, Maryland USA). Weight was measured 
to the nearest 0.1 kg using Seca Electronic Scale (Seca, Hamburg, Germany) and 
mid upper arm circumference (MUAC) was measured using a non-stretchable tape. 
Only less than half of the mothers could recall their pre-gestational weight. It is 
suggested that pre-gestational weight can be estimated if weight within fifteen 
weeks of pregnancy is available [26]. Since most of the women appeared late to the 
clinic (gestational age at booking ranged 8-32 weeks with the mean of 20 weeks), it 
was difficult to obtain pre-gestational weight. MUAC is known to be relatively 
Chapter 2    
40 
 
stable during the course of pregnancy and it was highly correlated with pre-
pregnancy BMI [27,28]. Women were, therefore, categorized according to MUAC as 
normal (MUAC <28 cm) and overweight (MUAC >28 cm). The categorisation based 
on the assumption that there was a negligible change of MUAC during pregnancy 
and that BMI = 0.1036*MUAC (mm) – 3.9 as suggested by Khadivzadeh [29]. 
 
Socio-demographic data and physical activity 
Data on socio-demographic and risk factors were retrieved from the ANC cards 
(gravida, gestational age based on last menstrual period, HIV status, previous 
stillbirths), or collected using pre-tested structured questionnaires (marital status, 
education level, source of income, family history of diabetes, and birth weight of 
the previous child).  
Physical activity was assessed retrospectively by using short form of the 
International Physical Activity Questionnaire (IPAQ) (revised version 2002) which 
was translated into Kiswahili. The IPAQ short form is designed and tested for adults 
(age range 15 to 69 years (IPAQ 2005). The IPAQ short form assess specific types of 
activity such as walking, moderate intensity activities and vigorous intensity 
activities. Women were asked to recall their activities from the day of the interview 
up to seven days backward. Data was reported as metabolic equivalents (METS) 
according to IPAQ scoring protocol which categorized women into high, moderate 
and low METS groups.  
 
Data analysis 
IBM SPSS Statistics version 19 was used for data analysis. Student’s t-test, Mann-
Whitney U test and Chi-square test were used for comparing selected 
characteristics variables between urban and rural women and among those with 
and without GDM. Variables which were found to be significantly different 
between the groups with and without GDM were analyzed using multiple logistic 
regression to determine the adjusted odds ratios. Differences between groups 
were considered significant if p< 0.05.  
 
Results 
In total, 910 women were studied (609 in urban and 301 in rural) and 900 
participated in an OGTT (599 in urban and 301 in rural) (Table 2.1). Mean 
gestational age (28.1 weeks), height (155.2 cm), and mid-upper arm circumference 
(27.2 cm) were similar for the two areas. Women in rural areas were younger (26.7 
years) than in the urban areas (27.5 years), were more in the high activity level and 
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had lower blood pressure levels. Mean fasting blood glucose for women in urban 
areas (4.6, SD 1.0 mmol/L) was greater than that for women in rural areas (4.0,SD 
0.8 mmol/L). Similarly, mean 2-hr blood glucose was greater for women in urban 
areas (6.1, SD 1.1 mmol/L) than for women in rural areas (5.1, SD 1.1 mmol/L).  
Table 2.1: Selected characteristics of women attending ANC in urban and rural 
areas, Tanzania 2011-2012 
Characteristic Urban (N =609) Rural (N=301) P-value 
Age (years) 27.5 (5.0) 26.6 (5.3) 0.017 
Gestational age (weeks) 28.1 (4.8) 28.2 (5.6) 0.684 
Height (cm) 155.3 (6.0) 155.0 (6.2) 0.461 
MUAC (cm) 27.3 (3.8) 27.1 (3.3) 0.461 
Systolic blood pressure (mmHg) 114.8 (15.2) 111.1  (11.5) 0.001 
Diastolic blood pressure (mmHg) 72.5 (11.4) 70.4 (9.5) 0.004 
Fasting blood glucose   (mmol/L) 4.6 (1.0) 4.0 (0.7) 0.001 
2-hour blood glucose (OGTT) 
(mmol/L)* 6.1 (1.1) 5.1 (1.0) 0.001 
Haemoglobin (g/dl) 10.1 (1.6) 10.0  (1.4) 0.119 
    
Education level    
Informal 38 (6.2) 44 (14.2) 
0.001 
Primary 420 (69.0) 199  (66.1) 
Secondary 131 (21.5) 47  (15.6) 
Post-secondary  20 (3.3) 11 (3.7) 
Source of income    
House works 293 (48.1) 87 (28.9) 
0.001 
Salary/wage 104  (17.1) 25 (8.3) 
Petty business 209 (34.3) 87 (28.9) 
Agriculture 3 (0.5) 102 (33.9) 
Gravidity    
Prime 171 (28.1) 82 (27.2) 
0.241 
Second 196 (32.2) 81 (26.9) 
Third 130 (21.3) 69 (22.9) 
Four or more 112 (18.4) 69 (22.9) 
Birth weight of the previous child 
Low birth weight (<2.5 kg) 22 (5.6) 15 (7.7) 
0.430 Normal birth weight (2.5 – 4 kg) 316 (80.8) 159 (81.5) 
High birth weight (≥4 kg) 53 (13.6) 21 (10.8) 
 
Level of physical activity 
 
   
High 171 (28.1) 126 (41.9) 
0.000 Moderate 314 (61.6) 139 (46.2) 
Low 125 (20.4) 36 (12.0) 
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Family history of type 2 diabetes      
Yes 88 (14.4) 25 (8.3) 
0.008 
No 521 (85.6) 276 (91.7) 
Previous still birth    
 
Yes 93 (15.3) 34 (11.3) 
No 
516 (84.7) 
267 (88.7) 
0.103 
 
Alcohol drinking     
Yes 77 (12.6) 23 (7.6) 
0.023 
No 532 (87.4) 278 (92.4) 
HIV status        
Positive 59 (9.7) 12 (4.0) 
0.002 
No 580 (90.3) 289 (96.0) 
Continuous variables are presented as Mean (SD) and categorical variables as absolute 
numbers (percentage); *N= 599 for urban and 301 for rural groups 
 
Family histories of diabetes, previous still births, alcohol drinking and positive HIV 
status were more prevalent in the urban than in the rural areas. Agricultural work 
was the main source of income in the rural women, housework in the urban 
women. Urban women had a higher educational level. Mean fasting and post-
glucose load levels, MUAC and Hb levels did not differ according to gestational age 
(Table 2.2).  
 
Table 2.2: Mean blood glucose levels, MUAC and Hb according to gestational age 
Variable 
Gestational age (weeks) 
P-value 
≤24 
(n=276) 
25-29  
(n=241) 
≥30 
(n=393) 
Fasting blood glucose 
(mmol/L) 
4.4 (1.1) 4.4 (0.9) 4.4 (1.0) 0.669 
Blood glucose 2-hr OGTT 
(mmol/L)* 
5.8 (1.1) 5.7 (1.2) 5.7 (1.3) 0.816 
MUAC (cm) 27.2 (3.6) 27.4 (3.6) 27.1 (3.6) 0.591 
Haemoglobin (g/dl) 10.3 (1.5) 10.0 (1.6) 10.0 (1.5) 0.176 
Data:  mean (SD); * n = 272 for gestational weeks ≤24, 238 for 25 to 29 gestational weeks 
and 390 for ≥30 gestational weeks 
 
Overall prevalence of GDM (n=54) averaged 5.9% (95% CI: 4.5 - 7.7), with 8.4% 
(95% CI: 6.3 - 10.9) in urban area and 1.0% (95% CI: 0.2 - 2.9) in rural areas (Table 
2.3). When using lower cutoff points for fasting blood glucose levels (5.1 mmol/L) 
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as suggested by the International Association of Diabetes and Pregnancy Study 
Groups (IADPSG), overall prevalence of GDM (n=108) is 13.1%, (95% CI: 11.4 – 
15.4), with 17.7% (95% CI: 14.9 – 20.9) in urban area and 3.7% (95% CI: 2.0 – 6.5) in 
rural areas.  
Table 2.3: Prevalence of GDM in ANC according to area of residence, Tanzania 
2011-2012 
Area N 
WHO criteria IADPSG** criteria 
Prevalence (%) 95% CI 
Prevalence 
(%) 95% CI 
Overall 910 5.9 4.5 - 7.7 13.1 11.4 – 15.4 
Rural  301 1.0* 0.2 - 2.9 3.7 2.0  – 6.5 
Urban  609 8.4* 6.3 - 10.9 17.7 14.9 – 20.9 
Data: n (%) 
* Comparing urban and rural GDM prevalence: p<0.001 
** Prevalence estimated using fasting blood glucose cutoff according to IADPSG  
(≥5.1 mmol/L). 
 
Mean and standard deviation of fasting glucose was 6.3 (SD 1.7) mmol/L for the 
GDM group and 4.3 (SD 0.8) mmol/L for the non-diabetic group (Table 2.4). 
Additionally, mean 2-hr glucose level was 8.2 (SD 1.6) mmol/L for the GDM group 
and 5.6 (SD 1.0) mmol/L the non-diabetic group. Glycosuria was observed in only 
two mothers, who were also identified as GDM using fasting blood glucose levels. 
Out of the 54 GDM cases eight, were identified based on fasting blood glucose 
levels only (twice fasting blood glucose ≥ 6.1 mmol/L). The others were identified 
with fasting blood glucose ≥ 6.1mmol/L and/or 2 hour blood glucose ≥ 7.8 mmol/L.  
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Table 2.4: Mean blood glucose levels at fasting and after oral glucose tolerance test 
among women without and with GDM 
Category Normal (N = 856) GDM (N = 54) P-value 
Fasting BG (mmol/L) 4.3 (0.8) 6.3 (1.7) 0.000 
BG 2-hr OGTT 
(mmol/L) 
5.6 (1.0) 8.2 (1.6) 0.000 
Identification procedure of the 54 women with GDM 
 n % 
Two FBG ≥ 6.1mmol/L, No OGTT 8 14.8 
One FBG ≥ 6.1mmol/L, RBG >11mmol/L 2 3.7 
FBG ≥ 6.1mmol/L and BG  2 hr OGTTG < 7.8 mmol/L 12 22.2 
FBG <6.1mmol/L and BG 2 hr OGTT ≥7.8 mmol/L 25 46.3 
First fasting ≥ 6.1mmol/L, Second fasting 
<6.1mmol/L, BG 2 hr OG TT≥7.8mmol/L  
7 13.0 
Total 54 100 
Mean blood glucose levels (SD) 
FBG: fasting blood glucose 
RBG: random blood glucose levels 
BG 2 hr OGTT:  blood glucose two hours after OGTT 
 
Prevalence of GDM was not significantly associated with mothers’ age, level of 
physical activity, gestational age, and gravida, birth weight of the previous child or 
previous caesarean section (Table 2.5). GDM showed an inverse association with 
Hb levels, with a higher prevalence in women with anemia (6.7%) compared to 
those without anemia (3.9%).  GDM was more prevalent in women with MUAC ≥28 
cm (8.0% vs 4.6%, p = 0.030), a positive family history of type 2 diabetes, (11.2% vs 
5.3%, p = 0.007) and in those with a previous still birth (12.6% vs 4.9%, p <0.001). 
To establish the independent association of these variables with GDM, we used 
multiple logistic regression. This showed that previous stillbirth was independently 
associated with a 2.8 times elevated risk of GDM (OR 2.8, 95% CI: 1.5-5.4). For a 
positive family history of type 2 diabetes the adjusted OR was 2.1 (95% CI: 1.1-4.2), 
and for high MUAC (≥ 28cm) 1.9 (95% CI: 1.1-3.3). Women with normal 
haemoglobin levels had a reduced risk of GDM compared to women with anaemia 
(adjusted OR 0.45, 95% 0.22-0.93). 
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Family history of type 2 diabetes      
Yes 88 (14.4) 25 (8.3) 
0.008 
No 521 (85.6) 276 (91.7) 
Previous still birth    
 
Yes 93 (15.3) 34 (11.3) 
No 
516 (84.7) 
267 (88.7) 
0.103 
 
Alcohol drinking     
Yes 77 (12.6) 23 (7.6) 
0.023 
No 532 (87.4) 278 (92.4) 
HIV status        
Positive 59 (9.7) 12 (4.0) 
0.002 
No 580 (90.3) 289 (96.0) 
Continuous variables are presented as Mean (SD) and categorical variables as absolute 
numbers (percent ge); *N= 599 for urban and 301 for rural groups 
 
Family histories of diabetes, previous still births, alcohol drinking and positive HIV 
status were more prevalent in the urban than in the rural areas. Agricultural work 
was the main source of income in the rural women, housework in the urban 
women. Urban women had a higher educational level. Mean fasting and post-
glucose load levels, MUAC and Hb levels did not differ according to gestational age 
(Table 2.2).  
 
Table 2.2: Mean blood glucose levels, MUAC and Hb according to gestational age 
Variable 
Gestational age (weeks) 
P-value 
≤24 
(n=276) 
25-29  
(n=241) 
≥30 
(n=393) 
Fasting blood glucose 
(mmol/L) 
4.4 (1.1) 4.4 (0.9) 4.4 (1.0) 0.669 
Blood glucose 2-hr OGTT 
(mmol/L)* 
5.8 (1.1) 5.7 (1.2) 5.7 (1.3) 0.816 
MUAC (cm) 27.2 (3.6) 27.4 (3.6) 27.1 (3.6) 0.591 
Haemoglobin (g/dl) 10.3 (1.5) 10.0 (1.6) 10.0 (1.5) 0.176 
Data:  mean (SD); * n = 272 for gestational weeks ≤24, 238 for 25 to 29 gestational weeks 
and 390 for ≥30 gestational weeks 
 
Overall prevalence of GDM (n=54) averaged 5.9% (95% CI: 4.5 - 7.7), with 8.4% 
(95% CI: 6.3 - 10.9) in urban area and 1.0% (95% CI: 0.2 - 2.9) in rural areas (Table 
2.3). When using lower cutoff points for fasting blood glucose levels (5.1 mmol/L) 
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Table 2.5: Number of prevalence cases of GDM in selected risk categories, 
Tanzania 2011-2012 
Variable 
Normal (N = 
856) GDM (N =54) 
P 
value 
Age (years)     
 < 25 years 302 (94.7) 17 (5.3) 
0.755  25 - 29 years 292 (94.2) 18 (5.8) 
 ≥30 years 262 (93.2) 19 (6.8) 
Gestational 
age (weeks)  
   
 ≤24 weeks 257 (93.1) 19 (6.9) 
0.722  25 - 29 weeks 228 (94.6) 13 (5.4) 
 ≥30 weeks 371 (94.4) 22 (5.6) 
Gravidity     
 Prime 236 (93.3) 17 (6.7) 
0.834  two 262 (94.6) 15 (5.4)  three 189 (95.0) 10 (5.0) 
 ≥four 169 (93.4) 12 (6.6) 
MUAC (cm)     
 (MUAC <28cm) 524 (95.4) 25 (4.6) 0.030 
 (MUAC ≥28cm) 332 (92.0) 29 (8.0) 
 
Level of physical activities 
 High 285 (96.0) 12 (4.0) 
0.243  Moderate 422 (93.2) 31 (6.8) 
 Low 149 (93.1) 11 (6.9) 
 
Birth weight of the previous child 
(kg) 
 
  
 Low birth wt. (<2.5kg) 
36 (97.3) 1 (2.7) 
0.648  Normal (2.5 - 3.9kg) 448 (94.3) 27 (5.7) 
 Large birth wt 
(≥4kg) 
71 (95.9) 3 (4.1) 
Previous Caesarean section    
 Yes 55 (91.7) 5 (8.3) 0.250  No 528 (95.1) 27 (4.9) 
Previous still 
 Yes  111 (87.4) 16 (12.6) 
0.001  No  
745 (95.1) 38 (4.9) 
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Family history of diabetes 
 Yes 100 (88.5) 13 (11.5) 0.007  No 756 (94.9) 41 (5.1) 
Anaemia    
 Anaemia (Hb<11g/dl) 601 (93.3) 44 (6.7) 0.098 
 Normal (Hb ≥ 11 g/dl) 248 (96.1) 10 (3.9)  
Data:  Given as absolute numbers (percentage)  
 
 
Discussion 
The main objective of this study was to assess prevalence of GDM and associated 
risk factors in urban and rural Tanzania. Prevalence of GDM was higher in the urban 
community, and much higher than observed in 1993. 
We used WHO criteria including fasting and 2-hr glucose levels, because this was 
more cost- effective and more applicable to our field setting than other criteria. 
According to WHO, GDM is considered present if capillary fasting blood glucose is ≥ 
6.1 mmol/l (110 mg/dl) or 2-hour glucose load ≥7.8 mmol/l (140 mg/dl) [1]. The 
American Diabetes Association (ADA) recommends two or more positive results: 
fasting blood glucose above 5.3 mmol/l (95 mg/dl)), 1 hour 75-g oral glucose load 
of 10 mmol/l (180 mg/dl) or 2 hour of >8.6 mmol/l (155 mg/dl) [30]. The 
International Association of Diabetes and Pregnancy Study Groups (IADPSG) 
proposed the cutoff point for fasting normoglycemia to be < 5.1 mmol/l (92 mg/dl) 
and 2 hour after 75 gm glucose load to be less than 8.5 mmol/l (155 mg/dl) [31, 
32]. A recent review concluded, however, that both WHO and IADPSG criteria 
similarly identified women at risk for adverse pregnancy outcomes, but that higher 
inconsistencies between studies were seen for IADPSG criteria [33]. This may be 
due to the low fasting glucose cutoff proposed by IADPSG. It is important to note 
that using IADPSG criteria, our prevalence would be more than two times higher 
than observed currently using WHO criteria. 
 
GDM is increasing in most countries around the world, the prevalence more likely 
to occur in older women, those with family history and high BMI, and varying 
among racial or ethnic groups [11,12]. In our study, overall prevalence of GDM was 
5.9%. This shows a large increase since the 1990’s, where 0% was reported in 
studies done in rural and urban Tanzania [20,21].  
Our result for the rural area indicates a low prevalence, 1%, compared to other 
studies in Sub-Saharan Africa. Higher prevalence were found in rural communities 
in South Africa (8.8%), Ethiopia (3.7%); and also in India (6.7 and 9.9%) [7,9,14,19]. 
The Ethiopian study, however, was done in a rural minority which suffered from 
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famine and droughts for long time, hence mothers had persistent chronic 
malnutrition which may have resulted in intrauterine growth retardation and 
subsequent high GDM risk [19]. A higher prevalence (11.6%)  was reported for 
urban setting in Nigeria, where women attending ANC during their third trimester 
were screened using WHO criteria [34].  
In general, the prevalence in our urban population is similar to that reported for 
developed countries [12]. Differences between rural and urban areas have been 
reported before, for example in India, where the overall prevalence of GDM was 
13.9%, varying between the urban (17.8%), peri-urban (13.8%) and rural areas 
(9.9%) [9].   
In our study the biggest difference between the rural and urban women was in 
educational level and occupation. About one third of the rural women were 
engaged in agriculture, which is energy intensive activity compared to urban 
mothers who were mostly doing light house works. Also a study in Cameroon 
reported higher physical activity energy expenditure by rural compared to urban 
population [35]. It is likely that changes in dietary habits and sedentary life styles 
observed in developing countries are responsible for the increase in obesity and 
metabolic syndrome [22, 36], as well as for the increase in GDM as we observed in 
Tanzania. Notably, the association of GDM and physical activity was not significant, 
possibly due to the method used to collect physical activity data. IPAQ was 
validated in African adult population [37], but not in pregnant women. Additionally, 
most of our women reported to have changed their activity pattern since they 
became pregnant. Higher physical activity level before or in early pregnancy was 
shown to be associated with reduced risk of GDM [38], but was not asked for in 
detail in our study.  
High GDM prevalence was observed in mothers with family history of type 2 
diabetes, previous stillbirth, high MUAC and anemia. Several other studies reported 
positive family history of type 2 diabetes to be associated with GDM [10,11]. In 
developing countries, however, most diabetic patients especially in the rural areas, 
die undiagnosed [22], hence more people could have unknown genetic disposition 
to diabetes, and we probably have underestimated the genetic potential. High 
MUAC is a reflection of high BMI [27]. We used it because BMI could not be 
estimated for most of the women, as they did not know their pre-pregnancy 
weight.  
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In addition, we observed that the prevalence of GDM was relatively higher in 
women with Hb< 11 g/dl. This was in contrast with other studies reporting that 
prevalence of GDM was reduced in women with low haemoglobin levels [39, 40]. 
However, in our population anemia was highly prevalent; 70% of the women had 
Hb levels lower than 11 g/dl. The most common cause of anemia in pregnant 
women in developing countries is iron deficiency [41]. Generally, diabetes is more 
often associated with iron overload, or hemochromatosis [42]. However, we cannot 
exclude that iron deficiency anemia is accompanied by other micronutrient 
deficiencies, like zinc deficiency, which may contribute to development of diabetes 
[43]. It is also possible that high observed anemia rate is caused by malaria [41], 
and our results reflect the co-occurrence of GDM and infections. Although 
advanced maternal age, gestational age, gravidity and macrosomia are known 
determinants of GDM [44], no clear association between GDM and these risk 
factors was observed.  
Our study was cross-sectional in nature and screening was done during ante natal 
clinic visits. Women were not followed until delivery, and women who might have 
un-diagnosed type 2 diabetes were classified as having GDM; however, these were 
likely few. We excluded women who were teenagers and who were less than 20 
weeks pregnant at time of the survey. GDM was, however, detected even in 
women aged less than 25 years and those with gestational age below 24 weeks, 
which indicates that universal screening, could be appropriate in the Tanzanian 
urban population.  
Conclusion 
The prevalence of GDM is higher than expected in the urban community in 
Tanzania. Although it is difficult to compare prevalence with other countries due to 
variations in screening methods and diagnostic criteria, there is a general 
observation that prevalence of GDM is increasing in Sub Saharan Africa. Proper 
planned screening, care and prevention strategies for GDM would improve 
maternal and child care and prevent future increase in type 2 diabetes in the 
country.  
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Abstract  
Aim: The prevalence of gestational diabetes mellitus (GDM) is increasing in most 
parts of the world, but less is known on the trend in Sub Saharan Africa (SSA). We 
therefore systematically reviewed publications on prevalence and risk factors for 
GDM in this region. 
Methods: We conducted a systematic search in PubMed and reviewed articles 
published until June 2014 and searched the references of retrieved articles. We 
explored sources of heterogeneity among prevalence proportions with meta-
regression analysis.  
Results: In 1069 articles retrieved, 22 studies conducted in six out of the 47 SSA 
countries were reviewed; half of them were from West Africa, specifically Nigeria. 
High heterogeneity between the studies was noted, which could not be 
significantly explained by study setting, population, diagnostic criteria, or time 
trend but we observed a relatively higher prevalence in studies done after the year 
2000, when women at risk were selected and when more current diagnostic criteria 
were used. Risk factors reported in more than one studies were overweight and/or 
obesity, family history for Type 2 diabetes, GDM in previous pregnancy, previous 
still birth, previous macrosomic child and age >30 years. 
Conclusions: There are few studies on prevalence and risk factors for GDM in SSA 
and heterogeneity is high. Prevalence was up to about 14% when high-risk women 
were studied. Preventive actions should be taken to reduce the short and long-
term complications related to GDM in SSA. 
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Introduction 
Recently, the global prevalence of hyperglycaemia in pregnancy in women 20-49 
years was estimated to be 16.9% and affecting 21.4 million live births, in 2013, and 
more than 90% of cases are estimated to occur in low and middle income countries 
[1]. The prevalence varies depending on the population and diagnostic criteria 
used. For example, it can be up to 100% higher when International Association of 
Diabetes in Pregnancy Study Group (IADPSG) criteria is used compared to 1999 
WHO criteria [2, 3]. Regarding the  estimated number of cases of hyperglycaemia in 
pregnancy, Africa ranks second after South East Asia [1]. Gestational diabetes 
mellitus (GDM) is the common cause of hyperglycaemia in pregnancy, accounting 
for about 90% of all diabetes during pregnancy [4]. Usually GDM goes away after 
the baby is born [5], nevertheless, it makes a woman prone to GDM in later 
pregnancies, and is associated with long term health risks to the mother as well as 
the child, such as predisposition to obesity, metabolic syndrome and diabetes later 
in life [6-9]. It is also associated with maternal and perinatal outcomes including 
pregnancy induced hypertension, preeclampsia, ante-partum hemorrhage, 
caesarean, preterm birth, birth trauma and congenital anomalies [10]. Like with 
type 2 diabetes mellitus, the highest prevalence in GDM may be seen in urban 
areas, partly due to increased overweight and obesity, and changes in dietary and 
physical activity patterns.  
Understanding the prevalence and the risk for GDM in Africa may provide evidence 
on how interventions should be targeted to reduce the magnitude of the problem, 
to improve maternal and child health and to reduce the burden of Type 2 DM in the 
region. 
A 2011 review on diabetes in Sub Saharan Africa (SSA) included the prevalence of 
gestational diabetes and reported it  to range from 0% to 9% based on five studies, 
the latest one being published in 2007 [11]. A more recent review on the 
prevalence of GDM in Africa reported data from 14 studies conducted in six African 
countries, and reported the prevalence to range from 0% in Tanzania to 13.9% in 
high risk women in Nigeria [12]. However, these reviews did not investigate the 
sources of heterogeneity between the studies. In addition, risk factors were not 
addressed.  
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We conducted a systematic review of literature to assess prevalence and trends of 
GDM, and to examine associated risk factors in published articles from original 
research conducted in SSA.  
Methods 
Search strategy and study selection 
We conducted a systematic literature search for published papers on gestational 
diabetes in SSA in PUBMED database, published until June 2014. A comprehensive 
key word search strategy for related terms associated with diabetes and pregnancy 
and Sub Saharan Africa, Sub-African region or country specific were used without 
language restriction (Appendix 3.1). To expand the search, wildcard symbol “*” was 
used and the search words or phrases were combined using Boolean operators. We 
included original published articles, short communications and letter to the editor 
for studies conducted in SSA and in humans, reporting prevalence and or risk 
factors for GDM in any SSA countries regardless of screening and diagnostic criteria 
used, and regardless of method used for selection of participants. Studies, which 
reported only type 1 and or type 2 diabetes, were excluded. A manual search for 
additional studies was done using references cited in the reviewed articles.  
Retrieved articles were transferred to EndNote library X7 where sorting for 
duplicates was performed. Titles and abstracts were screened by one author (AM) 
and when decision could not be made through the abstract alone, full articles were 
acquired for the third stage of screening. Full articles were examined for inclusion 
by two authors (AM, EF); disagreement was settled by discussion through joint 
review of the article. Two articles in French, reporting results of the same study, 
were translated by one investigator and reviewed for inclusion by the two authors. 
However, they were excluded as information to establish prevalence and diagnostic 
criteria was lacking. Number of articles not meeting inclusion criteria and reasons 
for exclusion are shown in Figure 3.1 and details in Appendix 3.2. When more than 
one article reporting similar results were retrieved, the most informative article 
was included. Authors were contacted to provide extra information, such as on 
sampling procedure, the year the study was done and or study setting, when 
deemed necessary.  
Data extraction 
The main findings regarding prevalence and risk factors for GDM were summarized 
by two authors in a prepared excel sheet under subheadings agreed upon by all 
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authors. The subheadings included study title, name and contact details for first 
author, country, year when the study was conducted (i.e. year study ended), year 
of publication sample size, study design, setting, study population, selection of 
participants, mean age, mean gestational age, exclusion criteria, screening method 
(random, fasting or OGTT), diagnostic criteria used, prevalence (including 95% CI), 
risk factors and key conclusion(s). When a single study reported more than one 
prevalence proportion, based on e.g. study setting or subsample, or compared 
diagnostic criteria, data were extracted separately and each was considered as 
separate study in meta-regression analysis. We used the definition of GDM 
according to WHO: carbohydrate intolerance resulting in hyperglycaemia of 
variable severity with onset or first recognition during pregnancy. The definition 
applies irrespective of whether or not insulin is used for treatment or the condition 
persists after pregnancy [13]. Prevalence proportions and confidence intervals (CI) 
reported by each study were recorded or calculated from the given information 
whenever necessary using spreadsheets for analysis of Epidemiologic Data by 
Rothman 2005 (version of Nov 10, 2005). We followed the PRISMA checklist 
(Appendix 3.3) for reporting of systematic reviews [14]. We developed a review 
protocol and immediately started the review; the protocol was not registered.  
 
Risk of bias 
Two reviewers assessed the studies included for the risk of bias independently and 
any disagreement was resolved through a discussion until they reached consensus. 
We adopted a risk of bias tool developed by Hoy et al [15] and modified it to suit to 
our study. The tool consists of ten items that assess sampling, attrition, 
measurement and reporting bias (Appendix 3.4a). The validity of methodology, 
appropriateness and reporting of results were assessed, and whenever the 
information provided was not enough to assist in making judgement for a certain 
item we agreed to grade that item with a “NO” meaning high risk of bias.  Each 
article was graded as either with low, moderate or high risk of bias depending on 
the number of items judged “yes”. We included all articles in the synthesis of 
results but only articles judged to have low or moderate risk of bias were included 
in meta-regression analysis (Appendix 3.4b). 
 
Statistical analysis  
We first performed arcsine transformation of the prevalence proportions to handle 
the distribution asymmetry [16]. Arcsine transformation was preferred to logit 
transformation because with very small prevalence proportions that approaches 
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zero, variance for proportions tend to be magnified, hence variance instability 
would persist even after logit transformation [16]. We used the random effect 
model to estimate prevalence proportion and the 95% CI. Heterogeneity between 
studies was assessed using I2 statistics [17]. In order to identify possible sources of 
heterogeneity among prevalences, mixed effect meta-regression models were used  
[18]. The variables considered were year the study/survey was completed (as a 
continuous variable); study setting (rural and mixed or urban), gestational age of 
the studied population during diagnosis (all trimesters or ≥24 weeks), diagnostic 
criteria (older and relatively recent), and population included (general or high risk). 
The older criteria included O’Sullivan, NDDG, WHO 1985 and own, while the more 
recent ones were ADA 2002, 2010, WHO 1999 and EASD. All statistical analyses 
were performed using R Studio 0.98 program utilizing R statistical language version 
2.15.3 using Metafor commands.  
 
 
Results 
A total of 1064 single articles and five articles from manual search were retrieved 
and transferred to EndNote library. Titles and abstracts were screened and 1031 
articles were excluded because they were either irrelevant, conducted outside SSA, 
referred to other types of diabetes or reviews (Figure 3.1). Thirty-seven articles 
were accessed as full paper and finally 22 articles of studies conducted from 1969 
to 2014 were included in the review (Table 3.1). Six articles reported more than 
one prevalence proportion (three compared less risk with high-risk groups, two 
compared diagnostic criteria and one compared rural and urban populations).  
With respect to risk of bias, ten studies were considered to have low risk of bias 
(45.5%), five (22.7%) were classified as having moderate risk of bias and seven 
studies (31.8%) had high risk of bias (Table 3.1 & Appendix 3.4b).   
Of all the included studies, eleven were conducted in West Africa, five in South 
Africa and six in East and Central Africa. Characteristics of included studies are 
shown in Table 3.1. Sample size for the individual studies ranged from 58 in a 
prospective cohort in urban Tanzania [19] to 12,030 in a retrospective review of 
delivery registries in Nigeria [20]. 
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Fig 3.1: Flow diagram for selection of the studies and reasons for exclusion
Relevant titles 
(n = 122) 
Records identified through 
database searching 
(n = 1064  ) 
Additional records identified 
through other sources 
(n = 5 ) 
Records screened 
(n =  1069 ) 
Records excluded 
after title screening 
(n =  947 ) 
Abstracts  excluded 
(n =  84 ) 
Full articles assessed 
for eligibility  
(n =38) 
Full-text articles excluded, 
 (n = 16) 
Reasons 
Review;  not relevant (GDM 
not reported); out of the 
region; repeated/published 
twice in different years; 
pregnant women with Type 
2 diabetes; comparison 
normal glucose range; 
survey of experts opinion 
regarding prevalence, 
screening and management 
of GDM; insufficient  data to 
establish prevalence; blood 
glucose measured after 
delivery/after foetal loss 
(Appendix 3.2) 
 
Studies included in the 
review 
(n =  22 ) 
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authors. The subheadings included study title, name and contact details for first 
author, country, y r when the study was conducted (i.e. year study ended), year 
of publication sample size, study design, setting, study population, selection of 
participants, mean age, mean gestational age, exclusion criteria, screening method 
(random, fasting or OGTT), diagnostic criteria used, prevalence (including 95% CI), 
risk factors and key conclusion(s). When a single study reported more than one 
prevalence proportion, based on e.g. study setting or subsample, or compared 
diagnostic criteria, data were extracted separately and each was considered as 
separate study in meta-regression analysis. We used the definition of GDM 
according to WHO: carbohydrate intolerance resulting in hyperglycaemia of 
variable severity with onset or first recognition during pregnancy. The definition 
applies irrespective of whether or not insulin is used for treatment or the condition 
persists after pregnancy [13]. Prevalence proportions and confidence intervals (CI) 
reported by each study were recorded or calculated from the given information 
whenever necessary using spreadsheets for analysis of Epidemiologic Data by 
Rothman 2005 (version of Nov 10, 2005). We followed the PRISMA checklist 
(Appendix 3.3) for reporting of systematic reviews [14]. We developed a review 
protocol and immediately started the review; the protocol was not registered.  
 
Risk of bias 
Two reviewers assessed the studies included for the risk of bias independently and 
any disagreement was resolved through a discussion until they reached consensus. 
We adopted a risk of bias tool developed by Hoy et al [15] and modified it to suit to 
our study. The tool consists of ten items that assess sampling, attrition, 
measurement and reporting bias (Appendix 3.4a). The validity of methodology, 
appropriateness and reporting of results were as essed, and whenever the 
information provided was not enough to assist in making judgement for a certain 
item we agreed to grade that item with a “NO” meaning high risk of bias.  Each 
article was graded as either with low, moderate or high risk of bias depending on 
the number of items judged “yes”. We included all articles in the synthesis of 
results but only articles judged to have low or moderate risk of bias were included 
in meta-regression analysis (Appendix 3.4b). 
 
Statistical analysis  
We first performed arcsine transformation of the prevalence proportions to handle 
the distribution asymmetry [16]. Arcsine transformation was preferred to logit 
transformation because with very small prevalence proportions that approaches 
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Study characteristics and prevalence of GDM according to region. 
West Africa: All the 11 studies published from1987 to 2014 were conducted in 
Nigeria. Most of these studies (9 out of 11) were done in tertiary university 
teaching hospitals [20-28]. The remaining two studies were done in selected clinics 
[29, 30]. One study compared prevalence using WHO and NDDG diagnostic criteria 
[23]; two studies compared women with and without risk factors [27, 31], and one 
study compared prevalence among women with and without macrocosmic child 
[26]. Prevalence of GDM ranged from 0.3% (95% CI: 0.2 – 0.5) in a descriptive 
cohort study which used modified O’Sullivan criteria for GDM diagnosis in 2000 
[22]to 13.9% (95% CI: 11.5 – 16.4) in high risk women referred for OGTT in a 
metabolic clinic at a university teaching hospital which used WHO criteria  in 2009 
[28]. The general trend shows increasing of GDM in Western Africa with time 
(Figure 3.2). 
 
 
 
 
 
 
 
 
 
South Africa:  The earliest study was done in 1969 [32] and the latest in 2010 [33]. 
The highest prevalence was observed in 1969, a study among Indian women with 
one or more risk factors (23%,95% CI 18.9-29.2) [32].  With regard to ethnicity, one 
study was done in a rural Bantu population [34], two in a mixed ethnic population 
[33, 35], one in subjects from Indian origin [32] and one among combined Indians 
origin and coloured minority [36]. In this sub- region, a general trend could not be 
Figure 3.2:  Trend of GDM in West Africa: Studies published from 1987 to 2014 
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clearly seen from the plot (Figure 3.3), likely because of the variation in ethnic 
groups studied. 
 
 
 
 
 
 
 
 
 
 
East and Central Africa: We reviewed six studies from this region; four of them 
were conducted in East Africa (Tanzania, and Ethiopia) [2, 19, 37, 38] and two in 
Central Africa (Cameroon and Congo) [39-41]. The oldest study was a community 
survey in rural Tanzania in 1989 reporting no existence of GDM in the study 
population (0%) [37], and the most recent study was published in 2014 on rural and 
urban clinics in Tanzania reporting a prevalence of 1% (95% CI: 0.2-2.9) and 8.4% 
(95% CI 6.3-10.9) respectively, using WHO diagnostic criteria [2]. Almost all the 
studies in East and Central Africa used WHO criteria except the study in Cameroon 
where American Diabetes Association (ADA) criteria was used and a cohort study in 
Congo where the authors reported using WHO criteria for diagnosis of GDM but 
blood glucose was measured fasting only. Studies done in early nineties showed 
low prevalence specifically compared to the studies done after 2010 (Figure 3.4). 
Figure 3.3: Trend of prevalence of GDM for the studies done in South Africa 
from 1969 to 2010 
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Screening practices and diagnosis criteria  
In most studies, screening was done at gestational age of ≥ 24 weeks. Except of one 
Tanzanian study, which excluded teenagers, other studies assessed women 
attending ANC regardless of their age using either universal or selective screening 
based on risk factors. The commonly used diagnosis criteria were WHO 1985/1999, 
reported in 13 studies, two studies used ADA criteria (either 2002 or 2010) and 
older ones applied NDDG (1979) or O’Sullivan criteria (1964), own local criteria or a 
combination of methods (Table 3.1). Thus, there were differences  in screening and 
diagnosis criteria used even among studies done within the same country and same 
period. Two studies compared two diagnosis criteria, WHO and NDDG/ EASD, 
where more women were diagnosed using WHO as compared to other two criteria: 
11.6% (95% CI 7.0-17.8) vs 4.6% (95% CI 1.7-9.8) in Nigeria [23] and 3.8 (95%CI 6.0-
10.5) vs 1.6% (95% CI 1.0-2.2) in South Africa [36].  
 
Figure 3.4:  Trend of GDM in East and Central: studies published from 1991 to 
2014  
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Sources of heterogeneity 
As indicated in the methods, only studies judged as having low or moderate risk of 
bias were included in the meta-regression. The meta-regression analysis showed 
high heterogeneity among the reviewed studies ( I2 = 100, p < 0.001), hence results 
could not be reliably pooled. None of the study characteristics were significantly 
associated with the prevalence (Table 3.2) and in all models the heterogeneity 
remained high (I2 =100%, p< 0.001). Mutual adjustment in meta-regression was not 
possible due to limited power.  
 
Table 3.2: Prevalence estimates according to  selected study characteristics  
Variable Prevalence (%) 
95% CI 
P- value* Lower Upper 
Study setting 
Rural 3.52 1.80 5.76 
0.59 
Urban  4.59 2.54 7.18 
Diagnostic criteria^ 
Old criteria^  4.25 2.58 6.30 
0.39 Recent 
criteria^^ 
5.11 
2.27 
8.95  
Population studied 
less risk 3.76 2.26 5.60 
0.21 
high risk 6.52 2.01 13.24 
Year the study was 
completed 
< year 2000 3.17 2.15 4.37 
0.37 
≥ year 2000 5.06 1.68 10.01 
Study sub-region 
West Africa 4.90 1.44 10.10 
0.40 
South Africa 3.92 2.23 6.04 
East and Central 
Africa 
3.25 1.27 6.03 
*P-value derived from meta-regression of prevalence on study characteristic. 
^ O’Sullivan, NDDG, WHO 1985 and own 
^^ ADA 2002, 2010, WHO 1999 and EASD 
 
Risk factors associated with GDM 
Associations with potential risk factors for GDM were reported in six studies; four 
from Nigeria [25, 27, 28, 30], one from Cameroon [40] and one from Tanzania [2]. 
The commonly reported risk factors were overweight or obesity classified using 
MUAC, BMI, or body weight, family history of diabetes, previous unexplained 
stillbirth, previous foetal macrosomia and age ≥30 years. Polyhydramnios and 
current glycosuria were reported to be associated with GDM in only one study 
(Table 3.3). In four studies, assessed associations were not adjusted for 
confounders. 
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Table 3.3: Risk factors associated with GDM as reported in the reviewed studies 
done in SSA published between 1969 and 2014 
Risk factors Study OR (CI) Comments 
MUAC ≥28cm 
 
Mwanri et al. 
(2014) 
1.9 (1.1 – 3.3) Adjusted for previous still 
birth, family history of 
diabetes, haemoglobin level 
BMI ≥ 25  Fawole et al. 
(2014) 
2.3 (1.0 - 5.1) Unadjusted OR 
Obesity (>90 kg) Anzaku & 
Musa (2013) 
NR Significantly associated with 
higher likelihood of GDM 
(Univariate)* 
Family history of Type 2 
diabetes mellitus 
Mwanri et al 
Mwanri et al. 
(2014) 
2.1 (1.1 – 4.2) Adjusted for previous still 
birth, MUAC and 
haemoglobin level  
Kuti et al. 
(2011) 
NR Independent association 
using multiple regression 
model 
Previous GDM Kuti et al. 
(2011) 
NR Independent association 
using multiple regression 
model 
Fawole et al. 
(2014) 
123.7 (58.2-
263.2) 
Unadjusted OR 
Previous/unexplained  
still birth 
Fawole et al. 
(2014) 
3.1(1.2-8.5) Unadjusted OR 
Mwanri et al. 
(2014) 
2.8 (1.5 – 5.4) 
 
Adjusted for MUAC, family 
history of diabetes, 
haemoglobin level 
Previous foetal 
macrosomia  
Fawole et al. 
(2014) 
 
3.9 (1.5-10.7) Unadjusted OR 
Fawole et al. 
(2014) 
 
3.25 (1.0-10.5) Adjusted for stillbirth, BMI, 
family history for type 2 
diabetes 
Anzaku & 
Musa (2013) 
 
11.1 (2.9-42.1) Adjusted for age, obesity, 
polyhydramnios, current 
glycosuria 
Age categories (≥35 
years) 
(Ewenighi et 
al. 2013) 
NR Significant using Chi-square 
test in three age categories 
Age ≥31 years 
 
Anzaku & 
Musa (2013) 
NR Significantly associated with 
higher likelihood of GDM 
(Univariate)* 
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Kuti et al. 
(2011) 
 Independent association 
using multiple regression 
model 
Age ≥30 years Jao et al. 
(2013) 
NR Adjusted for gestational age, 
family history of diabetes 
mellitus, HIV and pre-
pregnancy BMI  
Polyhydramnios Anzaku & 
Musa (2013) 
NR Significantly associated with 
higher likelihood of GDM 
(Univariate)* 
Current glycosuria (Anzaku & 
Musa (2013) 
NR Significantly associated with 
higher likelihood of GDM 
(Univariate)* 
* Significant in univariate analysis using chi-square or fisher tests; NR: not reported 
MUAC: mid upper arm circumference; OR: Odds Ratio; BMI: Body Mass Index 
 
Discussion 
Prevalence and trend of GDM 
We systematically reviewed existing literature to assess the prevalence of GDM and 
its associated risk factors in SSA. We identified 22 studies conducted in six out of 
the 47 SSA countries; half of the studies (eleven studies) were from West Africa, 
specifically Nigeria. We observed higher prevalence proportions, although not 
significantly so, when selective screening for only high-risk women was done 
compared to universal screening, when studies were more recent, or when more 
recent diagnostic criteria were used. 
Regardless of diagnostic criteria and study setting, we generally observed that the 
prevalence of GDM in SSA is in a range comparable to the 2 to 6% as reported for 
European countries [42], and even higher prevalence proportions were observed 
after selective screening. Our graphs also indicate that the prevalence of GDM 
increased with time. Similar results were reported in some Asian countries [43], 
where the evidence of increased in trend was noted in China. The observed 
increase in prevalence of GDM with time is likely to be due to changes in lifestyle 
associated with urbanization, including dietary changes and sedentary lifestyle, 
which lead to overweight and obesity. Obesity is rising in SSA as well [44]; and 
specifically, in Africa, it has been shown that obesity is more prevalent in women 
than in men [45].  Another factor could be that women are becoming pregnant at 
more advanced age, which has recently been reported for SSA as well [46, 47].  
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Different screening and diagnostic criteria were used and individual studies which 
compared different diagnostic criteria found that there were significant difference 
in prevalence when different criteria were used  [23, 36]. Variation in methods for 
screening and diagnosis of GDM was also reported among other European and 
Asian countries [42, 43]. However, our meta-regression analysis did not show 
statistically significant associations of diagnostic criteria with the prevalence of 
GDM.  
More studies were conducted in urban compared to rural areas, but the meta-
regression analysis did not show any influence of study setting on the prevalence of 
GDM. This may be in contrast to results from India, where higher prevalence 
proportions in urban compared to rural populations were reported [48, 49]. On the 
other hand, in Nigeria and Ethiopia prevalence proportions in rural populations 
were similar to those reported for urban communities[30, 34, 38]. This may be due 
to differences in diagnosis criteria used or other factors, such intrauterine exposure 
of the studied population to undernutrition which is an additional risk factor for 
GDM [50, 51].  
Risk factors  
The reported risk factors in our review were advanced maternal age, overweight 
and obesity, previous macrosomia, previous still birth, family history of Type 2 
diabetes mellitus, history of GDM in the previous pregnancies, polyhydramnios and 
glycosuria [2, 25, 27, 28, 30, 40]. This is similar to results of studies in other regions 
which reported advanced maternal age (>30 years), BMI and history of GDM as risk 
factors for GDM [52]. However, three of our reviewed studies did not find a 
significant association between GDM and family history of Type 2 diabetes [25, 30]. 
Undiagnosed diabetes is highest in SSA [1]; hence the family history for type 2 
diabetes might not be known to many people, thus underestimating the frequency 
of a positive family history.  
Three reviewed studies identified overweight or obesity as a risk for GDM, but all 
used different classifications. Of the two Nigerian studies, one used BMI cut off of 
≥25 kg/m
2[27] and the other one used weight of > 90kg [25]. A study in Tanzania 
used MUAC ≥28 cm [2]. In SSA setting, weigh measurements is not regularly done 
so it is difficult to estimate pre-pregnancy weight accurately from maternal recall. 
Another possible estimation would be BMI during first visit [53], but this is 
hampered by late initiation of antenatal clinic visits. There is a need for further 
studies to establish BMI cut offs during pregnancy and to better classify obese and 
overweight women during pregnancy in SSA. 
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Several studies in our review included selective screening based on risk factors, and 
reported that it was a common practice in e.g. Nigeria [22, 26, 28] and South Africa 
[33]. However, the criteria for identifying women at risk were different, even in 
studies done within the same country. Higher GDM prevalence in women with at 
least one risk factor compared to the general population implies that selective 
screening and or counselling of a high-risk group could be a better option in SSA as 
there are limited resources. However, if selective screening is to be used, there is a 
need for establishing simple, suitable and acceptable criteria for identifying women 
at risk in the SSA setting.  
Limitations 
This review presents up to date information on the prevalence and risk factors for 
GDM in SSA. Nevertheless, it is important to mention some limitations. Although 
most studies excluded known diabetes patients, due to the high prevalence of 
undiagnosed type 2 diabetes mellitus in the African population some women 
diagnosed as having GDM might have had type 2 diabetes mellitus, which was 
undiagnosed until when they were pregnant. In addition, very few studies indicated 
to have tested the women after delivery to investigate disappearance of GDM. In a 
rural Ethiopian study, among the 33 women diagnosed with GDM 15 (45%) had 
blood glucose levels in the diabetes range, 4 to 6 weeks postpartum, which shows 
that they might have had undiagnosed diabetes [38]. Hence, the true prevalence of 
GDM in SSA was probably overestimated. All reviewed studies were from six out of 
47 SSA countries, and half of them (50%) were from only one West African country, 
Nigeria. Hence, it is difficult to draw conclusion regarding the prevalence and risk 
factors for GDM in all SSA countries. In addition, we included studies done in 
different ethnic groups other than African. Gestational diabetes was noted to vary 
according to ethnicity and/or racial differences where some ethnic or racial groups 
were relatively at higher risk compared to others irrespective of their BMI [54]. 
However, this does not affect our conclusion. 
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Conclusion 
There are few studies on prevalence and risk factors for GDM in SSA. The 
heterogeneity of the reviewed studies was high, and could not easily be explained 
by selected study characteristics. The prevalence was as high as about 14% when 
women with at list one risk factor were studied, which indicates that preventive 
actions should be taken to reduce the short and long term complications related to 
GDM in SSA. 
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Appendix 3.1: Search terms used for final search 20th June 2014 
Search 
Add to 
builder 
Query 
Items 
found 
Time 
#9 Add Search ((((((((((((((diabet* OR hyperglycemi* OR 
glucose intolerance OR gestational diabetes OR 
impaired glucose tolerance OR diabetes mellitus 
OR postprandial glucose tolerance)) OR glucose 
tolerance)) AND (((pregnan*) OR gestation*) OR 
Gravid*))) OR gestational diabetes)) AND ((Africa* 
OR East Africa* OR North Africa* OR Central 
Africa* OR Angola* OR Benin* OR Botswan* OR 
Burkina Faso OR Burkinabe* OR Burundi OR 
Cameroon* OR Cape Verde* OR "Central African 
Republic" OR Chad* OR Comor* OR Congo* OR 
Cote d'Ivoire OR Ivory Coast OR Ivorian OR 
Djibouti* OR Dominica* OR Ecuador* OR Guinea* 
OR Eritrea* OR Ethiopia* OR Gabon* OR Gambia* 
OR Ghana* OR Kenya* OR Lesotho OR Liberia* 
OR Madagasca* OR Malawi* OR Mali* OR 
Mauritania* OR Mauritius OR Mozambi* OR 
Namibia* OR Niger* OR Rwanda* OR Senegal* 
OR Seychell* OR Sierra Leone* OR Somali* OR 
South Africa* OR Sudan* OR Swaziland OR Swazi 
OR Tanzania* OR Togo* OR Tonga* OR Uganda* 
OR Zambia* OR Zimbabwe*)))))) AND Human) 
NOT animal) 
1064 02:29:4 
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Appendix 3.2: Characteristics of studies that were excluded after full screening of 
the article 
Author (Year of 
publication) 
Title Reason for exclusion 
Macaulay et al (2014) Gestational diabetes mellitus in 
Africa: A systematic review 
Review  
Jiwani et al (2012)  Gestational diabetes mellitus: 
results from a survey of country 
prevalence and practices 
Worldwide survey, experts 
opinion regarding 
prevalence, screening and 
management of GDM 
Hall et al (2011)  Diabetes in Sub Saharan Africa 
1999-2011: epidemiology and 
public health implications. A 
systematic review 
Review  
Cpyrky et al (2008) Gestational diabetes mellitus - an 
analysis of risk factors 
Out of the region (Poland) 
Challis et al (2002)  
 
Gestational diabetes mellitus and 
foetal death in Mozambique: an 
incident case-referent study 
checked after delivery or 
child loss hence does not fit 
in to GD definition 
Van Bogaert (1998) Gestational diabetes mellitus--are 
African diagnostic criteria 
warranted? 
Diagnosis criteria 
Kinnear and Ojo (1966)  Pregnancy and diabetes in Nigeria Already known Type 2 
diabetic women 
Hailu and Kabede 
(1994)  
High-risk pregnancies in urban 
and rural communities in central 
part of Ethiopia 
Assessed risk factors 
associated with poor birth 
outcome but GDM was not 
assessed. 
Iloki et al (1993)  Diabetes and pregnancy in Africa: 
a pathology often not recognized 
Most information is missing  
Iloki et al (1992)  Diabetes and pregnancy in Africa. 
An often overlooked pathology 
Same data and content as 
Iloki 1993 
Fraser (1981)  The effect of pregnancy on the 
normal range of the oral glucose 
tolerance in Africans 
Compared blood glucose 
range in normal and 
pregnant women 
Gestational diabetes in Sub Saharan Africa 
81 
 
Notelovitz (1974)  
 
Gestational diabetes in general 
practice 
Not relevant, discussed the 
role of health practitioner 
Notelovitz (1970)  Diabetes screening during 
pregnancy 
Screening criteria 
Notelovitz (1970) 
 
The pregnant Bantu diabetic Not enough information to 
establish prevalence 
Notelevitz (1969). The pregnant Natal Indian 
diabetic 
Description of Indian 
diabetic pregnant women 
Notelovitz  (1968)  The pregnant Natal Indian 
diabetic-facts and fancies 
repeated results in another 
published paper by the same 
author 
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Appendix 3.3: PRISMA Checklist 
Section/topic  # Checklist item  
Reported 
on page 
#  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, 
or both.  
 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal 
and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review 
registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of 
what is already known.  
 
Objectives  4 Provide an explicit statement of questions being 
addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
 
Eligibility 
criteria  
6 Specify study characteristics (e.g., PICOS, length of 
follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria 
for eligibility, giving rationale.  
 
Information 
sources  
7 Describe all information sources (e.g., databases with 
dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
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Search  8 Present full electronic search strategy for at least one 
database, including any limits used, such that it could be 
repeated.  
 
Study 
selection  
9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
 
Data 
collection 
process  
10 Describe method of data extraction from reports (e.g., 
piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from 
investigators.  
 
Data items  11 List and define all variables for which data were sought 
(e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
 
Risk of bias in 
individual 
studies  
12 Describe methods used for assessing risk of bias of 
individual studies (including specification of whether this 
was done at the study or outcome level), and how this 
information is to be used in any data synthesis.  
 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, 
difference in means).  
 
Synthesis of 
results  
14 Describe the methods of handling data and combining 
results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
 
Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
 
Additional 
analyses  
16 Describe methods of additional analyses (e.g., sensitivity 
or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
 
RESULTS   
Study 
selection  
17 Give numbers of studies screened, assessed for eligibility, 
and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
 
Study 
characteristics  
18 For each study, present characteristics for which data 
were extracted (e.g., study size, PICOS, follow-up period) 
and provide the citations.  
 
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if 
available, any outcome level assessment (see item 12).  
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Results of 
individual 
studies  
20 For all outcomes considered (benefits or harms), present, 
for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence 
intervals, ideally with a forest plot.  
 
Synthesis of 
results  
21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency.  
 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias across 
studies (see Item 15).  
 
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., 
sensitivity or subgroup analyses, meta-regression (see 
Item 16)).  
 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of 
evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, 
users, and policy makers).  
 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk 
of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
 
Conclusions  26 Provide a general interpretation of the results in the 
context of other evidence, and implications for future 
research.  
 
FUNDING   
Funding  27 Describe sources of funding for the systematic review 
and other support (e.g., supply of data); role of funders 
for the systematic review.  
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Appendix 3.4a: Risk of bias assessment tool: Adapted from the Risk of Bias Tool for 
Prevalence Studies developed by Hoy, Brooks, Woolfe et al. (2012) 
Name of the author and year of 
publication......................................................................................... 
Risk of Bias Item Answer:  
Yes (Low Risk) or No (High risk) 
External Validity  
1. Was the study target population a close representation 
of the national pregnant population in relation to 
relevant variables? 
 
2. Was the sampling frame a true or close representation 
of the target population? 
(risk factors used appropriate?) 
 
3. Was some form of random selection used to select the 
sample, OR, was a census undertaken? 
 
4. Was the likelihood of non-participation bias minimal? 
(i.e. ≥75% response rate)? 
 
Internal Validity  
5. Were data collected directly from the subjects? (as 
opposed to medical records) 
 
6. Were acceptable diagnostic criteria for GDM used?  
7. Was a reliable and accepted method of testing for 
blood glucose utilised? 
 
8. Was the same mode of data collection used for all 
subjects? 
 
9. Was GDM tested for within the advised gestational 
period of 24-28 weeks? 
 
10. Were the numerator(s) and denominator(s) for the 
calculation of the prevalence of GDM appropriate? 
 
11. Summary item on the overall risk of study bias 
LOW RISK OF BIAS: 8 or more “yes” answers. Further 
research is very unlikely to change our confidence in the 
estimate. 
MODERATE RISK OF BIAS: 6 to 7 “yes” answers. Further 
research is likely to have an important impact on our 
confidence in the estimate and may change the estimate. 
 
HIGH RISK OF BIAS: 5 or fewer “yes” answers. Further 
research is very likely to have an important impact on our 
confidence in the estimate and is likely to change the 
estimate. 
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Abstract 
Aim: Hypertensive disorders of pregnancy (HDP) is one of the leading causes of 
maternal and perinatal mortality worldwide. This study examined prevalence and 
potential risk factors for HDP among pregnant women in Tanzania.   
Methods: We examined 910 pregnant women, age ≥20 year, mean gestational age 
27 weeks, from rural (n=301) and urban (n=609) areas during their usual antenatal 
clinic visits. Hypertension was defined as clinic SBP ≥140 mmHg or DBP ≥90 mmHg. 
Dietary assessment included dietary diversity score (DDS) using 16 food groups. 
Multiple logistic regression analysis was used to assess the independent association 
of risk factors associated with prevalence of hypertension.   
Results: Hypertension was observed in 70 women (7.7%). After excluding the 8 
women who were already on management, 62 women (6.9%) had HDP, prevalence 
being higher in urban (8.1%) compared to rural area (4.4%). For the urban area, 
mother’s age (OR 1.10; 95% CI 1.03 – 1.20), gestational age (OR 1.10; 95% CI 1.02-
1.20), mid-upper arm circumference (MUAC) (OR 1.13; 95% CI: 1.01-1.23), DDS (OR 
1.31; 95%CI 1.20-1.60) and being HIV positive (OR 2.40; 95% CI 1.10-5.18) were 
independently associated with HDP. When adjusted for proteinuria, associations 
with HIV status and MUAC weakened. In the rural area, HDP risk increased with age 
and gestational age.  
Conclusion: Prevalence of HDP was higher in urban compared to rural area, which 
points at high risk for preterm delivery, low birth weight and future cardiovascular 
diseases. The observed risk factors identify risk groups to be screened and targeted 
for prevention. The role of HIV status needs to be further explored. 
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Introduction 
Hypertensive disorders are the most common medical problems in pregnancy and 
account for about 10% of maternal deaths worldwide. They affect women in every 
region, causing 9% of maternal deaths in Africa and Asia, over 16% in industrialized 
countries and more than 25% in Latin America and the Caribbean [1]. Hypertension 
during pregnancy is usually thought of as a short term problem that resolves itself 
after delivery but still carries significant risk to the mother such as risk of 
recurrence, cardiovascular complications, stroke and renal disease [2, 3]. It has also 
been associated with elevated risk of preterm birth, low birth weight and low Apgar 
score [4]. It is estimated that approximately 30% of hypertensive disorders of 
pregnancy (HDP) are due to chronic hypertension and 70% are due to gestational 
hypertension [5]. However, due to low screening and poor health seeking 
behaviour in Tanzania, it is likely that the majority of the pregnant women do not 
know their hypertension status before pregnancy.  
Risk or predisposing factors for HDP include older maternal age (above 30 years), 
multiple pregnancy, diabetes, obesity, family history of preeclampsia and excessive 
weight before or during pregnancy [6-9]. Rural residence, low socioeconomic 
status, urinary tract infection, inter-pregnancy spacing and stress were also 
reported as risk factors [6]. In addition, hypertension was associated with placental 
malaria infection and non-proteinuric hypertension in women living in malaria-
hypo endemic area [10]. However, risk factors for HDP may differ among various 
ethnic groups and by degree of prenatal care [8, 11]. Although Antenatal clinic 
(ANC) attendance in Tanzania is generally high (96%), only about two third (68%) of 
the pregnant women had their blood pressure measured and about half (52%) had 
their urine collected [12]. There is limited information on HDP and possible 
attributable factors in Tanzania.  
Like HDP, prevalence of gestational diabetes mellitus (GDM) is increasing 
worldwide [13] and it is also becoming a public health concern in Sub Saharan 
African countries where prevalence was reported to vary across the region and 
have been increasing in the past decade [14, 15]. Some studies suggest that 
gestational diabetes, glucose intolerance and insulin resistance have a role in HDP 
[16,17].  Nevertheless, few studies in Sub Saharan Africa explored association of 
blood glucose level and HDP in an African population.   
This study aimed at assessing the prevalence of HDP among rural and urban 
women attending ANC in randomly selected centres and to determine the 
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association between GDM and other factors with HDP.  The results will help in the 
surveillance and management of mothers at risk and hence reduce maternal and 
child morbidity and mortality associated with HDP. 
Methods 
Study design and setting 
A cross sectional study was conducted from August 2011 through May 2012 in 
selected health facilities in Morogoro and Dar es Salaam regions. The study 
population was women attending ANC in two selected health facilities from each of 
the three districts in Dar es Salaam region and two health facilities in Kilombero 
district, Morogoro region. A total of 910 women, at gestational age of 20 to 36 
weeks were assessed during ANC visits. Women with serious medical conditions, 
those with known type 1 or type 2 diabetes mellitus, those who were hospitalised 
and women who could not tolerate oral glucose tolerance test (OGTT) were 
excluded. In assessing the risk factors, we also excluded eight women who were 
hypertensive before pregnant since they might have changed their lifestyle hence 
modified risk factors. 
 
Data collection 
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) was measured 
from mid-upper-arm of the left side while the respondent was sitting and relaxed 
for 10 minutes before the actual measurement, using a digital blood pressure (BP) 
device (Microlife BPA100, Widnau, Switzerland) which was validated [18]. Two BP 
measurements were done within an interval of five to ten minutes. Average systolic 
and diastolic BP were recorded in mmHg and were used for analysis. Hypertension 
during pregnancy was defined as SBP of 140 mmHg or higher and DBP of 90 mmHg 
or higher measured after 20 weeks of gestation in women previously unknown to 
be hypertensive. Women with HDP were referred to see the doctor for further 
investigation and treatment.  
Women were requested to collect midstream urine on the spot in a provided 
sterilized disposable plastic container. Urine samples were tested within one hour 
for glucose, ketones, leucocytes and protein using dipstick made with a color 
sensitive pads (urine strip 10 C, Dialeb GmbH, Austria). Women were considered 
with proteinuria when the dipstick was +1 or more in the absence of urinary tract 
infection [19].  
Blood glucose was measured in capillary blood at fasting state and at two hours 
after 75 gram oral glucose tolerance test using HemoCue Glucose B-201 
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(Ängelholm AB, Sweden) and recorded in mmol/L during the usual visit for ANC. 
Diagnosis of GDM was based on WHO criteria [15]. 
Haemoglobin (Hb) concentrations were measured using HemoCueHb 201+ 
Haemoglobin photometer (HemoCue AB, Ängelholm, Sweden) and recorded to the 
nearest 0.1 g/dl.  Women were classified as having severe (<7 g/dl), moderate (7 to 
9.9 g/dl), mild (10 to 10.9 g/dl) anemia or having normal Hb (≥11 g/dl).  
Dietary assessment was done using a validated dietary diversity questionnaire [20]. 
Respondents were asked to recall all the foods consumed in the previous 24 hours 
immediately prior to the survey. They were prompted to include all snacks and 
foods eaten outside home and details of the ingredients added to each food were 
noted. Consumption of a particular group scored 1, and if a group was not 
consumed a score of 0 was given. Dietary diversity score (DDS), an indicator of 
nutrient adequacy and a proxy measure of nutritional quality of an individual’s 
diet[21, 22], was defined as a total count of different food groups consumed in the 
past 24 hours without considering the amount or portion size. Number of food 
groups used in dietary diversity can vary according to the study objective, and 
currently there is no internationally recommended food group list to be included in 
the score at individual level for different age/sex groups [20]. We used the 
questionnaire with 16 food groups to capture micronutrients intake as well as 
consumption of sweets and beverages which are known to be associated with 
metabolic syndrome. All foods consumed were categorized in one of the 16 food 
groups depending on the nutrient composition in the food composition table [23]. 
The food groups included cereals; white roots and tubers; vitamin A rich vegetables 
and tubers; dark green leafy vegetables; other vegetables; vitamin A rich fruits; 
other fruits; organ meat; flesh meat; eggs; legume, nuts and seeds; fish and sea 
foods; milk and milk products; oil and fats; sweets; spices, condiments and 
beverages. DDS was divided into three categories and classified as low (0 to 5), 
medium (6 to 8) and high (9 to 16). 
Women were interviewed about their age, marital status, education level, 
occupation and family history of diabetes using a pre-tested structured 
questionnaire. Information on current pregnancy, gestational age, parity and HIV 
status was obtained from ANC card and or interviews. Multipara mothers were 
asked to recall age of the previous last child and this was verified through growth 
monitoring card during the next visit. The information on age of the previous child 
or years after the last pregnancy was used to estimate child spacing or inter-
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pregnancy duration. Gestational age was estimated using the first date of last 
normal menstrual period which is the commonly used method in most antenatal 
clinics in Tanzania, and ultrasound was not done.  
Physical activity was assessed retrospectively by using the short form of the 
International Physical Activity Questionnaire (IPAQ) which was translated into 
Kiswahili. The IPAQ short form is designed and tested for adults aged 15 to 69 years 
[24] The IPAQ short form assess specific types of activity such as walking, moderate 
intensity activities and vigorous intensity activities. Women were asked to recall 
their activities from the day of the interview up to seven days backward. Data was 
reported as metabolic equivalents (MET-minutes per week) according to IPAQ 
scoring protocol which categorized women into high, moderate and low METS 
groups [25].  
Anthropometric measurements were taken during antenatal visit. Weight of the 
mothers (in kg) was measured using Seca electronic scale (SecaGmbh and Co.kg 
22061, Hamburg, German). Height (in cm) was measured without shoes using 
height measuring board (Shorr productions, Maryland USA). Weight was recorded 
as for the first visit for women whose visit to ANC was the first during that pregnant 
and those who had previous visit, weight during first visit was retrieved from ANC 
card and used to calculate BMI at booking. Mid-upper-arm circumference (MUAC) 
was measured using non-stretching MUAC tape and recorded to the nearest cm. 
Like other developing countries, most Tanzanian women could not recall their pre-
pregnancy weight. Additionally, weight gain monitoring is not possible due to 
limitations of facilities and staff and due to late start of ANC visits [12].  MUAC was 
therefore used as a proxy for pre-pregnancy BMI. MUAC is known to be relatively 
stable during the course of pregnancy and was highly correlated with pre-
pregnancy BMI in a previous study [26]. MUAC was further divided into quartiles 
which were numbered sequentially from Q1 (the group with lowest MUAC values 
≤24.5 cm) to Q4 which was the group with highest MUAC values (≥29.0 cm).  
Ethical consideration 
The protocol of this study was approved by Tanzania National Institute of Medical 
Research and the respective District Authorities. The participants were informed 
about the study, its objectives, expected outcomes, benefits and risks for their 
participation, and ensured confidentiality. Informed verbal or written consent was 
obtained from the participants and in some cases from their partners. All 
information obtained from the participants was confidential and all who were 
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identified with any condition requiring medical attention were referred to medical 
doctor in charge of the reproductive and child health clinic for further assessment 
and treatment. 
 
Data Analysis 
Data were entered, cleaned and analysed using IBM SPSS Statistics version 19. 
Maternal socio-demographic characteristics and biosocial data were compared 
between those living in rural and urban areas. In addition to descriptive analysis, 
categorical variables were compared using Chi-Square test while comparison of 
means was done using Student’s t-test. Univariate analysis was done to identify 
variables associated with presence of HDP. Crude odds ratio (OR) and OR adjusted 
for age, gestational age and/or MUAC were calculated. Multiple logistic regression 
analysis was done to assess independent association of selected variables with 
HDP. All variables with p-value of ≤0.125 in the univariate analysis were entered in 
the model and analysed using backward elimination. Presence of proteinuria was 
included in a second multiple regression model. Data were stratified according to 
residence. In the analyses age, gestational age, number of years since last 
pregnancy, MUAC and DDS were treated as continuous variables. 
 
Results  
Majority of the studied women were married (83%), and less than a quarter (23%) 
had secondary education or higher. Pregnant women in the rural area were 
younger, had more number of children, higher mean gestational age at first visit 
and lower BMI at booking (Table 4.1). The mean SBP was 111 mmHg (95% CI: 109.8 
– 112.5) vs 114.6 mmHg (95% CI: 113.6 -116.0) in rural compared to urban women; 
DBP was 70.2 mmHg (95% CI: 69.3-71.5) vs 72.4 mmHg (95% CI: 71.6-73.4). Mean 
DDS in urban women (6.7; 95% CI 6.6-6.9) was significantly higher than in rural 
women (6.4; 95% CI:6.3-6.6), whereas mean MUAC and gestational age were 
similar in both groups. Twelve women (4.0%) in rural area and 59 women (9.8%) in 
the urban area were HIV positive. About two out of five women in the rural area 
and one out of five women in the urban had high physical activity level. Alcohol 
drinking was more common in the urban (12%) compared to rural area (8%). 
Smoking is uncommon for Tanzania women, only seven women reported to smoke 
and they were all from the urban area 
.
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Table 4.1: Characteristics of the studied women in urban and rural areas 
(2011/2012 survey, Tanzania) 
Characteristic 
Rural (n=298) Urban (n=604) P-
value Mean 95%-CI Mean 95%-CI 
Age (years) 26.6 26.0 - 27.2 27.5 27.1 - 28.0 0.016 
Current gestational age 
(weeks) 28.1 27.6 - 28.8 28.1 27.7 - 28.5 0.770 
1st visit Gestational age 
(weeks) 21.0 20.0 - 21.0 18.0 17.6 - 18.3 0.000 
Parity 2.6 2.4 - 2.8 2.4 2.5 - 2.5 0.046 
MUAC (cm) 27.1 26.7 - 27.5 27.2 26.5 - 27.6 0.463 
BMI (Kg/m2) 26.1 25.6 - 26.5 26.7 26.3 - 27.0 0.045 
Systolic blood pressure 
(mmHg) 111.0 109.8 - 112.4 114.6 113.6 - 116.0 0.000 
Diastolic blood pressure 
(mmHg) 70.3 69.3 - 71.5 72.4 71.6 - 73.4 0.007 
Haemoglobin level (mg/dl) 9.9 9.7 – 10.1 10.1 9.9 – 10.2 0.130 
Fasting blood glucose 
(mmol/L) 4.0 3.9 - 4.1 4.6 4.5 - 4.7 0.000 
2-hr blood glucose (mmol/L) 5.1 4.9 - 5.2 6.1 5.9 - 6.2 0.000 
DDS16 6.4 6.3 - 6.6 6.7 6.6 - 6.9 0.006 
 n % N %  
Marital status      
Married 277 93.0 539 89.2 0.074 Single 21 7.0 65 10.8 
Education level      
Informal 43 14.4 36 6.0 
0.000 Primary 197 66.1 418 69.2 Secondary and post-
secondary 58 19.5 150 24.8 
Occupation      
House work 87 29.2 292 48.3 
0.000 Formal employment 25 8.4 1.2 16.9 Petty business 87 29.2 207 34.3 
Agriculture 99 33.2 3 0.5 
DDS      
Low 75 25.2 122 20.2 
0.008 Medium 202 67.8 400 66.2 
High 21 7.0 82 13.6 
METS      
Low 35  22.3 122 28.1 
0.000 Medium 137 30.5 312 51.7 
High 126 42.6 170 20.2 
HIV Positive 12 4.0 59 9.8 0.003 
Proteinuria 2 0.7 67 11.1 0.000 
Alcohol drinking (yes) 23 7.7 74 12.3 0.039 
Values for continuous data are Mean (95% CI of the mean), categorical data are n (%), P 
values are from t-test and Chi-square test 
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Prevalence of HDP was 7.7% (95% CI 6.0 – 9.4). After excluding the 8 women who 
were already on management and hence probably modified their risks, 62 women 
(6.9%; 95%CI; 5.2 – 8.5) had HDP, the prevalence being higher in the urban (8.1%; 
95% CI: 6.8 – 11.4 ) compared to the rural area (4.4%; 95% CI: 2.1 – 6.7) (Table 4.2).  
The mean SBP for the hypertensive group was 146.6 (SD 16.9) mmHg and ranged 
from 140 to 189 mmHg; mean DBP was 97.7 (SD 10.0) mmHg and ranged from 90 
to 126 mmHg. Among women with HDP 23 (37.1%) had proteinuria while among 
women with normal BP 46 (5.5%) had proteinuria. In univariate analysis, women 
with five or more previous pregnancies, a pregnancy more than 10 years since the 
last pregnancy, more than 30 weeks of gestation and those with previous still birth 
were more likely to have HDP. Likewise, there was higher prevalence of HDP in 
women with MUAC in  the highest quartile compared to those in the lowest 
quartile (14% vs 4.6%), in HIV positive compared to those without HIV (14.1% vs 
6.3%), with proteinuria compared to those without (33% vs 4.7%) and in those with 
high DDS (13.6%) compared to those with medium (7%) or low DDS (3%). When 
adjusted for age and gestational age, only area of residence, MUAC, proteinuria 
and DDS remained significant. Other factors such as familial history of type 2 
diabetes mellitus, GDM, Hb level, physical activity, occupation and education were 
not significantly associated with hypertension. Although the rural and urban 
difference was reduced when adjusting for age and gestational age, the difference 
persisted even after adjusting for other education, marital status, occupation, 
parity, MUAC and HIV status (OR 2.01; 95%CI 1.03-3.94). Proteinuria was present in 
18.3% of HIV infected women compared to 6.7% in uninfected women (P<0.001). 
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Table 4.2: Comparison of selected socio-economic, obstetric and biochemical risk 
factors among women  with and without HDP (ANC survey 2011/2012) 
Characteristic NBP HDP 
Crude OR (CI) Adjusted OR (CI)  n % n % 
Residence       
Rural 285  95.6 13  4.4 1 1 
Urban 555  91.9 49  8.1 1.94 (1.03 – 3.63) 1.90 (1.1 – 3.6) 
Age*       
≤ 24 years 305  95.6 14  4.4 1 1 
25 to 29 years 296  95.8 13  4.2 0.96 (0.44 – 2.07) 0.84 (0.38 – 1.82) 
30 to 34 years 165  93.8 11  6.2 1.45 (0.65 – 3.27) 1.10 (0.47 – 2.55) 
≥ 35 years 74  75.5 24  24.5 7.1 (3.49 – 14.32) 5.32 (2.55 – 11.10) 
MUAC       
Q1 (≤ 24.5 cm) 218  95.2 11  4.8 1 1 
Q2 (24.5 – 26.9 cm) 206  95.8 9  4.2 0.87 (0.35 – 2.13) 0.72 (0.29 – 2.00) 
Q3 (27.0 – 29.0 cm) 228  93.4 11  4.6 0.96 (0.41 – 2.25) 0.83 (0.35 – 2.00) 
Q4 (≥ 29.1 cm) 118  85.4 31  14.2 3.27 (1.60 – 6.68) 1.12 (1.1 – 1.7) 
Number of previous pregnancies 
First 242  95.7 4  4.3 1 1 
2 to 4 539  93.7 36  6.3 1.47 (0.74 – 2.94) 0.92 (0.42 – 2.01) 
≥ 5 59  79.7 15 20.3 5.59 (2.44 – 12.81) 1.91 (0.67 – 5.40) 
 
Birth spacing 
< 5 years 312  95.1 16  4.9 1 1 
5 to 9 years 168  91.3 16  8.7 1.86 (0.91 – 3.81) 1.43 (0.68 – 3.00) 
≥ 10 years 60 83.3 12  16.7 3.9 (1.76 – 8.66) 2.18 (0.94 – 5.12) 
Gestational age** 
≤24 weeks 264  96.0 11  4.0 1 1 
25 – 29 weeks 255  93.4 16  6.6 1.71 (0.78 – 3.75) 1.7 (0.77 – 3.78) 
≥ 30 weeks 351  90.9 35  9.1 2.39 (1.19– 4.80) 2.4 (1.20 – 4.88) 
Previous still birth      
No 729  95.7 48  6.2 1 1 
Yes 111  88.8 14  11.2 1.92 (1.02 – 3.60) 1.72 (0.90 – 3.30) 
History of diabetes      
No 736  93.2 54  6.8 1 1 
Yes 104  92.9 8  7.1 1.05 (0.48 – 2.27) 0.98 (0.45 – 2.16) 
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GDM 
No 789  92.9 60  7.1 1 1 
Yes 51  96.2 2  3.8 0.52 (0.12 – 2.17) 0.48 (0.11 – 2.06) 
HIV status       
Negative 779  93.7 52  6.3 1 1 
Positive 61  85.9 10  14.1 2.46 (1.20 – 5.07) 1.79 (0.85 – 3.80) 
Positive +ART 37  88.1 5  11.9 2.02 (0.76 – 5.37) 1.35 (0.49 – 3.68) 
Positive newly 
diagnosed 24  82.8 5  17.2 3.12 (1.14 – 8.51) 2.63 (0.94 – 7.35) 
Protein in urine       
Negative 794 95.3 39 4.7 1 1 
Positive 46 66.7 23 33.3 10.18 (5.61 – 18.454) 9.62 (5.17 – 17.01) 
Hb levels       
<7.0 g/dl 24 85.7 4 14.3 1 1 
7.0 – 9.9 g/dl 346 93.3 25 6.7 0.42 (0.13 – 1.29) 0.39 (0.12 – 1.27) 
10.0 – 10.9 g/dl 234 92.5 19 7.5 0.39 (0.12 – 1.25) 0.41 (0.12 – 1.38) 
 ≥11.0g/dl 234 91.5 22 8.5 0.48 (0.15 – 1.54) 0.45 (0.14 – 1.49) 
Education       
Informal 73  92.4 6  7.6 1 1 
Primary 568  92.4 47  7.6 1.10 (0.42 – 2.44) 1.20 (0.48 – 3.00) 
Secondary and 
post-secondary 199  95.7 9  4.3 0.55 (0.20 – 1.60) 0.77(0.26 – 2.33) 
Occupation       
House works 350  92.3 29  7.7 1 1 
Formal 
employment 122  96.1 5  3.9 0.50 (0.89 – 1.31) 0.46 (0.17 – 1.23) 
Petty business 273  92.6 21  7.9 0.93 (0.52 – 1.66) 0.73 (0.40 – 1.34) 
Agriculture 95  93.1 7  6.9 0.90 (0.38 – 2.09) 0.61 (0.25 – 1.50) 
DDS       
Low 191  97.0 6   3.01 1 
Medium 560  93.0 42  7.0 2.39 (0.99 – 5.71) 2.54 (1.04 – 6.16) 
High 89  86.4 14  13.6 5.01 (1.86 – 13.46) 5.84 (2.11 – 16.15) 
Physical activities (METS) 
Low 144  91.7 13  8.3   
Medium 418  93.1 31  6.9 0.72 (0.34 - 1.51) 0.82 (0.38 – 1.75) 
High 278  93.9 18  6.1 0.82 (0.42 – 1.61) 0.97 (0.48 – 1.93) 
NBP, normal blood pressure  
*Adjusted for MUAC; **Adjusted OR for age, other variables adjusted for age and gestational age. 
Chapter 4 
100 
 
In multivariate analysis, in the urban area risk of HDP increased with age of the 
mother (OR 1.10; 95%CI 1.03 – 1.20), gestational age (OR 1.10; 95%CI 1.10 – 1.20), 
MUAC (OR 1.13; 95%CI: 1.01–1.23) and DDS (OR 1.31; 95%CI: 1.20–1.61) (Table 
4.3). Additionally, those with HIV positive were 2 times more likely to have HDP (OR 
2.4; 95% CI 1.10 – 5.18). In the rural area, the risk of HDP increased with the 
increase in age (OR 1.12; 95%CI 1.00-1.24), gestational age (OR 1.14; 95%CI 1.01 – 
1.30) and slightly but not significant with MUAC (OR 1.15; 95%CI 0.99 – 1.35).  
Table 4.3: Predictors of hypertension during pregnancy derived from logistic 
regression with backwards elimination 
Characteristic Adjusted OR CI P-value 
Urban    
Age (year) 1.10 1.03 – 1.20 0.004 
Gestational age (weeks) 1.10 1.02 – 1.20 0.015 
MUAC  (cm) 1.13 1.01 – 1.23 0.026 
DDS  1.31 1.20 – 1.61 0.011 
HIV positive 2.40 1.10 – 5.18 0.036 
Previous still birth 1.90 0.92 – 3.96 0.085 
Rural    
Age (year) 1.12 1.00 – 1.24 0.042 
Gestational age (weeks) 1.14 1.01 – 1.30 0.039 
MUAC (cm) 1.15 0.99 – 1.35 0.073 
 
When proteinuria was added to the model as a risk factor in the urban area, the 
results for MUAC, previous stillbirth and HIV status weakened and HIV status and 
MUAC were not significant anymore (Table 4.4). 
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Table 4.4: Predictors of hypertension during pregnancy derived from logistic 
regression after adjusting for proteinuria in urban population 
Characteristic Adjusted OR CI P-value 
Urban    
Proteinuria  6.94 3.48 – 13.85 0.000 
Age (year) 1.10 1.03 – 1.18 0.004 
Gestational age (year) 1.08 1.01 – 1.17 0.032 
MUAC (cm) 1.07 0.99  – 1.16 0.097 
DDS  1.30 1.07 – 1.61 0.014 
HIV positive  1.98 0.86 – 4.61 0.111 
Previous still birth  1.53 0.70 – 3.36 0.288 
 
Discussion  
This study reports prevalence of HDP and associated risk factors among rural and 
urban Tanzanian women attending ANC. The overall prevalence of HDP (6.9%) was 
comparable to worldwide estimations of 5 to 10% [7, 27]. Lower prevalence was 
observed in other studies conducted in Africa [28, 29], as well as in a previous study 
in rural Tanzania [30]. Much higher occurrence of HDP  (32.7%) was reported in 
South East Nigeria [31]. Rural-urban difference in prevalence of HDP was also 
reported in Ghana (3.1% in urban vs 0.4% in rural) [28].  
The rural-urban differences in HDP observed in this study could partly be explained 
by high prevalence of HIV in urban compared to rural pregnant women, higher DDS 
and differences in mean age of the respondents. There are also obvious differences 
in blood glucose levels, education, occupation and physical activity level among 
rural and urban women, but none was found to be associated with HDP in this 
study.  
We found that HDP increased with maternal age, even after controlling for MUAC. 
This is similar to results of studies in other parts of the world [7, 9, 32]. In rural and 
urban Ghana no association was found between maternal age and BP [28], while in 
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Occupation       
House works 350  92.3 29  7.7 1 1 
Formal 
employment 122  96.1 5  3.9 0.50 (0.89 – 1.31) 0.46 (0.17 – 1.23) 
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*Adjusted for MUAC; **Adjus ed OR for age, other variables adjusted for  and gestational age. 
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Cameroon young age was identified as a risk factor for HDP (OR 2.6; 95% CI 1.5–
4.7) [33]. In our study teenagers were excluded; however, a higher prevalence of 
HDP was noted among women above 35 years compared to those below 25 years. 
In addition, maternal BMI may influence the association between maternal age and 
the risk of HDP[34]. In our study, also when controlled for age and gestational age 
MUAC was independently associated with HDP. Several studies reported BMI to be 
one of the major contributing factors to HDP [8, 28, 31]. The prevalence of obesity 
among women attending ANC in Tanzania increased from 3.6% in 1995 to 9.1% in 
2004 [35]. This means HDP and associated factors may also increase with time if 
serious preventive action is not taken specifically regarding reducing overweight 
and obesity before conception. 
Women living with HIV had a significantly higher prevalence of HDP (14.1%) 
compared to their normal counterparts (6.3%) (OR 2.4; 95%CI 1.1–5.2). The 
prevalence was even higher among the newly diagnosed HIV positive women 
compared to those who were already on anti-retroviral therapy (ART). A review 
and meta-analysis on HIV and the risk of direct obstetric complications showed 
some evidence for increased odds of HDP with HIV infection (OR: 1.46, 95% CI: 
1.03–2.05), although with high between study heterogeneity [36]. In the general 
Sub-Saharan African population [37] and in other studies among HIV infected 
patients, HIV or ART was not associated with hypertension [38, 39]. However, our 
data analyses also showed that the presence of proteinuria in HIV positive women 
may explain this observation, as the association between HIV status and HDP 
reduced when proteinuria was adjusted for. Proteinuria could be  a result of 
chronic kidney disease which may have resulted from high BP [40, 41]. HIV 
infection has been associated with both acute kidney injury and chronic kidney 
disease [42] and studies in Africa reported improvement of kidney function with 
the use of ART [43, 44], thus could explain higher prevalence of HDP among people 
who had not started ART compared to these already using ART.  
We observed rural-urban differences in mean DDS, and there was 1.3 increased 
odds of having HDP with increased number of food groups in urban but not in rural 
women. Although using different number of food groups, studies in Sri Lanka and in 
Tanzania reported positive associations of DDS with obesity [45, 46]. A study in 
Teheran found an inverse association between DDS and the risk of high blood 
pressure, impaired glucose homeostasis and high triglyceride levels [47], but the 
probability of being obese increased with DDS quartiles [48]. In South Africa, higher 
mean diastolic blood pressure was observed in the low DDS group [49]. A study in 
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Mexican men reported that DDS was positively correlated with micronutrient 
adequacy and fruits and vegetable intake but also with percentage of energy from 
total and saturated fats and cholesterol intake [50]. The authors concluded that in 
other settings than those with high prevalence of malnutrition, higher food 
diversity may not predict a healthier diet.  
While most studies reported significant associations between HDP and GDM or 
insulin resistance [16, 17, 51], we did not find any association between GDM and 
HDP. Similar results were observed in Bangladesh and in Cameroon [52, 53], where 
there was no difference between mean SBP and DBP among women with and 
without gestational diabetes. In a study by Hendriks et al. in the general non- 
pregnant population in Nigeria, Kenya, Tanzania and Namibia; the association BP 
and blood glucose levels was only found in Nigerian population [37]. Lack of 
association between GDM and BP could be due to ethnic differences which needs 
further exploration since there were only few studies conducted in Africa.  
Our study has some limitations. DDS data was collected from a single 24 hour 
dietary recall to represent usual intake, and counting of food groups does not 
necessarily consider the amount consumed. Additionally, each food group was 
given equal weight regardless of its contribution to the risk of hypertension during 
pregnancy. We assessed physical activity using questionnaire which is more 
subjective to recall bias, and some women might have changed their activity 
pattern since they became pregnant. 
The assessment of gestational age was based on last menstrual period reported by 
the mother and thus relies on memory. This might have underestimated or 
overestimated the actual gestational age especially in the rural area because of low 
education level and late booking to the  ANC. Our study might have been 
confounded by other factors such as genetics, exposure to pollutants and stress 
during pregnancy, which were not considered. Blood pressure was estimated from 
two measurements during a single visit and at the clinic setting, hence the true 
prevalence might have been overestimated to some extent [54]. However, this is 
the regular practice in Tanzanian antenal care. Finally, the diagnosis of HDP 
requires good knowledge on hypertension before pregnancy. We excluded known 
hypertensives, but due to lack of regular checkups in our African population some 
of the HDP might have been regular hypertension. Despite of the above limitations, 
the study still provides necessary information regarding risk factors for HDP in 
Tanzanian women. 
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Conclusion 
Prevalence of HDP in Tanzania is higher than most of the African countries which 
signals risks for preterm delivery, low birth weight and future cardiovascular 
disease. Among the identified risk factors MUAC, which is a proxy for BMI, and DDS 
were the modifiable risk factors. Interventions to reduce HDP should target 
overweight and obese women before conception. Moreover, dietary diversity is  
important regarding micronutrient intake, but in an urban setting it probably also 
indicates high energy intake, thus further studies are needed specifically on DDS in 
relation to hypertension among pregnant women. Higher prevalence was also 
noted among HIV positive women, thus special attention and proper counselling 
may be provided to this particular group during ANC visits.  
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Abstract 
Aim: Various diseases and health conditions have been shown to be associated 
with birth weight and delivery complications. This study was undertaken to 
determine risk factors for macrosomia and low birth weight in a cohort of 
Tanzanian women. 
Methods: A prospective study was conducted in Dar es Salaam city from 2011 
through 2012 among 609 pregnant women ≥20 years of age, investigated at mean 
gestational age 28 weeks for blood glucose levels, blood pressure, anthropometry 
and socio-demographic data. Information on birth weight, sex of the child, mode of 
delivery and delivery complications was collected at follow-up by telephone 
interviews of 466 (76.5%) women who could be contacted after delivery. A term 
birth weight was available for 443 babies (72.7%). Multiple logistic regression 
analysis was used to study the factors associated with macrosomia and low birth 
weight. Macrosomia was defined as birth weight ≥ 4000g and low birth weight as 
birth weight <2500 g.  
Results: The mean birth weight was 3200 g (SD 450) ranging from 1800 g to 5500 g. 
Sixteen children (3.6%, 95% CI 2.2-5.8) were born with low birth weight and 26 
babies were macrosomic (5.9%, 95% CI 4.0-8.5). Gestational diabetes (GDM) and 
marital status were independently associated with increased risk of macrosomia 
whereas, compared to housewives, women who were self-employed had reduced 
risk of macrosomic delivery. When previous stillbirth and birth weight of the 
previous child were added to the model (n=282), only GDM (3.43, 95% CI 1.01-
11.64) and birth weight of the previous child (OR 2.29 per kg, 95% CI 1.13-4.68) 
remained significantly associated with macrosomic delivery. Presence of 
hypertension was the main predictor of low birth weight (OR 3.75, 95% CI 1.11-
12.68). 
Conclusion: Prevalence of macrosomia was higher than that of low birth weight in 
infants of women above 19 years in the capital city of Tanzania. Women with GDM 
or a previous macrosomic child had an increased risk of giving birth to a 
macrosomic infant. Hypertension was independently associated with low birth 
weight. Proper management of women with GDM and hypertension during 
pregnancy is necessary to reduce the risk of adverse birth outcomes. 
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Introduction 
Foetal macrosomia is associated with an increased risk of morbidity and mortality 
to both the pregnant woman and her new born. It is usually defined as birth weight 
greater than or equal to 4000-4500 g, or > 90th percentile or two standard 
deviations of birth weight for gestational age [1]. In the developing countries, 
prevalence of macrosomia in 23 countries ranged from 0.5% in India to 13.9% in 
Algeria [2]. Risk factors for macrosomia include maternal age, height, higher parity, 
infant of male sex, post term pregnancy, diabetes, gestational diabetes mellitus 
(GDM), and maternal obesity [2, 3]. 
 
Likewise, low birth weight defined as weight at birth less than 2500 g regardless of 
gestational age, is an indicator for maternal and child ill-health and nutritional 
status [4]. It is associated with an increased mortality rate in the first year of the 
infant’s life, developmental problems in childhood and the risk of various diseases 
in adulthood [5, 6]. For example, in China and in Nigeria early life exposure to 
famine was a risk for hyperglycaemia later in life, the association being aggravated 
by exposure to a Western diet in adulthood [7, 8]. Globally, it is estimated that 20 
million infants are born with low birth weight, about 96% of them in the developing 
countries [4].  
 
Several studies have associated both low birth weight and macrosomia with 
increased risk of metabolic syndrome later in life. A study in Taiwan reported that  
children with macrosomia  or with low birth weight had 2 to 3 times increased risk 
for type 2 diabetes when compared to the reference group after adjustment for 
age, sex, BMI, family history and socioeconomic status [9]. The authors also 
observed more frequently components of the metabolic syndrome, such as obesity 
and high blood pressure, among subjects born with high birth weights. Also other 
studies reported specifically low birth weight [6] or macrosomia [10, 11] as a risk 
factors for type 2 diabetes, obesity and hypertension in young adults.  
Various diseases and health conditions have been associated with birth weight and 
delivery complications. Studies in Tanzania have shown that anaemia during 
pregnancy results in low birth weight, still births and increased risk of delivery 
complications [12, 13]. In contrast to many studies which associate hyperglycaemia 
with macrosomia, Darling and others [14] reported an increased risk of low birth 
weight among Tanzanian women with hyperglycaemia during pregnancy.  A recent 
study reported a prevalence of GDM of 8.4% in urban area in Tanzania [15]. The co-
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existence of GDM, hypertension, obesity, HIV infection and anaemia may 
contribute to delivery complications especially when each is poorly managed. We 
therefore assessed prospectively the risk of adverse birth outcomes, low birth 
weight and macrosomia among women in Tanzanian urban region. 
 
Methods 
Study population 
The study was a prospective cohort, part of a larger study conducted in 2011 
through 2012 which included selected antenatal care facilities in rural and urban 
Tanzania. The recruitment involved pregnant women ≥20 years. and at ≥ 20 weeks 
of gestation during their usual antenatal clinic (ANC) visit [15].  
A total of 609 pregnant women attending ANC during the survey period in six 
selected health facilities in Dar es Salaam, an urban region in the East Coast of 
Tanzania consented to participate. All women with previously diagnosed type 1 or 
type 2 diabetes mellitus, those with sickle cell anaemia, already known twin 
pregnancy and those with non-African origin were excluded. Details are given 
elsewhere [15]. Women were examined during their usual ANC visit at a mean of 
28 gestational weeks and followed up until delivery using mobile telephone 
communication. The study protocol was approved by Tanzania National Institute of 
Medical Research and permission to conduct the study was provided by Sokoine 
University of Agriculture, the District Directors and District Medical Doctors of Ilala, 
Temeke and Kinondoni districts (Dar es Salaam). 
Data collected during recruitment 
Socio-demographic information was obtained using a structured pretested 
questionnaire which was administered through face to face interview. Maternal 
demographic and clinical information that is routinely captured at the first prenatal 
visit was extracted from the ANC cards. Information on current pregnancy such as 
gestational age, gestational age when ANC was started, weight during first visit, HIV 
status and information related to previous pregnancies, including prior stillbirth, 
and personal or family history of diabetes mellitus was obtained from ANC 
maternity card with verification from the mother. Gestational age is usually 
estimated using the last menstrual period as reported by the mother during the 
first ANC visit. Age and birth weight of the previous child was obtained from the 
mother by recall.  
Anthropometric measurements were done during antenatal visit at the health 
facility. Weight of the mothers (in kg) was measured using Seca electronic scale 
Maternal risk factors for low birth weight and macrosomia 
113 
 
(Seca Gmbh and Co.kg 22061, Hamburg, German). Height (in cm) was measured 
without shoes using height measuring board (Shorr productions, Maryland USA). It 
was categorized into two categories, that is <150 cm and ≥150 cm, based on the 
Tanzanian antenatal guideline.  
 
Mid-upper-arm circumference (MUAC) was measured using a non-stretching MUAC 
tape and recorded to the nearest centimeter. Since most of the women appeared 
late to the clinic (gestational age at booking ranged 8-32 weeks with mean 20 
weeks), it was difficult to obtain pre-gestational weight. MUAC is known to be 
relatively stable during the course of pregnancy and it was highly correlated with 
pre-pregnancy BMI [16, 17], hence we used MUAC as a proxy for BMI as explained 
elsewhere [15]. MUAC was further divided into quartiles which were numbered 
sequentially from Q1 (the group with lowest MUAC values ≤24.5 cm) to Q4 which 
was the group with highest MUAC values (≥29.0cm).  
Blood glucose was measured in capillary blood at fasting state and at two hours 
after 75 g oral glucose tolerance test using HemoCue Glucose B-201 (Ängelholm 
AB, Sweden) and recorded in mmol/L. Diagnosis of GDM was based on WHO 
criteria [18]. 
Haemoglobin (Hb) concentration were measured in capillary blood using HemoCue 
Hb 201+ Haemoglobin photometer (HemoCue AB, Ängelholm, Sweden) and 
recorded to the nearest 0.1 g/dl.  Women were classified as anaemic (Hb<11 g/dl) 
or normal Hb (≥11 g/dl) [19].  
Systolic and diastolic blood pressure (BP) was measured from mid-upper-arm of the 
left side while the respondent was sitting and relaxed for 10 minutes before the 
actual measurement, using a digital BP device (Microlife BPA100, Widnau, 
Switzerland). Two readings were taken with an interval of five minutes to ten, and 
the average systolic and diastolic BP was recorded in mmHg. Hypertension was 
defined as systolic BP of 140mmHg or higher and/or diastolic BP of 90mmHg or 
higher. Hypertension disorders of pregnancy (HDP) included chronic hypertension, 
hypertension with proteinuria and hypertension diagnosed after 20th week of 
gestation [20]. 
Women were requested to collect midstream urine on the spot in a provided 
sterilized disposable plastic container. Urine samples were tested immediately for 
glucose, ketones, leucocytes and protein using dipstick made with a color sensitive 
pads (urine strip 10 C, Dialeb GmbH, Austria). Women were considered with 
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proteinuria when the dipstick was +1 or more in the absence of urinary tract 
infection [21].  
Physical activity was assessed retrospectively by using the short form of the 
International Physical Activity Questionnaire (IPAQ) which was translated into 
Kiswahili. Catergories of low, moderate or high physical activity level were 
calculated using the syntax provided in the IPAQ manual. Dietary diversity data 
were collected using a dietary diversity questionnaire, as described elsewhere [15]. 
Total dietary diversity score was divided into three categories and classified as low 
(0 to 5), medium (6 to 8) and high (9 to 16). 
Data collected during follow up 
Birth outcome data were collected from mothers using mobile telephone 
interview. The primary outcome of the study was birth weight. Other outcomes 
included mode of delivery, preterm births, stillbirths, neonatal death, malformation 
and reasons for Caesarean section. 
During recruitment, participants were informed about the follow-up telephone 
interview to collect data on birth outcomes. Among the 609 women recruited 530 
(87%) provided telephone numbers so that they could be contacted after delivery. 
Among those who provided their telephone contacts, 64 (12%) could not be 
reached and we managed to communicate with 466 mothers (76.5%). Data on 
overall birth outcomes were available for 458 women, whereas birth weight data 
was available for 443 women (Figure 5.1). 
Telephone interviews as a method for data collection is regarded as a useful 
method due to flexibility and cost effectiveness especially if it is a follow-up [22, 
23]. According to TDHS 2010, 78% of Tanzania urban residents own mobile 
telephones [24] and a survey conducted in 2010 in Dar es Salaam, mobile 
telephone ownership was more than 80% [25]. In our study, 87% of the participants 
provided telephone contacts and overall 77% could be contacted.  
Infants birth weight was categorised as low birth weight (<2500 g), normal birth 
weight (2500 to 3999 g) and macrosomia (≥4000 g) when born between 37 and 42 
gestational weeks [26]. Preterm birth was defined as live birth before 37 
gestational weeks. Stillbirth was defined as baby who was born without any sign of 
life after 24 gestational weeks. Neonatal death included children who died within a 
period of 28 days after birth.  
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Data analysis 
Data were entered and analysed using IBM SPSS program version 19.0, Chicago, IL. 
Results were recorded as means and standard deviations for continuous variables 
and numbers and percentages for the categorical variables. Students T-test for 
continuous variables and Chi-Square test for categorical variables were used to 
assess differences in characteristics according to follow-up status. Comparison of 
birth outcomes in women with and without GDM and those with and without HDP 
were done using Chi-square test. Differences in continuous and categorical 
variables according low birth weight and macrosomia compared to those with 
normal birth weights were assessed by ANOVA or Chi-square test, respectively. 
Logistic regression analysis was done to determine the main factors associated with 
macrosomia and low birth weight. In multiple logistic regression models, 
confounders with p< 0.2 in bivariate analyses were included to examine the 
adjusted association of these factors with the delivery of a macrosomic or low birth 
weight baby. For logistic regression, birth weight was dichotomized to normal and 
high when macrosomia was the outcome and as low and normal when low birth 
weight was the outcome. In both the low birth weight and macrosomia models, the 
first model included all women with birth weight data, while the second model 
included  previous stillbirth and previous birth weight as covariates, hence 
primiparous (n=161) were excluded. 
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Figure 5.1: Flow diagram of the cohort 
Total sample recruited  
(N= 609) 
Excluded n = 143 (23.5%):  
 79 (13%) had no 
telephone number 
 64 (12%) could not be 
reached 
Contacted to provide birth outcome 
information: n = 466 (76.5%) 
Excluded n = 8 (1.7%) 
 Twins:  n = 6  
 Miscarriage/abortion: n= 1 
 Maternal and child death: 
n=1  
Final sample for analysis of  
stillbirth: n = 458 (75.2%) 
Excluded n=15 (3.2%) 
 Premature birth: n = 3 (0.7%) 
 Stillbirths: n = 12 (2.6%) 
Final sample for analysis on birth weight:  
n = 443 (72.7%) 
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Results 
Sample characteristics of the missed and accessed study population 
Women with complete data were on average older (27.8 vs 26.4 yrs.), taller (155.6 
vs 154.5 cm) and had higher MUAC (27.5 vs 26.5 cm) compared to women who 
were lost to follow-up (Table 5.1). Other anthropometric, socio-demographic and 
biochemical indices were similar between the two groups. 
 
Table 5.1: Anthropometric, Sociodemographic and biochemical indices: Comparison 
between loss to follow-up and the available study group of pregnant women during 
the survey in Dar es Salaam 2011/2012 
Variable 
Missing  
(n = 143) 
Available 
(n = 466) 
P-value Mean SD Mean SD 
Age (years) 26.4 4.8 27.8 5.1 0.002 
Height (cm) 154.5 5.8 155.6 6.0 0.05 
MUAC (cm) 26.5 3.4 27.5 3.8 0.005 
BMI at booking (kg/m2) 24.5 4.0 25.3 4.6 0.054 
Gestational age at booking 
(wks.) 18.4 4.1 17.8 4.7 0.165 
Gestational age during survey 
(wks.) 27.5 5.0 28.3 4.7 0.085 
Parity 2.4 1.2 2.4 1.3 0.576 
Systolic BP (mmHg) 115.0 14.0 114.7 15.5 0.865 
Diastolic BP (mmHg) 72.1 10.8 72.6 11.8 0.679 
Haemoglobin (g/dl) 10.0 1.6 10.1 1.6 0.480 
Fasting BG  (mmol/L) 4.5 0.8 4.6 1.0 0.215 
2-hr BG (mmol/L) 6.0 1.1 6.1 1.1 0.577 
      
 n % n %  
Education:                         
Informal 10 7.0 28 6.0 
0.252               Primary 105 73.4 315 67.6 
Secondary or higher 28 19.6 123 26.4 
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Marital status      
Married 115 80.4 392 84.1 
0.300 
Single 28 19.6 74 15.9 
Primary source of income      
Housewife 78 54.5 212 45.5 
0.102 Salary/wage 23 16.1 73 15.7 
Self employed 42 29.4 181 38.8 
HIV status               
              Negative 128 89.5 422 90.6 
0.711 
              Positive 15 10.5 44 9.4 
Family history of Type 2 diabetes  
No 125 87.4 396 85.0 
0.469 
Yes 18 12.6 70 15.0 
Parity      
              Prime 38 23.6 133 28.5 
0.647 
              Multipara 105 73.4 333 71.5 
 
Association of GDM and HDP with birth outcome 
We analysed information collected on birth outcome from 466 women who were 
recruited in our study as shown in Figure 5.1. Caesarean delivery was reported by 
6.3% and the reasons were either preeclampsia (n=4), previous scar (n=7), 
obstructed labour (n=5), macrosomia (n=3), pelvic disproportional (n=2), breach 
(n=6) and placenta previa (n=2). Two out of the three preterm births were 
associated with hypertension. There was no clear association between GDM and 
birth outcomes. Comparing delivery complications among women with and without 
HDP, 7.5% versus 2.2% had stillbirths, 5% versus 1.7% reported neonatal deaths, 
while 5% versus 0.2% experienced preterm delivery respectively (Table 5.2). 
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Factors associated with low birth weight and macrosomia 
Birth weight ranged from 1800 g to 5500 g with a mean of 3200 g (SD 450). Sixteen 
infants (3.6%; 95% CI 2.2-5.8) had low birth weight while 26 were macrosomic 
(5.9%; 95% CI 4.0-8.5). Mean birth weight for the macrosomic infants was 4260 g 
(SD 364) while for the low birth weight it was 2194 g (SD 181).  
Fifty-one percent of the children were female. The prevalence of macrosomia was 
almost twice as high in boys (7.8%) compared to girls (4.0%). Among the 45 women 
who were diagnosed with GDM the frequency of macrosomic infants was higher 
(18.2%) than in normoglycaemic women (4.5%) (Table 5.3). None of the GDM 
women had a child with low birth weight. Among women with HDP the prevalence 
of low birth weight was significantly higher (11.4%) compared to the normotensive 
group (2.9%). In univariate analysis, besides GDM and hypertension, a significant 
difference in birth weight was observed among maternal occupation categories. 
Housewives had more frequent macrosomic infants while self-employed women 
had more frequently low birth weight. In addition, married women had more 
frequent a low birth weight infant while single women had more frequent a 
macrosomic child. Although not statistically significant, a higher occurrence of 
macrosomia was observed in women with previous macrosomic child (13.2% vs 
5.7%), multiparity (6.7% vs 3.9%) and those with family history of diabetes (9.0% vs 
5.3%).
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Table 5.3: Prevalence of low birth weight and macrosomia according to different 
maternal characteristics among women attending ANC in Dar es Salaam city 
(2011/2012) 
 
Characteristics of the 
mother 
LBW (n=16) Normal (n=401) Macrosomia 
(n=26) 
 
Mean SD Mean SD Mean SD P 
value 
Birth weight current 
child (g) 
2194 180 3212 323 4265 364 0.000 
Birth weight previous 
child (g) 
3121 520 3307 684 3668 488 0.040 
Gestational age at 
recruitment (weeks) 
26.9 5.2 28.4 4.7 28.6 5.1 0.477 
Gestational age at 
starting ANC (weeks) 
16.9 5.1 17.9 4.7 18.3 4.5 0.653 
        
 N % n % n % P 
value 
Sex of the child        
    Male 7 3.2 193 88.9 17 7.8 
0.213    Female 9 4.0 208 92.0 9 4.0 
Marital status        
   Married 15 4.1 337 91.1 18 4.9 
0.076    Single 1 1.4 64 87.7 8 11.0 
Occupation        
   Housewife 5 2.5 176 88.4 18 9.0 
0.035    Salary/wage 1 1.4 67 95.7 2 2.9 
   Self employed 10 5.7 158 90.8 6 3.4 
Education        
   Informal 1 3.4 24 92.3 1 3.4 
0.619    Primary 13 4.3 274 90.4 16 5.3 
   Secondary or higher 2 1.8 103 90.4 9 7.9 
Chapter 5 
122 
 
Age         
<25 yrs. 2 1.5 123 91.8 9 6.7 
0.265 
≥25 yrs 14 4.5 278 90.0 17 5.5 
Height        
<150 cm 3 4.7 58 90.6 3 4.7 
0.812   ≥150 cm 13 3.4 348 9.05 23 6.1 
MUAC quartiles        
  Q 1 (<24.5 cm) 3 2.9 94 92.2 5 4.9 
0.446 
  Q 2 (24.5 – 26.9 cm) 3 2.7 100 90.1 8 7.2 
  Q 3 (27.0 – 29.0 cm) 3 2.8 101 94.4 3 2.8 
  Q 4 (>29 cm) 7 5.7 106 86.2 10 8.1 
GDM         
   Yes 0 0.0 36 81.8 8 18.2 
0.001    No 16 4.0 365 91.5  18 4.5 
Hypertension        
   No 12 2.9 371 90.9 25 6.1 
0.027    Yes  4 11.4  30 85.7 1 2.9 
Anaemia        
   Yes 10 3.3 276 90.5 19 6.2 
0.772    No 6 4.3 125 90.6 7 5.1 
HIV status        
   Positive 1 23.0 39 90.7 3 7.0 
0.853    Negative 15 3.8 362 90.5 23 5.8 
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Parity        
   Prime 2 1.6 121 94.5 5 3.9 
0.166    Multipara 14 4.4 280 88.9 21 6.7 
Family history of diabetes 
   Yes 0 0.0 61 91.0 6 9.0 
0.127    No 16 4.3 340 90.4 20 5.3 
Physical activities        
   Low 4 4.2 84 87.5 8 8.3 
0.422    Medium 9 3.9 213 92.2 9 3.9 
   High 3 2.6 104 89.7 9 7.8 
DDS        
   Low (< 4 4.3 83 88.3 7 7.4 
0.382    Medium 12 4.1 265 91.1 14 4.8 
   High 0 0.0 53 91.4 5 8.6 
Previous stillbirth        
   No 9 3.8 211 90.6 13 5.6 
0.021    Yes 5 10.4 37 77.1 6 12.5 
LBW: low birth weight; GDM: gestational diabetes mellitus; DDS: Dietary diversity score; 
MUAC: mid upper arm circumference 
Two models were fitted to assess the association of risk factors with macrosomia. 
The first model included GDM, child’s sex, marital status and occupation. Women 
with GDM had about five times higher risk of giving birth to a macrosomic infant 
compared to normoglycemic ones (OR 4.77, 95% CI 1.87-12.21) and single women 
had three times increased risk of a macrosomic child (OR 3.23, 95% CI 1.27-8.22) 
compared to married women. Furthermore, compared to housewives, women who 
were self-employed had a reduced risk of macrosomic delivery (OR 0.36, 95% CI 
0.16-0.95). Variables included in the second model were GDM, marital status, 
occupation, child’s sex, birth weight of the previous and still birth child, and only 
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GDM (3.43, 95% CI 1.01-11.64) and birth weight of the previous child (OR 2.29, 95% 
CI 1.13 – 4.68) remained significantly associated with macrosomic delivery (Table 
5.4).
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Table 5.4: Crude and adjusted associations between selected risk factors and 
macrosomic births among women attending ANC in Dar es Salaam city (2011/2012) 
Variable Crude 
OR 
95% CI P 
value 
Adjust
ed OR^ 
95% CI P-
value 
Model 1 (n=443)       
GDM 4.70 1.91 - 11.57 0.000 4.77 1.87 – 12.21       0.001 
Childs sex (Male) 2.05 0.89 – 4.70 0.09 1.93 0.82 – 4.54 0.134 
Marital status (Single) 2.41 1.00 – 5.77 0.043 3.23 1.27 – 8.22 0.014 
Occupation       
   Housewife 1   1   
   Formal employment 0.29 0.07 – 1.31 0.108 0.23 0.05 – 1.09 0.062 
   Self employed 0.34 0.14 – 0.93 0.034 0.36 0.16– 0.95 0.038 
Model 2 (n=282)* 
GDM 4.58 1.49 – 14.09 0.008 3.43 1.01 – 11.64 0.048 
Marital status (Single) 2.25 0.76 – 6.63 0.141 2.32 0.72 – 7.51 0.160 
Occupation       
   Housewife 1   1   
   Formal employment 0.53 0.11 – 2.48 0.418 0.46 0.09 – 2.32 0.343 
   Self employed 0.39 0.14 – 1.16 0.091 0.43 0.14 – 1.32 0.139 
Birth weight of 
previous child (kg) 
2.16 1.12 – 4.16 0.021  2.29 1.13– 4.68 0.022 
Previous stillbirth 2.43 0.87 – 6.75 0.008 2.65 0.86 – 8.20 0.090 
*Including only multiparous women 
 
Similarly, two models were fitted to assess factors associated with low birth weight 
(Table 5.5). Variables included in the first model were HDP and occupation, and the 
second model included HDP, occupation and previous still birth. In both models, 
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women with HDP had about four times increased risk for low birth weight (OR:  
4.10, 95% CI 1.23-13.66 and 3.75, 95% CI 1.06 -13.25, for the first and second 
model, respectively) compared to those who had normal blood pressure.  
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Table 5.5: Crude and adjusted associations between selected  risk factors and 
macrosomic births among women attending ANC in Dar es Salaam city (2011/2012) 
Variable Crude 
OR 
95% CI P 
value 
Adjusted OR* 95% CI P-
value 
Model 1 (n=443)       
HDP 4.26 1.29 – 13.98 0.017 4.10 1.23 – 13.66 0.021 
Occupation       
   House wife 1   1   
   Formal 
employment 
0.56 0.07 – 4.89 0.602 0.62 0.07 – 5.48 0.670 
   Self-
employment 
2.37 0.79 – 7.06 0.123 2.39 0.79 – 7.21 0.120 
Model 2 (n=282)* 
HDP  4.07 1.18 – 13.96 0.026 3.75 1.11– 12.68 0.033 
Occupation       
   House wife 1   1   
   Formal 
employment 
0.83 0.09 – 7.63 0.866 0.98 0.10 – 9.38 0.993 
   Self-
employment 
2.37 0.71 – 7.91 0.161 2.44 0.71 – 8.34 0.154 
Previous 
stillbirth 
2.91 0.93 – 9.10 0.067 2.67 0.83 – 8.62 0.101 
*Included multiparous 
 
Discussion 
In our cohort, stillbirths occurred more often among women with hypertension 
compared to normotensive ones, but GDM was not significantly associated with 
adverse birth outcomes. Regarding birth weight, 5.9% of the infants were 
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macrosomic and 3.6% had low birth weight. GDM, occupation, marital status and 
previous macrosomia were independent risk factors for macrosomia, while 
hypertension was the main risk factor for low birth weight.  
GDM is a known risk factor for other delivery complications. However, we did not 
find a significant association between GDM and stillbirths, preterm delivery, 
malformations or neonatal deaths, although the number of adverse birth 
outcomes, especially Caesarean deliveries, was higher among GDM. Due to few 
cases the power to detect such associations may have been limited. Furthermore, 
measurements of blood glucose and blood pressure were done at baseline, at 
mean gestational age of 28 weeks, and women were informed of their status, and 
hence some lifestyle modification may have taken place which might have 
improved birth outcomes to some extent.  
We found significant associations of HDP with stillbirth and low birth weight. Other 
studies suggest that high blood pressure is associated with placental dysfunction 
which can result in foetal growth restriction [27]. Similar results were reported by 
other studies in Africa [28-30] and in a population-based case-control study in India 
[31].  
The occurrence of low birth weight in our study was lower than in earlier studies in 
urban Tanzania [32, 33], and was about half of the national estimates (TDHS 2010). 
This may be due to the high maternal age of our study population since we 
excluded teenagers [34]. A recent study in Dar es Salaam reported a high 
prevalence of low birth weight among underweight women and also noted an 
increase in pregnancies in older age in recent years [35].In our study the prevalence 
of underweight among pregnant women was low; using a MUAC cut-off of 22 cm, 
underweight was prevalent in 3.2% while using BMI at booking (<18.5 kg/m2) 
underweight was 3.4%. Conversely, the prevalence of obesity (MUAC ≥33 cm) was 
9.9% and using BMI at booking of ≥30 kg/m
2 it was 14.7%. The current trend of 
women becoming pregnant at more advanced age, the increased prevalence of 
obesity and overweight in women of reproductive age and the existence of 
diabetes during pregnancy are likely to contribute to the observed number of 
macrosomic infants.  
A review by Barro et al [36] reported that about 50% of the low birth weights in low 
and middle income countries are preterm. In our study we excluded two preterm 
births, the rest of the women reported to have delivered at full term, which may 
explain the low occurrence of low birth weight in our study population. It is also 
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possible that some children who were stillborn had low birth weight, but their 
weight was not accessed. 
The observed prevalence of macrosomia was within the range reported in other 
African studies [37-39]. It is important to note that variation in incidence of 
macrosomia may be due to different weight cut-offs used in different studies. 
Compared to our study a higher incidence of 8.1% and 14.6% was reported in two 
Nigerian studies [37, 38] with a similar classification for macrosomia. Using a higher 
cut-off (≥4500 g), a lower frequency was reported in another Nigerian study [40].  
Women with GDM and those with previous macrosomic child had an increased risk 
of macrosomic deliveries even after adjustment for MUAC and child’s sex. GDM is 
one of the commonly known predictor of macrosomia [2, 39]. The elevated glucose 
level in the foetus as a result of maternal hyperglycaemia may result in 
overstimulation of the foetal pancreas and foetal hyperinsulinemia, and hence 
foetal growth [41].  
BMI is a known risk factor for macrosomia [42], and has been shown to be a 
stronger predictor compared to maternal glucose levels [43]. In our study, GDM 
and birth weight of the previous child were predictors of macrosomia, but we did 
not find a significant association between maternal MUAC quartiles with 
macrosomia. It is possible that high pregnancy weight gain or high waist 
circumference before conception could be a determinant of macrosomia in our 
study population. Pre-pregnant waist circumference was, for example a risk factor 
for macrosomia independent of BMI among black women [44]. However, pre-
pregnancy waist and weight gain during pregnancy were not assessed in our study. 
Single women were more likely to give birth to a macrosomic infant compared to 
married ones. This is contrary to an earlier study in Tanzania where single mothers 
were more likely to give birth to low birth weight infants [32]. The differences could 
be due to characteristics of the studied population; this previous study had a 
mixture of urban and rural women while our study was done in the urban area. 
Self-employed women and those with formal employment were less likely to have 
a macrosomic infant compared to housewives, which could be due to a more active 
lifestyle among these two groups. 
Studies in Tanzania and in Ethiopia showed that women with HIV infection were at 
an increased risk of delivering a low birth weight infant [35, 45, 46]. Although we 
observed a high prevalence of HIV (9.7%), it was not associated with still birth or 
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low birth weight. About two thirds of the HIV positive women (62.8%) were taking 
micronutrient supplements which might have improved birth outcome [47].  
Short stature [48] and anaemia [12, 13] are also recognized risk factors for low 
birth weight. Nevertheless, we did not find a clear association in our study, possibly 
due to small number of low birth weight deliveries. Other studies identified 
smoking and alcohol intake as risk factors for low birth weight [49, 50], but in our 
study only 0.9% of the participants were smoking and about 14% were drinking 
alcohol and none were associated with low birth weight.  
The recall method for assessing birth weight and other delivery outcomes has been 
used previously in the demographic and health surveys in Tanzania [24]. In the 
developed countries recall of pre-and perinatal factors was found to be good and in 
agreement with hospital records [51, 52]. In  African studies, maternal recall of 
child’s birth weight was moderately in agreement with recorded values in Uganda  
for children above four years [53], while it was found to be good in rural Kenya 
[54]. The accuracy of the recall depended on factors such as maternal education, 
place of delivery and the time lapse from delivery [53]. In our study there could be 
bias regarding the birth weight of the previous child, due to the time lapse from 
previous delivery to current pregnancy. However, for the current child we expect 
minimal recall bias because of the short time lapse between delivery and the 
interview and due to prior notification of the participants regarding the follow up.  
In fact, birth weight was rather being read as recorded on the card immediately 
after delivery.   
Women lost to follow up (23.5%) were on average younger, shorter and had lower 
MUAC, which are all determinants of birth weight. This limited the variation in age, 
height and MUAC to some extent, and this could be an additional reason for not 
finding and association with birth weight in our study. Birth weights might have 
been slightly over-or underestimated due to inaccurate estimation of gestational 
age, hence some of the low birth weight might be preterm deliveries, and some 
macrosomic births might be post term deliveries. Other causes of still births like 
syphilis and malaria were not addressed [55], but unless the participant was re-
infected, the two infections were universally checked and treated. Also, universal 
malaria prophylaxis for all pregnant women is usually given during ANC visit in the 
second and third trimester. Finally, the study was conducted in an urban setting 
(Dar es Salaam) with higher proportions of institutional deliveries compared to 
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other areas in Tanzania, hence the results cannot be generalized to other parts of 
the country. 
In conclusion, the prevalence of macrosomia was higher than that of low birth 
weight in offspring of women ≥20 years in Dar es Salaam. Thus, it seems that the 
double burden of malnutrition exists in the study area even at the infancy stage, 
where low birth weight and macrosomia exist in the same population. Women with 
GDM diagnosed during usual ANC visits had an increased risk for macrosomia. 
Hypertension during pregnancy was associated with low birth weight regardless of 
maternal age and MUAC, and it was a risk factor for stillbirth. This highlights the 
importance of screening and lifestyle interventions for women at risk. 
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Abstract 
Aim: To assess opportunities and challenges for including blood glucose testing 
during usual antenatal care (ANC) in Tanzania. 
Methods: A review of published literature and government documents on maternal 
and child health care delivery in Tanzania was performed. Additional data were 
collected through a survey that included 24 randomly selected health facilities 
(HFs) from Dar es Salaam region. Health workers responsible for ANC from each of 
the selected HF were interviewed using a pretested structured questionnaire 
focusing on the practice of screening for gestational diabetes (GDM) during ANC.  
Results: The quality of ANC was generally regarded as inadequate due to limited 
human resources, low level of counselling skills, and shortage of equipment and 
drugs. The following services were offered by all the surveyed HFs: measurement of 
blood pressure, weight and height, immunization, education and counselling for 
HIV and prevention of mother to child transmission, and for pregnancy danger 
signs. About 92% of the HFs tested urine for albumin and glucose. Out of 12 private 
HFs surveyed, three (25%) reported to always perform a random blood glucose 
measurement to all women attending ANC. The cost of this measurement ranged 
from one to four dollar per sample (1500 to 6000 TZS). According to the ANC health 
workers, blood glucose testing is important but the government should provide 
guidelines, materials and training.  
Conclusion: Diabetes screening during pregnancy is already in place in most of the 
ANC in Dar es Salaam by testing urinary glucose and albumin in every woman 
attending ANC. As the sensitivity of glycosuria for GDM is low, selective blood 
glucose testing during ANC visits using the existing HIV testing and counselling 
program as an entry-point may be an option. Studies on the actual cost for such a 
program including management of GDM in the Tanzanian setting are necessary.  
 
 
 Blood glucose testing during ANC visits: opportunities and challenges 
139 
 
Background 
Sub Saharan Africa (SSA) has the highest maternal mortality in the world, with the 
majority of maternal deaths being attributed to haemorrhage, infections, 
obstructed labour and hypertension [1, 2]. In Tanzania, there is a slight decrease in 
maternal mortality from 578 to 454 per 100,000 in the last 10 years, but Tanzania is 
still among the countries with the highest maternal mortality in SSA [3]. In addition, 
it is one of the top ten countries with highest stillbirths rate, reported to be >25 per 
1000 births [4]. In most cases, interventions to address maternal mortality and 
stillbirths are implemented in the reproductive and child health (RCH) care during 
prenatal and postnatal visits. Reproductive and child health clinics, therefore, are 
considered as a point of care where interventions for prevention, screening and 
management of GDM could be implemented, starting during antenatal care (ANC).  
Although GDM and unrecognized type 2 diabetes mellitus may lead to maternal 
and foetal morbidity and mortality in SSA, timely diagnosis and management 
strategies rarely exist in this part of the continent. Studies show that prevalence of 
GDM in Tanzania has increased from 0% to 5.9% in about 20 years [5, 6]. These 
findings suggest that something has to be done at the ANC level. The only screening 
strategy currently in place is urine analysis. A glucose test in urine has low 
sensitivity in detecting women with GDM, and is therefore not recommended [7, 
8]. The International Diabetes Federation recognizes identification and treatment 
of GDM as a global priority [9]. Every pregnant woman is supposed to attend 
antenatal clinic (ANC) more than once during the course of the pregnancy, which 
offers a unique opportunity for education and intervention to prevent adverse 
pregnancy outcomes and to establish lifestyle changes.  
The main objective of this study was to assess existing opportunities and possible 
challenges for including GDM screening during usual ANC visits in Tanzania. We 
therefore reviewed literature on the ANC services. Additionally, we conducted a 
survey among health facilities in an urban setting (Dar es Salaam) to investigate the 
possibilities of integrating blood glucose testing in the usual ANC regimen within 
the current protocol. We also investigated the attitude of health care providers 
regarding screening, counselling and management of GDM. The study was intended 
to provide information to guide in development of strategies for implementing 
diabetes screening during pregnancy.  
 
Chapter 6 
140 
 
Methods 
Review of health care services in Tanzania 
Various published reports and scientific studies conducted in Tanzania were 
reviewed to establish the state of health care services, the main focus being on 
ANC with reference to the WHO’s guides on antenatal care procedures. The 
internet was searched to identify relevant reports and scientific papers. The 
literature presented includes the Tanzanian health care system and the Tanzanian 
ANC system. 
 
Health facility survey 
Sampling procedure 
A health facility survey was conducted in Dar es Salaam, Tanzania, from February 
through March 2013. Dar es Salaam region is the largest city in the country with a 
population of about 4.3 million. According 2010 data the region has 449 HFs, 28 
hospitals, 29 health centres and 392 dispensaries. About half of the HFs (244) offer 
ANC services, 133 being private and 91 being government managed [10].  
Health facilities in the region offering RCH services were stratified into hospitals, 
health centres and dispensaries. All health facilities owned either by individuals, 
groups of people, faith based organization or parastatal were grouped under 
private managed HFs. While hospitals were purposively selected, health centres 
and dispensaries were randomly selected. The number and distribution of the 
included health facilities is shown in Table 6.1. 
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Data collection and analysis 
Pretested structured questionnaire was administered through face to face 
interview with the in-charge of the ANC services in each health facility. The 
questionnaire covered quantitative and qualitative information including health 
facility information, availability of delivery services, availability of health 
education/counselling, physical assessments, laboratory services, blood glucose 
testing, costs per sample, equipment and availability of drugs. Other aspects in the 
questionnaire were personnel training and infrastructure. Respondents were also 
asked about their views regarding glucose testing for pregnant women attending 
ANC. A checklist was used to assess ANC facility infrastructure, supplies and 
equipment and health care practices during ANC clinic. Descriptive analysis was 
done using IBM SPSS program version 19.0, Chicago, IL. and results were presented 
as frequencies (number and percentages).The study was approved by the Tanzania 
National Institute of Medical Research. For the government facilities, permission 
was also obtained from the district medical officer and the in-charge of the 
selected health facility. The facility director provided permission for private health 
facilities.  
 
 
Results 
Literature review 
Health service delivery in Tanzania 
The health care delivery system in Tanzania is well organized. As per the 
assessment carried out in 2012, there were a total of 6663 health facilities in the 
country, comprising 241 (4%) hospitals, 742 (11%) health centres and 5680 (85%) 
dispensaries [11]. 
 
The health care system operates in a model of a pyramid shape, the lowest level 
(base) being the community HFs owned by the village government. The second 
level includes the dispensaries and is the primary level for RCH services (Figure 6.1). 
The next level consists of health centres which also receive referrals from 
dispensaries. Higher up in the pyramid are the district hospitals, which also serves 
as district hospitals; together with the dispensaries and health centres they 
constitute the primary health care [12]. The regional hospitals receive referrals 
from the district hospitals or from the health centres depending on the severity of 
the problem. Most government and private dispensaries and health centres offer 
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ANC services daily, and women with pregnancy danger signs are referred either to 
the health centre, to the district referral hospital or regional referral hospital.   
 
Figure 6.1: Organization of health care system in Tanzania (Adopted from the Ministry of 
Health website:  http://www.moh.go.tz/index.php/health-services-in-tanzania)[13] 
Limited budget has always been a problem in the Tanzanian health care system. For 
example, in 2010/2011 the health budget was 9.8% of the national budget 
compared to 15% recommended by Abuja Declaration [14]. The government 
contribution to health was 54% and some interventions for prevention and 
counselling for HIV/AIDS and malaria depended mainly on foreign funds [15]. With 
regard to human resources, on average, only one third of the posts are filled, of 
which dispensaries and health centres have a shortage of more than 66% [14]. A 
study in five districts in the Southern part of Tanzania showed that only 14% of the 
recommended number of nurses and 20% of the clinical staff has been employed at 
the facility [16]. 
In 2003, the Tanzania Diabetes Association in collaboration with the Ministry of 
Health and Social Welfare established diabetes clinics which are currently run by 
the district, regional or national referral hospitals [17]. In 2006, there were 29 
diabetes clinics, the majority being within the regional hospitals. These clinics offer 
free consultations and the government subsidises medical and laboratory costs 
[18]. During ANC visits, women who are detected with hyperglycaemia from urine 
analysis or who show typical symptoms of diabetes during pregnancy are referred 
to the diabetes clinic. 
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Antenatal care in Tanzania 
Antenatal care is important for a wide range of preventive and curative services 
and it is offered in RCH. This is also where pregnant women are informed on the 
importance of being attended by skilled health personnel for delivery and post-
delivery care.  
In Tanzania, maternal and child health services started in 1974. Since then, several 
guidelines and strategies for promoting improved maternal and child health have 
been developed and disseminated [19, 20]. This included the reproductive and 
child health strategic plan, with the main goal to reduce maternal, neonatal and 
child morbidity and mortality by strengthening health systems and increasing 
access to RCH services[19, 21].According to the National Health Policy, all antenatal 
services are free; in addition pregnant women are exempted from paying health 
service user fees at the government health facilities. However, this is not 
implemented fully, and for some services such as laboratory services and drugs 
pregnant women are forced to pay. This is often the case when a particular service 
is not offered and when drugs are out of stock at the health facility [16]. In private 
facilities offering RCH services, women pay for almost every service, except family 
planning, HIV and counselling on prevention of mother to child transmission 
(PMTCT) that are supported by the government. 
 
In 2001 the World Health Organization (WHO) issued guidance on a new model of 
ANC called goal-oriented or focused antenatal care (FANC), for implementation in 
developing countries [22, 23]. Tanzania has adopted this WHO recommendation of 
a minimum of four ANC visits during pregnancy, since 2002. The FANC guideline 
recommends that during these four visits, blood pressure, haemoglobin estimation, 
weight gain, testing of urine for albumin and glucose, fundal height, foetal lie and 
movements or heart rate are assessed. Measurement of height and testing for 
syphilis, HIV status, blood group and Rhesus factor are recommended to be done at 
least once during the course of pregnancy. Other ANC services include preventive 
strategies for tetanus, malaria, anaemia and mother to child HIV-transmission, 
education on possible complications and preparation for delivery care of new-born, 
family planning as well as treatment of detected ill-health [22].   
Currently, PMTCT services have been integrated within the maternal, neonatal and 
child health platform, where HIV and syphilis testing is mandatory to all pregnant 
women attending ANC [24]. It is recommended that those who were not tested 
during pregnancy, they should be checked during labour or postnatal care.  
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There is high coverage of HIV testing and counselling. In 2011/2012, about 80% of 
pregnant women tested for HIV and 76% received results [25]. The incidence of 
testing and receiving results was higher in urban areas (89.6%) compared to rural 
areas (73.2%), with also a higher proportion of women receiving results in the 
urban (89.6%) compared to rural areas (73.2%).  
Quality of Antenatal Care 
Several studies have attempted to assess the quality antenatal and childbirth care 
in Tanzania. Most of the studies were conducted in the rural areas. Duysburg et al 
(2013) assessed the quality of antenatal and child care in selected rural health 
facilities in Burkina Faso, Ghana and Tanzania [26, 27]. They reported satisfactory 
quality of ANC and child birth services, but noted  that there was poor and less 
efficient counselling as only one out of three women was counselled on pregnant 
danger signs. Moreover, there was poor health education, laboratory examinations 
were rarely performed, and there was inadequate monitoring of the mother and 
the newborn during childbirth. Poor counselling was also reported by Pembe et al. 
[28]. 
 
A cross-sectional study in Tanzania, Uganda and Burkina Faso assessed the health 
worker’s compliance to the FANC [29]. The authors revealed that there was 
substantial variation in the provision of antenatal care services among health 
facilities within and among the country sites, but generally, the workers omitted 
some of the practices stipulated in the FANC guidelines. Also, reagents for 
laboratory tests and drugs as outlined in the guidelines were often out of stock in 
most facilities. Similar findings of failure to follow FANC guideline were reported by 
different studies done in Kilombero, Ngorongoro and Rufiji districts of in 
Tanzaniaand shortage of materials and high workload due to absentism were 
mentioned as reasons for not following the guideline [30-32]. 
In a rural clinic in Morogoro region, Nyamtema et al [33] observed that attendance 
was generally good since 83% of the mothers had at least two visits. Necessary 
equipment for measuring blood pressure, stethoscopes, weighing scales, HIV test 
kits, and malaria prevention drugs, mebendazole and folic acid were available in 
more than 90% of the HFs. However, glucose and albumin sticks were rarely 
available. They further concluded that there was a substandard quality of care 
resulting from shortage of staff and lack of material resources [33]. Other 
researchers assessed the reasons for late initiation of ANC in selected rural districts 
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and revealed perceived poor quality of care, including poor patient–provider 
relationship, late recognition of pregnancy and lack of social and economic support 
from the partner as the most common reasons for starting ANC late [34, 35].  
Gupta et al [36]assessed factors associated with attending four or more ANC visits. 
They observed that being informed about signs of pregnancy related complications, 
having blood pressure measured and having urine and blood samples taken during 
the ANC visit, were associated with higher rates of ANC visits. This study concluded 
that efficiency in ANC depended on the number of staff, structural quality of care, 
process quality of care and perceived quality of care.  
In conclusion, general attendance to ANC in Tanzania is good. However, the quality 
of care varies across the country. Observed substandard ANC services were mainly 
attributed to inadequate human workforce (number and skills) and lack of regular 
supply of materials and drugs as well as limited socioeconomic support leading to 
less number of visits or late initiation of ANC.  
Results from the survey 
Among the 24 HFs in Dar es Salaam investigated, the average number of women 
attending ANC per day was 28 (range 10-75). Average gestational age for starting 
ANC was 20 weeks. Blood pressure, height and weight measurements were taken 
in all HFs. Additionally, immunization, education and counselling for HIV, PMCTC, 
and pregnancy danger signs were also offered in all surveyed HFs. However, 
emergency transport was available in less than half of the HFs. Five HFs did not 
have delivery services and one faith based centre did not have family planning 
education due to religious reasons (Table 6.2).  
 
Table 6.3 shows the laboratory assessments that are performed at the HF and 
whether the women had to pay or not for the service. All biochemical assessments 
were done in the general laboratory except for syphilis and HIV tests which were 
done by RCH nurses at the ANC clinic. In few of the clinics, biochemical assessments 
were free of charge. Urine test for glucose and albumin was a common practice in 
almost all clinics (91.7%). 
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Table 6.2: ANC services, counselling and availability of facilities and equipment in 
the surveyed health facilities 
Service N % 
Immunization 24 100 
Family planning 23 95.8 
HIV/AIDS 24 100 
PMTCT 24 100 
HemoCue (Hb) 21 87.5 
Emergency transport 10 41.7 
Computer 17 70.8 
Internet connection 8 33.0 
Waiting room 20 83.3 
Glucometer 12 50.0 
Health education and counselling 
Diet and nutrition 21 87.5 
Danger signs 24 100 
Hygiene 23 95.8 
Breast feeding 22 91.7 
STI 24 100 
Medicine use 24 100 
Hb: Haemoglobin; PMTCT: Prevention of mother to child transmission; STI: Sexual 
transmitted infections 
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available. They further concluded that there was a substandard quality of care 
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researchers assessed the reasons for late initiation of ANC in selected rural districts 
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Table 6.3: Laboratory tests and charges 
 Is the test done Charged 
Test Always Rarely Never Yes  No 
n % n % n % n % n % 
Malaria (BS) 20  83.3 4 16.7 0 0.0 16  66.7 8  33.3 
Hb 20  83.3 4 16.7 0 0.0 14  58.3 10  41.7 
Blood group 15  62.5 8 33.3 1 4.2 14  60.9 9  39.1 
HIV 23  95.8 1 4.2 0 0.0 3  12.5 21  87.5 
Syphilis 14  58.3 10 41.7 0  0.0 10  41.7 14  58.3 
Urine 
analysis 
22  91.7 2 8.3 0 0.0 13 54.2 11  45.8 
Stool 
analysis 
3  12.5 3 12.5 18 75.0 4 16.7 0 0.0 
Ultrasound 4  16.7 6 25.0 14  58.3  10  41.7 0 0.0 
 
Current practice and opinion regarding diabetes screening during pregnancy 
In private facilities, blood glucose was checked always in three (25.0%), rarely in 
four (33%) and not done in five (41.7%) (Table 6.4). In the government facilities, 
blood was tested for glucose rarely in nine HFs (75%) and three facilities did not 
perform the test at all. In the HFs where blood glucose test was performed, it was 
always done regardless of the last meal and using portable glucometer; oral 
glucose tolerance tests were seldomly done. Every positive case found was referred 
to the gynaecologist within the same HF, to the district hospital or to the diabetes 
clinic. A total of 13 HFs (54%) reported to selectively carry out blood glucose testing 
to women with glycosuria or those with obvious clinical symptoms of 
hyperglycaemia. However eight HFs (33.3%) reported to never have found any 
glycosuria. 
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Table 6.4: Blood glucose testing during pregnancy: Comparison of surveyed 
government and private HFs 
Variable  Government (n=12) 
 
Private (n=12) 
 
  N % n % 
Blood glucose 
tested 
Always 0  0.0 3  25.0 
Rarely 9  75.0 4  33.3 
Never 3  25.0 5  41.7 
Type of test 
(for those who 
do the test) 
Universal 0  0.0 3  42.9 
Selective 9  100 4  33.3 
Testing 
procedure 
Random BG 9  100 7  100 
Device used Portable 
glucometer 
6  66.7 7  100 
Laboratory 3  33.3 0  0.0 
Paying for the 
test 
Yes 2  22.2 7  100 
No 7  77.7 0  0.0 
 
Health workers liked the idea of blood screening for GDM but they mentioned that 
this would include several changes in the ANC protocol, and hence modification of 
ANC cards and training of care providers. Also, the government should commit to 
supply the glucometers and strips. In addition, some health care providers, 
especially those working at the district hospitals, expressed their concern that even 
the current protocol is not implemented properly. In most cases supplements, test 
kits and reagents are out of stock, so they were not sure how the introduction of a 
new item could be implemented unless there is donor support like for HIV/PMTCT 
interventions. One of the health workers from a government dispensary said 
“Blood from the mothers is drawn anyway for the syphilis and HIV tests, so it is easy 
to incorporate blood glucose test within that context. However, protocol and 
logistic supplies are very important”. 
Another statement from a health worker in one of the government hospitals that 
explained the possible challenges was “Even the current ANC protocol (FANC) is not 
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followed due to shortage of resources including personnel, I am worried if 
introduction of another item which will cost more time and personnel can work” 
Generally, there were mixed views with regard to blood glucose testing. While few 
health care workers felt that the current practice of glucose test in urine is enough 
the majority suggested that blood glucose test can be done with minimum 
additional cost 
The private hospitals charge a fee for most ANC services, except for PMTCT and 
micronutrient supplements which are provided by the government. The cost for a 
blood glucose test ranged from 1500 to 6000 Tanzanian shillings which is 
equivalent to about 1 to 4 USD per test (Table 6.4). Except in few private hospitals 
where a woman will be directly attended by a gynaecologist, in most cases the 
nurses were handling all women during ANC visit and referred them either to see 
the clinical officer in-charge of RCH, the gynaecologist, the health centre or to the 
district hospital depending on the complication(s)/pregnancy danger sign a woman 
has. The most common reported causes of referral included anaemia (Hb<8.5g/dl), 
hypertension, oedema/preeclampsia, mal-presentation, previous scar, under-age, 
malaria, multiple pregnancy, urinary tract infections, negative Rhesus factor, 
bleeding, lower abdominal pain and sometimes low stature (height <150cm) (Table 
6.5). 
Table 6.5: Reasons for referring pregnant woman to the specialist 
Reason for referral N % 
Low Hb (<7 g/dl) 17 70.8 
PIH 19 79.2 
malposition 15 62.5 
Previous stillbirth 13 54.2 
Sugar in urine 16 66.7 
Severe malaria 15 65.5 
History of caesarean 12 50.0 
Prolonged labour 12 50 
Negative RH factor 23 95.8 
Hb: Haemoglobin, PIH: pregnancy induced hypertension, RH: Rhesus factor 
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When asked about the kind of training received in the past five years, most RCH 
care providers attended training on HIV/PMTCT (95.8%), family planning (75.0%), 
FANC (66.7%), preeclampsia (66.7%).Less were trained on trained on nutrition 
(41.7%), and diabetes (16.7%).  
Discussion 
This study sought to summarise available literature on ANC in Tanzania and to 
assess possibilities of blood glucose testing for GDM during ANC visit. In our study, 
immunization, family planning, PMTCT and health education and counselling were 
regularly performed in almost all surveyed HFs. More than 90% of the HFs did urine 
analysis for glucose, albumin and leucocytes regularly and those with positive 
glycosuria were referred to district hospital or to the diabetes clinic. 
 
Similar with what was observed in the studies in rural areas [26, 27], some of the 
recommended test were not done in the urban setting. This was similar to what 
was reported in another study that there was inadequate infrastructure, 
equipment and supplies for perinatal care in Dar es Salaam public health 
institutions [37]. Other researchers reported poor quality of care in ANC in both 
private and government HFs in Dar es Salaam, but the private facilities were 
relatively performing better [38]. However, only few women can attend private 
HFs. In the rural area, urine testing for albumin and glucose was rarely done in 
most of the clinics [33]. Some clinics reported to have never found any woman with 
glycosuria, probably due to low sensitivity of urine test to identify GDM cases. In 
our previous study, most women with GDM had normal urine test for glucose [5], 
hence if screening is based on urine analysis instead of blood glucose test, most 
women will be left undiagnosed.  
Blood glucose test was done in few private HFs and the cost is considered high to 
an ordinary pregnant woman in Tanzania, but perhaps it is because these are profit 
making organisations. In reality, the actual cost for screening alone may be lower, 
but total cost for treatment, care and increased number of ANC visits may be high. 
Increased costs for care in women diagnosed with GDM was reported elsewhere 
[39]. Another issue may be the psychological impact for those who would be 
diagnosed with GDM due social stigma or fear of having a lifelong disease [40, 41].   
Chapter 6 
152 
 
Opportunities for blood glucose testing during ANC visit 
As commented by the respondents and based on the reports in literature, there are 
good opportunities for including diabetes screening in the usual RCH regimen. One 
of the opportunities is the existing screening for HIV and syphilis during ANC visit.  
In Tanzania, syphilis and HIV screening is a mandatory part of routine ANC. This is a 
good opportunity since blood is already drawn within the ANC and not in the 
central laboratories as it is done for other biochemical tests. Another opportunity is 
the existence of health/nutrition education and counselling for danger signs which 
could be utilized by adding a component of GDM as one of the danger signs. 
Although in most cases counselling is done in groups, it is still worth to train health 
care providers so that proper counselling to at risk individuals can be done during 
regular ANC counselling sessions.  
Several contacts to the RCH clinic including prenatal, postnatal and child care 
programmes would as well provide close follow-up of women with GDM or those 
with risk factors. According to the demographic and health survey of 2010, 96% of 
pregnant women had at least one visit, and there is good coverage for ANC as 
about 80% of the women live within 5km from ANC [3]. Overall, only half of the 
pregnant women gave birth at the health facility but variation between rural and 
urban areas was large, with 42% in the rural areas and more than 80% in the urban 
area. High institutional delivery especially in urban areas is an opportunity such 
that women identified or those who could have been missed during ANC can still 
be assessed for GDM during delivery. Moreover, there is a good organized referral 
system whereby district and regional hospitals are located in almost all districts and 
all regions respectively, which are better equipped and with more specialised 
doctors. Likewise, there are also established diabetic clinics to handle diabetes 
cases in almost every region and in most of the districts. 
The inclusion of urine tests for albumin and glucose as mandatory requirement for 
all pregnant women attending ANC shows that the danger of diabetes during 
pregnancy is already recognised by the government.   
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Challenges 
Next to the mentioned opportunities, there are also challenges which need to be 
addressed. Some were identified during the survey and others were reported in the 
reviewed literature. Limited human and materials resource were mostly reported 
among the factors affecting quality of ANC. These are also the two main recognized 
problems in Tanzanian health care [16]. 
Furthermore, the few present staff in ANC lacks several skills with regard to 
counselling and management of aspects related to pregnancy. In our study, most 
RCH care providers received in-service training on HIV/PMTCT, family planning, 
FANC and tuberculosis which could probably be due to donor support of the 
integrated management of childhood illness (IMCI) FANC and Safe Motherhood 
programmes. Training on diabetes was however rare. Management and counselling 
of women diagnosed with GDM is important, hence health care providers should 
be trained in proper education and counselling skills. In the urban Tanzanian 
region, the average time spent for the ANC visit is 15 and 9 minutes for the first and 
subsequent visits respectively [42]. In the rural Tanzania district, Pembe et al. 
reported deficiencies in counselling on danger signs during pregnancy and 
observed inadequate time for interaction between antenatal care providers and 
their clients [28]. The addition of another component which may need extra time 
for counselling may bring extra work load to the already overburdened health care 
providers, especially in settings with limited ANC providers.  
Another challenge is the cost. Lack of money was reported as one of the factors 
affecting number of ANC visits [35].  In our study, we found that testing blood 
glucose levels may be unaffordable for an ordinary Tanzanian woman if it will be 
implemented without government support. However, this was in private clinics 
which are mainly profit oriented. In the government clinics, the primary costs for 
screening and diagnosis would be for the glucometer and the  strips, which in that 
case may be low. However, the subsequent cost for management and treatment 
may be high [43]. The free access to exemption policy for ANC services is 
sometimes not applicable since mothers have to pay in private laboratories for 
check-ups done during ANC like urine tests and testing of blood group and Hb 
levels. We speculate that, women at risk may be willing to pay for the extra costs 
for GDM testing and treatment if they are informed well and their partners are 
involved. However, a well-planned study to assess additional costs and willingness 
to pay is needed to support such a policy.  
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With regard to screening and diagnosis guidelines, there is no guideline for blood 
glucose testing during ANC in Tanzania. A recent training manual for non-
communicable diseases  has a component of GDM and it recommends universal 
screening for all pregnant women aged above 30 years and selectively for those at 
risk [44]. The ANC card for recording all the assessments has been used as a guide 
for ANC services. Gross et al [31] found that some aspects recommended by FANC 
were missing in ANC cards and this was probably one of the reasons for not 
following all FANC procedures by some of the health care providers. In case GDM 
has to be included, there is a need to change the format of the existing ANC cards. 
Concluding remarks 
This review and HF survey describe existing health care with respect to ANC in 
Tanzania together with a discussion on possible opportunities and challenges for 
inclusion of GDM screening during ANC services. Our HF survey included 10% of the 
HFs offering ANC in Dar es Salaam city hence representativeness of the results to 
other regions in the country cannot be ascertained. Diabetes screening during 
pregnancy is already in place in most of the ANC in Dar es Salaam region. Urine test 
for glucose is part of the general ANC guideline. However, in rural areas it is 
seldomly done. While working on the existing challenges, blood glucose testing 
using the existing HIV/PMTCT as an entry point is suggested.  
Some argue that universal screening is more relevant as it detects more cases and 
may improve diagnosis and care, and eventually improve the outcome [45, 46]. In 
addition, those who advocate for universal screening also argue that some women 
(up to 30%) may be missed with selective screening and there are no additional 
cost when universal screening is compared with selective screening [45, 47]. On the 
other hand, treatment and management has only be proven to be effective among 
women with risk factors, thus emphasis selective screening [48]. Due to limited 
resources, selective screening based on risk factors would be more realistic in our 
setting. In that case, there is a need to develop scores relevant to the Tanzanian 
situation which can be used to easily identify women at risk. In addition, the ANC 
should be prepared for treating, counselling and regular follow-up of the identified 
GDM cases. As an alternative, women at risk can be identified using a risk score 
without blood glucose testing, and counselled for lifestyle modification to avoid 
adverse outcomes.  
Our results show that it is also important to improve awareness amongst 
healthcare providers at all levels. In addition, the mind set of obstetricians need 
also to be geared towards having an index of suspicion for those who may have 
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GDM. Setting-up guidelines, training and acquiring resources should start, and 
meanwhile further studies on the costs and benefits need to be done to justify 
blood glucose testing for screening in Tanzania especially in the urban areas where 
prevalence was relatively high.  
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The main focus of this thesis was to determine the prevalence of gestational 
diabetes mellitus (GDM) and its determinants in urban and rural areas in Tanzania 
and in Sub Saharan Africa (SSA). Five specific study questions were formulated 
(Chapter 1) and investigated in chapters 2 to 6. A total of 910 pregnant women 
attending antenatal clinics (ANC) in selected rural and urban areas were invited to 
participate. In this chapter the main findings are summarised followed by a 
discussion on methodological considerations and the public health relevance. 
Finally, suggestions for future research are given.  
 
The key findings are summarised below and in Table 7.1. The prevalence of GDM in 
Tanzania was high, with a much higher prevalence in urban compared to rural areas 
(Chapter 2). Risk factors associated with GDM were family history of diabetes, 
previous stillbirth, mid upper arm circumference (MUAC) ≥28cm overweight or 
obesity and anaemia. No significant association of other factors such as maternal 
height, age, gestational age or dietary diversity with GDM was observed.  
We identified 22 studies reporting the prevalence and or risk factors of GDM in six 
SSA countries (Chapter 3). Heterogeneity in the 15 studies with low or moderate 
risk of bias, that were included in a meta-regression analysis, was high. We 
observed a relatively higher prevalence in studies done after the year 2000 
compared to studies done before 2000 (5.1% vs 3.7%), when women at risk were 
examined compared to less risk (6.5% vs 3.8%) and when more current diagnostic 
criteria were used compared to older ones (5.11%vs 4.25%). In the studies 
conducted after the year 2000, the prevalence of GDM ranged from 0.3% (95% CI 
0.2-0.5) in a tertiary university hospital to 13.9% (95% CI 11.5-16.4) in a high risk 
population in Nigeria. When categorized into sub-regions, the prevalence 
proportion estimates were similar in West, East and South African studies (Table 
3.2). Six risk factors were reported in more than one study, namely advanced 
maternal age (≥30 years), overweight and obesity, previous macrosomic child, 
previous still birth, family history of type 2 diabetes and history of GDM. While 
definitions of other reported risk factors were similar, the definition for overweight 
or obesity was different in each study where by MUAC, body weight or BMI were 
used.  
The prevalence of hypertensive disorders of pregnancy (HDP) in the current study 
was 8.9% in the urban areas and 5.3% in the rural areas (Chapter 4). Advanced 
maternal age, high gestational age, increased MUAC, increased dietary diversity 
and being HIV positive were independently associated with HDP in urban women. 
Increased age and gestational age were identified as independent risk factors in 
rural women. We did not find a clear association between GDM and HDP.  
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Regarding the birth outcomes in the urban population, occurrence of macrosomia 
was higher than that of low birth weight (Chapter 5). We observed high occurrence 
of macrosomia in single compared to married women (11.0% vs 4.9%) and less 
occurrence among self-employed compared to unemployed (3.4% vs 9.0%). GDM 
and birth weight of the previous child were significantly associated with 
macrosomia, after adjustment for confounders, while presence of HDP was the 
main predictor of low birth weight. Other factors such as HIV status, anaemia, 
maternal height, education level and gestational age at first visit to the clinic were 
not associated with birth weight in our study population.  
 
We identified several challenges in the antenatal care system in Tanzania; the main 
ones being limited material and human resources (Chapter 6). The regular contacts 
of the pregnant women with the health care, HIV testing and the existing 
counselling services provide an opportunity for including selective blood glucose 
testing during antenatal care (ANC) visits.
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 Table 7.1: Summary of the main findings of studies described in this thesis 
Study population, setting, sample size  
and design 
Main findings 
 Research question: Is gestational diabetes mellitus  present in Tanzania? If yes, what are 
the determinants? (Chapter 2) 
Pregnant women (N=910); urban (n=609) 
and rural (n = 301); cross sectional survey 
 Overall prevalence of GDM was 5.9%.  
 Higher prevalence in urban (8.4%) 
compared to rural areas (1.0%) 
 Associated risk factors include MUAC 
≥28cm, previous stillbirth, anaemia and 
family history of diabetes 
 Research question: What is the burden and risk factors for gestational diabetes mellitus 
in Sub-Saharan Africa? (Chapter 3) 
Systematic review and meta regression 
analysis of gestational diabetes in SSA. 
Published journal articles in PubMed, 
manual search for identified potential 
articles from reference list 
 Few studies (n=22) from six SSA countries. 
 High heterogeneity among studies with 
low or moderate risk of bias(n=15)  
 Highest prevalence was up to 13.9% 
among high risk women 
 General trend shows increased prevalence 
in studies done after the year 2000   
 Research question: What is the prevalence and potential risk factor(s) for hypertension 
during pregnancy in women attending antenatal clinics in Tanzania? (Chapter 4) 
Pregnant women (N=910); urban (n=609) 
and rural (n = 301); cross sectional survey 
 Overall prevalence of hypertension during 
pregnancy was 7.7%;  higher prevalence in 
urban areas (8.9%) compared to rural 
areas (5.3%)  
 Associated risk factors:   
o urban areas: age, gestational age, 
MUAC, HIV and dietary diversity 
score 
o Rural areas: age and gestational age  
 Research question: What are the maternal risk factors for macrosomia and low birth 
weight? (Chapter 5) 
Urban women (n=466);  prospective 
cohort  
 Occurrence of macrosomia and low birth 
weight were 5.9% and 3.6% respectively.  
 GDM and previous macrosomic infant 
were associated with macrosomia 
 HDP was associated with low birth weight 
and stillbirth 
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 Research question: How is the Tanzania antenatal care system prepared to handle the 
rising challenge of diabetes in pregnancy? (Chapter 6) OR can blood glucose testing be 
integrated in the usual ANC services? 
Literature review, urban health facilities 
survey (n=12 private and n=12 
government facilities)  
 Diabetes screening using urine test for 
glucose is universally done in the urban 
area 
 The main challenge is limited human and 
material resources 
 Existing HIV counselling and testing can be 
used as an entry point for blood glucose 
testing with minor adjustment and training 
 Further studies on costs for screening and 
management are needed 
 
Methodological aspects 
Although methodological considerations were discussed in each chapter, this 
section will elaborate on issues to take into account when interpreting the findings 
or applying the methods used in this thesis in a different setting. The potential 
sources of error discussed possibly affect internal validity, are classified into 
selection bias, information bias and confounding [1].  
 
Selection of study participants 
Generally, selection bias may occur during enrolment or due to decline to 
participate or loss to follow-up. Our study was done in a rural and urban antenatal 
clinic setting where women attending antenatal care were invited and consented 
to participate (Chapter 2, 4, & 5).the majority of the Tanzanian women (96%) 
attend ANC at least once during pregnancy [2].  
In urban areas, 715 women were invited to participate, 637 qualified for 
examination and 599 completed OGTT. In the rural areas, 400 eligible women were 
invited to participate, 315 qualified for examination and 301 completed OGTT. 
Overall response rates were 89% and 79% in urban and rural areas respectively 
(Chapter 2 & 4). Loss to follow-up in the urban area was about 23% (Chapter 5). 
Based on the high ANC attendance rate and high response rates our study 
population can be seen as representative of the majority of the pregnant women in 
the studied areas.  
 
One of the inclusion criteria was pregnant women who were ≥20 years old during 
recruitment. We considered this age category to match the characteristics of rural 
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and urban women. According to Tanzania Demographic and Health Surveys (TDHS) 
(2010) [2], teenage pregnancy is relatively higher in rural (26%) compared to urban 
areas (15%), hence inclusion of teenage women would have resulted in a wider 
variation in the characteristics of the participants, but also more difficulties in in 
comparing the urban and rural areas. In addition, prevalence of GDM increases 
with age so it is less likely to find teenage women with GDM. We also limited our 
inclusion to women at gestational age ≥20 weeks, as placental hormones that 
affect glucose metabolism start increasing considerably at the second and third 
trimester [3]. The usual initiation of antenatal clinic attendance in Tanzania was 
also considered, which was around five months [2]. Most guidelines consider GDM 
screening at 24 to 28 gestational weeks and earlier for high risk women [4, 5]. 
Nevertheless, when stratified according to gestational age (<24 weeks, 25 to 29 
weeks and above ≥30 weeks), we observed no differences in mean blood glucose 
levels or mean MUAC between these three gestational age categories (Chapter 2). 
 
Information or misclassification bias 
Error in measuring exposure or outcome may cause information bias. The 
outcomes studied in this thesis include prevalence of GDM (Chapter 2), prevalence 
of HDP (Chapter 4) and birth weight (Chapter 5). Error in the prevalence estimate 
of GDM may occur if participants are classified as having GDM while they are not. 
To minimize this error, all women were categorised as having GDM or not based on 
a standard, the WHO 1999 criteria. It is recommended that the best way to 
diagnose GDM is the use of oral glucose tolerance test (OGTT) [6]. Nevertheless, 
ten women who did not undergo the OGTT were included (Table 2.4). Among 
them, eight women were diagnosed using two fasting blood glucose measurements 
≥6.1 mmol/L and two women by using fasting blood glucose ≥6.1mmol/L in 
combination with random blood glucose ≥7.8mmol/L. Blood glucose was measured 
using HemoCue glucose analyser. This portable glucometer is considered to be 
reliable and accurate for both fasting and OGTT glucose levels, and comparable to 
other accurate laboratory methods [7, 8].  
 
The definition of hypertensive disorders of pregnancy includes women with chronic 
hypertension, preeclampsia or pregnancy induced hypertension without 
preeclampsia [9, 10]. In this study, women were classified as being hypertensive 
during pregnancy if systolic blood pressure was ≥140mmHg or diastolic blood 
pressure ≥90mmHg regardless of the subtypes. In Tanzania, blood pressure is 
monitored during each ANC visit and the ANC guideline requires all women with 
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blood pressure ≥140/90mmHg to be referred to the medical doctor for further 
investigations and management. It is recommended that blood pressure 
measurements be repeated within the same week in another day [11, 12]. This was 
not possible in our setting so the true prevalence might be overestimated. Blood 
pressure measurements can be subject to bias due to cuff size relative to the arm, 
arm position or equipment used [13]. Measurements were taken by an 
experienced midwife and the automated device used was checked regularly. 
 
A child is classified correctly at birth into preterm, term or post term based on 
gestational age. According to WHO, low birth weight is defined as weight at birth of 
<2500 g and it includes preterm births, small for gestation i.e. <10th percentile, or 
born term but small [14]. In our study (Chapter 4), infants were classified into low 
birth weight or macrosomia if they were born within 37 to 42 gestation weeks.  
Accurate estimation of gestational age is essential for correctly classifying infants 
according to birth weight. Gestational age was extracted from ANC card. Although 
ultrasound is considered more accurate, in Tanzanian ANC the common method 
used for estimation of gestational age is based on the last menstrual period 
reported by the mother during first visit [15, 16]. Estimating gestational age by 
recall may be prone to some error because some women may have irregular 
menstrual cycle [17]. 
With regard to macrosomia, there is no universally accepted definition [18]. It 
varies from birth weight ≥4000 g to ≥4500 g, or the 90, 95 or 97 percentile of the 
population specific growth curve. In SSA the 90th percentiles of birth weight ranged 
from 3600 g in Niger to 4050 g in Algeria [19]. In our case, cut off of ≥4000 g was 
used.  
A source of error could be late weighing of the infant. It is recommended that birth 
weight should be measured within four hours after delivery [14]. As all women 
reported to have delivered in a health facility, we are convinced that infants were 
measured within the recommended duration. 
 
Error in the assessment of exposure variables 
Overweight and obesity: In general women are classified as overweight or obese 
using pre-gestational weight or weight measured during first visit if before 12 
gestational weeks. Only less than half of the women could recall their pre-
gestational weight and most of them started attending to the clinic late (gestational 
age at booking ranged 8-32 weeks with a mean of 20 weeks). We therefore used 
MUAC as a proxy for BMI. MUAC is known to be relatively stable during the course 
of pregnancy and it was highly correlated with pre-pregnancy BMI [20-22]. In our 
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study population MUAC and BMI at booking were correlated at r=0.78. In addition, 
we used receiver operating curve (ROC) analysis to assess the sensitivity and 
specificity of MUAC as a predictor of GDM and HDP as shown in Figure 7.1. The 
results of the ROC analysis showed that for GDM the area under the curve was 0.56 
(95% CI 0.48 – 0.64). The optimal cut-off point (the point that maximize sensitivity + 
specificity i.e. Youden Index J) for detecting GDM was 28.4 cm with sensitivity of 
0.46 and specificity of 0.70 (1-specificy = 0.30). This means that relying on a MUAC 
cut-off of 28 cm alone, only 46% of women with GDM will be correctly identified 
and 30% of women without GDM will have positive results. Considering HDP as the 
outcome, the area under the curve was higher, 0.65 (95% CI 0.58 - 0.72), with 
optimal cut-off point of 29.0cm; sensitivity was 0.50 and specificity is 0.78. This 
means relying on MUAC cut-off of 29 cm alone, only half of women with HDP will 
be correctly identified and 22% of women without HDP will receive positive results.  
Although it has rather low sensitivity for GDM and HDP, MUAC can be used to 
identify overweight/obese women during ANC visits so that they can be counselled 
for recommended pregnancy weight gain and monitored for GDM and HDP.  
 
 
 
Figure 7.1 ROC to assess for MUAC as a predictor for GDM and HDP 
 
Dietary diversity score: Dietary intake assessment was based on data collected 
using the 24-hour recall method. Foods consumed were assigned into pre-
determined food groups and a dietary diversity score was obtained by summing up 
the food groups consumed [23]. The FAO questionnaire has 16 food groups which 
are then aggregated to 9 food groups in assessing dietary adequacy for women 
[23]. We used all 16 food groups to capture micronutrient intake as well as 
consumption of sweets and beverages which are known to be associated with the 
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metabolic syndrome. In this method, each food group is assigned equal value 
irrespective of its health effect or nutritional quality.  
Recall bias is common in dietary recall methods and sometimes foods consumed 
outside home are forgotten [24]. This bias was minimised by using trained 
interviewers prompting for such occasions. Although a single 24-hour recall was 
thought to be sufficient [25], bias due to day-to-day variation of consumption 
cannot be ruled out completely. Up to seven days recall period was recommended 
and thought to be sufficient to minimize memory error [26]. In future, pre-
pregnancy dietary intake or dietary pattern analysis should be considered since 
they represent a broader picture of food and nutrient intake and may be a better 
predictor of disease risk [27, 28].  
.  
Physical activity: We assessed physical activity using the short form of the 
international physical activity questionnaire (IPAQ) which reports Metabolic 
equivalents (MET-minutes/week).Although an objective measure of physical 
activities during pregnancy is mostly recommended [29], wearing a pedometer or 
accelerometer may also affect the usual activity pattern. The device may also fail to 
record some activities for example, if it is put on the lower part of the body, the 
activities involving the upper part of the body like weight lifting or carying a load 
will not be recorded [30]. The method used was therefore considered appropriate 
and more practical for our setting. 
In this thesis, much higher METS-minutes per week in rural compared to urban 
women were observed, showing that the method may have satisfactorily classified 
women correctly into low, moderate or high level of physical activities per week. In 
future, other questionnaire based methods should be explored in comparison with 
the use of objective assessment of physical activities in pregnant SSA women. 
Anaemia:  Haemoglobin (Hb) concentrations were measured using HemoCue Hb 
201+ Haemoglobin photometer. This is one of the recommended equipment for 
measuring Hb levels [31]. To minimize systematic error, the glucometer was 
checked every day as recommended by the manufacturer. Anaemia was defined as 
Hb<11 g/dl [32]. Prevalence of anaemia in our study population was about 70%. 
Haemodilution that occurs during the second and third trimesters as well as 
altitude and smoking status may affect Hb concentrations in pregnant women [32]. 
We observed a similar prevalence of anaemia across gestational age; our study was 
done in the low land ( ≤1000 m above sea level) and smoking was not common in 
the study areas. Hb is always used as a proxy for iron deficiency anaemia during 
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pregnancy. It is estimated that majority of the low Hb levels in developing countries 
would be due to iron deficiency [31]. However, the use of serum ferritin was 
recommended to give better insight in prevalence of iron deficiency anaemia [33]. 
High levels of infection and inflammation may limit the use of serum ferritin as a 
biomarker for iron deficiency in SSA. [32]. Use of other biomarkers such as hepcidin 
and C-reactive protein in GDM should be further explored.  
Confounding  
Another possible source of error that can affect internal validity is confounding. 
Confounding occurs when a measure of association or relationship between 
exposure and outcome is distorted due to the presence of a  third variable, a 
confounder [34]. For example, from the literature, overweight or obesity and 
increased maternal age are known risk factors for GDM. Older women are also at 
higher risk for being overweight or obese. The association of overweight or obesity 
with GDM may therefore be confounded by age. Possible confounders reported in 
the literature were adjusted for in chapters 2, 4 & 5. However, due to the 
observational nature of our study, bias attributable to unmeasured (for example 
vitamin D and iron status, malaria, syphilis, socioeconomic status) or unknown 
confounders cannot be ruled out.  
 
Public health implication of the findings 
GDM is increasingly common in Tanzania and in SSA and is associated with 
increased risk of foetal macrosomia (Chapter 2, 3 & 5). In addition, the prevalence 
of HDP is high and it is associated with low birth weight and still births (Chapter 4 
&5). Thus, GDM and HDP during pregnancy pose a major public health challenge to 
the ill-equipped health system (Chapter 6). The much higher prevalence of GDM 
and HDP in urban compared to the rural areas implies that lifestyle plays a role in 
their occurrence.  
Although we did not find differences in MUAC among rural and urban women, the 
active lifestyle of rural women could be protective since the majority of them were 
engaged in agricultural work, hence had higher level of physical activities [35-37]. In 
addition, urban women had more diversified diet (Chapter 4) which is a reflection 
of their socioeconomic status. Like many other developing countries, changes in 
the food consumption pattern in SSA together with urbanisation have resulted in 
an increased prevalence of overweight and obesity. Lifestyle interventions 
targeting women of reproductive age to maintain normal body weight before 
conception, such as a healthy diet and regular physical exercise, may reduce the 
risk for GDM [38-40]. Planning intervention for women at risk will not only reduce 
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the risk of GDM but also for other metabolic complications associated with 
overweight and obesity. 
 
Diagnosis 
Worldwide, there are variations in screening methods and diagnostic criteria used 
for GDM. Some guidelines recommend two steps, the first step including a 
screening test with 50 g of glucose and the second one involving 100 g OGTT while 
others recommend one step using the 75 g OGTT (Chapter 1). Moreover, to 
recommend universal or selective screening, together with gestational age to start 
screening, is still a topic of debate. The new guideline of WHO 2013 [5] 
recommends diagnosis of GDM using 2 hr 75 g OGTT with a cut-off for fasting blood 
glucose of 5.1mmol/L, which is a lower cut-off as compared to WHO 1999 guideline 
which we used in our study. Due to variation in prevalence rates reported when 
different criteria are used in the same population, there have been always 
difficulties in comparing prevalence rates between different countries, so if 
implemented generally, it will make comparison of epidemiological studies in SSA 
easier. On the other hand, due to the lower cut-off for fasting glucose levels, more 
cases will be identified, where perhaps some of them will not benefit from the 
treatment [41]. For example, in our study, the prevalence of GDM was more than 
double (13.0%, CI 11.4-15.4) when IADPSG [42] criteria which is similar to the new 
WHO 2013 guideline was used [5]. In Nigeria, screening based on a checklist of risk 
factors was found to be more effective than universal screening [43]. Considering 
selective screening based on risk factors, if we would have screened pregnant 
women based on the six risk factors (MUAC ≥ 28cm, family history of diabetes, 
previous stillbirth, age ≥30 years and previous macrosomic child); four out of five 
women would have at least one of the risk factors; but about 15% of the GDM 
cases would be remained undiagnosed. Other studies that used different selection 
criteria found that up to 30% GDM cases would be missed with selective screening 
[44].  
 
Another aspect to consider is the need for OGTT for diagnosis. In most of the 
developing countries, OGTT may be challenging due to limited staff and logistical 
issues, and some women may fail to tolerate it. Other options like the use of fasting 
or random blood glucose could be more practical and cost-effective in this setting; 
however, there is a need for further exploration of this issue. Resource limited 
countries may need to set their own criteria, depending on the availability of 
resources [45]. 
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Treatment options 
Treating GDM is aimed at achieving glycaemic control to reduce preeclampsia, 
shoulder dystocia and macrosomia [46]. The commonly used treatment is dietary 
modification and physical activity together with blood glucose monitoring. 
Sometimes oral anti-diabetic agents or insulin may be used, depending on the 
severity [47]. In developing countries, insulin may be un-affordable to most 
pregnant women, hence oral hypoglycaemic agents such as metformin could be an 
alternative [48-50]. However, taking medication without a clear understanding may 
reduce compliance, so proper knowledge about the glucose intolerance state 
should be communicated to the mother. This calls for specific training of the health 
care providers especially those dealing with maternal and child health.  
 
Prevention 
Due to increased risk of metabolic syndrome in women with GDM, interventions 
should target both prevention of GDM and prevention of progression to type 2 
diabetes [51].There are limited intervention studies for reducing overweight or 
obesity in SSA, the main focus has been on undernutrition. A systematic review on 
interventions for preventing GDM showed that dietary counselling and low 
glycaemic index diets may have some benefits in preventing GDM [52]. Likewise, 
postpartum lifestyle interventions on diet, physical activities and weight reduction 
were shown to improve diabetes risk factors in women with GDM [53]. In our 
studies, overweight or obesity was associated with increased risk of GDM and HDP 
after adjustment for potential confounders such as age and gestational age 
(Chapter 2 &4). In the African context, weight reduction programmes or controlling 
weight gain during pregnancy may be a challenge due to cultural aspects of obesity 
in women [54, 55]. Obesity is regarded as beauty and perceived as a sign of 
prosperity, while slimness is viewed as unhealthy or sign of diseases. Dietary 
counselling may require women to change their usual diets in order to control 
blood glucose levels, which may fail due to lack of compliance. Public awareness is 
therefore very important in this setting. Also, targeting women at a younger age 
may be more beneficial than after conception or after delivery [56]. 
 
In observational studies, a higher level of physical activities before or during 
pregnancy was associated with a reduced risk of GDM [37] but intervention studies 
for prevention of GDM were less effective as compared to interventions for GDM 
management [57, 58]. The main reason given for failure of physical activity 
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interventions to prevent GDM may be compliance. Rural women are usually 
physically active due to the nature of their daily activities. In urban SSA, lifestyle 
and logistics do not allow recommended physical activity level for pregnant women 
which, in order to be effective, should include a walk at vigorous intensity for 25 
minutes per session or at least 35 minutes per session at a low intensity, together 
with a modified diet [59]. 
 
Another aspect considered for reducing progression to type 2 diabetes is breast 
feeding. In a review of observational and prospective studies, breast feeding was 
associated with improved glucose and lipid metabolism and reduced risk of type 2 
diabetes in women with GDM [60]. Breastfeeding may also be beneficial in 
preventing childhood and future obesity depending on the duration [61, 62]. In 
SSA, breast feeding is regarded as essential for every woman and duration is 
generally high, but exclusive breast feeding for the first six months is low [2, 63]. 
 
Most of the studies reported that high haemoglobin levels and high serum ferritin 
levels were associated with increased risk of GDM [64, 65]. In our study, we found 
that GDM was more prevalent in anaemic women compared to women with 
normal Hb levels (Chapter 2). Hb levels have been used as a proxy for iron 
deficiency anemia and as a guide for supplementation during antenatal care. The 
main cause of anaemia in most SSA countries is iron deficiency due to low dietary 
intake, but infections such as malaria and HIV, parasites, and vitamin A deficiency 
also contribute to anaemia during pregnancy [31, 66]. The interventions in place for 
prevention of anaemia during pregnancy include malaria treatment and 
prophylaxis, subsidised mosquito insecticide treated bed-nets, deworming and iron 
supplimentation. Iron overload due to supplimentation has not been reported, 
hence reinforcing the interventions to inrease Hb levels may also reduce the risk of 
GDM. Although high serum ferritin level was considered a risk for GDM [64, 67], 
randomized trials showed that iron supplimentation does not increase the risk of 
GDM [68, 69]. In women who were not anaemic and with risk factors for GDM, it 
was suggested that high iron intake may increase the risk for GDM [70]. There is 
limited studies on the effect of iron supplementation on glucose intolerance during 
pregnancy in SSA. 
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Suggestion for future research 
 
In view of our findings, the following suggestions for future research can be made: 
 Short and long term prospective studies are needed to evaluate the range 
of factors associated with GDM and birth outcomes in SSA. Attention 
should be given to pre-and post-gestational risk factors (such as MUAC, 
body fat, inflammation markers, waist circumference) that determine 
progression of type 2 diabetes, the effect on the child, recurrence of GDM 
in successive pregnancies and possible ways of reducing the risks. 
 Although women with GDM may return to normal after delivery, they may 
confuse their condition with type 2 diabetes if not properly counselled. It 
is therefore important to explore psychological effects in women 
diagnosed with GDM in Tanzania which will guide in planning for tailored 
counselling. 
 Studies on cost-benefit analysis for either universal or selective screening 
in SSA are needed and should include assessment of the extra costs for 
treatment, extra visits to ANC and general management of women 
diagnosed with GDM. 
 In the SSA setting, shortage of staff and limited resources is common in 
ANC. Diagnosis of GDM using OGTT may, therefore, be challenging. To 
implement selective screening, possible risk factors need to be explored. 
The existing challenges of OGTT as a diagnostic test call for further studies 
to establish easier and cost-effective way of diagnosis of GDM in the 
region.  
 Behaviour change for lowering blood glucose and preventing progression 
from GDM to type 2 diabetes depends on individual knowledge and 
attitudes. Qualitative studies focusing on women’s perception after 
diagnosis and their attitude towards behaviour change are lacking in SSA. 
 We observed that overweight/obesity was associated with increased risk 
for GDM and HDP. Behaviour change interventions to reduce 
overweight/obesity targeting women before conception should be given 
priority in SSA 
 There was high prevalence of anaemia in our study population, possibly 
due to the fact that the two study areas are malaria endemic. We 
recommend further studies to explore the co-existence of infection and 
GDM as well as the effect (if any) of iron supplementation on glucose 
intolerance during pregnancy in SSA. 
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Conclusion 
This is the first study that has assessed the burden of GDM and its determinants in 
Tanzania since 1990 and in SSA and explored the possibility of integrating blood 
glucose testing in the usual ANC in Tanzania. Gestational diabetes mellitus in 
Tanzania is increasing in parallel to the increasing prevalence of obesity and type 2 
diabetes mellitus. The association of overweight and obesity with both GDM and 
HDP provide an insight in the importance of weight reduction interventions. 
Strategies to prevent overweight and obesity before pregnancy will result in 
reduction of GDM and HDP and hence prevent intergenerational transmission of 
these chronic disorders. Proper utilization of available resources to include 
selective blood glucose testing during ANC visits is necessary and should be 
implemented together with lifestyle counselling.  
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The prevalence of overweight/obesity and type 2 diabetes is increasing in most of 
the Sub Sahara African (SSA) countries. The commonly given explanation for the 
observed increase is the change in lifestyle, such as food consumption and activity 
pattern, mainly due to urbanisation. Gestational diabetes mellitus (GDM) has been 
recognized as a potential risk factor for future type 2 diabetes to the foetus and the 
mother. Early identification and management reduce the risk of adverse outcomes, 
hence understanding the burden of GDM and its risk factors is important for better 
planning of preventive interventions to break the intergeneration cycle for type 2 
diabetes. 
 
This thesis aimed to determine the prevalence of gestational diabetes mellitus 
(GDM) and its determinants in urban and rural areas in Tanzania and in Sub 
Saharan Africa (SSA).  
We first assessed the prevalence and risk factors for GDM in Tanzania, comparing 
rural and urban areas (Chapter 2). This was achieved through a cross-sectional 
survey in selected antenatal care facilities where women attending clinic were 
requested to participate. We noted a higher prevalence of GDM in urban areas 
(8.4%) compared to rural (1.0%) areas, with an overall prevalence of 5.9%, which 
was much higher compared to what was reported in the 1990s. A possible 
explanation of the rural versus urban differences could be the nature of physical 
activity level as most of the rural women are engaged in agricultural work, which is 
more energy intensive. Family history of type 2 diabetes, overweight/obesity a 
defined as mid upper arm circumference (MUAC) ≥28 cm and previous stillbirth 
were significantly associated with presence of GDM. A higher prevalence was also 
observed among women with anaemia compared to those with normal 
haemoglobin levels. It is important to note that the prevalence varied according to 
the diagnostic criteria used; when using the diagnostic criteria recommended by 
the International Association of Diabetes in Pregnancy Study Group (IADPSG) with a 
lower cut-off for fasting glucose levels, the prevalence of GDM was more than 
double (13.0%). 
The burden of GDM and its risk factors in SSA was assessed through a systematic 
review and meta-regression analysis of published literature (Chapter 3). We 
retrieved only 22 studies conducted in six out of the 47 SSA countries, most of 
them from Nigeria. We found high heterogeneity between the studies, which could 
not be explained by any of the variables in a meta-regression analysis. Prevalence 
was up to 14% when high-risk women were studied. Commonly reported risk 
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factors were overweight and/or obesity, family history for type 2 diabetes, GDM in 
previous pregnancy, previous still birth, previous macrosomic child and age >30 
years. 
In Chapter 4, we assessed the prevalence of hypertension during pregnancy (HDP), 
which is another risk factor for delivery complications. During pregnancy, GDM and 
HDP often occur together. Although blood pressure is always measured during 
antenatal clinic visits, the occurrence of HDP in Tanzanian population is rarely 
reported. Like with GDM, there was relatively high prevalence of HDP in the 
studied population. Overall prevalence was 7.7%, which was higher in the urban 
areas (8.9%) compared to the rural areas (5.3%). The observed risk factors for HDP 
in urban areas were advanced maternal age, increased MUAC and increased 
dietary diversity. HIV positive women were also at increased risk, with higher 
prevalence in the newly diagnosed compared to those already on anti-retroviral 
therapy. In the rural areas, the risk for HDP increased with age and gestational age. 
Maternal risk factors for macrosomia and low birth weight were assessed in 466 
women from Dar es Salaam who were followed-up for birth outcome by telephone 
(Chapter 5). Higher occurrence of macrosomia (5.9%) was observed compared to 
occurrence of low birth weight (3.6%) in women above 20 years. This shows 
existence of the double burden of malnutrition in the studied population even at 
the infancy stage. Women with GDM and those with a previous macrosomic child 
had increased risk for becoming a macrosomic infant, while those with HDP had an 
increased risk for stillbirths and low birth weight. 
In Chapter 6, the opportunities and challenges for blood glucose screening in 
Tanzanian antenatal care were studied through a literature review and an urban 
health facility survey. The main challenge observed was the limited availability of 
both human and material resources. We found that diabetes screening during 
pregnancy is already in place using urine glucose testing, and it was regularly done 
in the urban setting. However, the sensitivity of an urinary glucose test in 
identifying women with GDM is low. The existing counselling and testing for HIV 
provides an opportunity to include blood glucose testing for GDM. However, the 
costs for GDM management are not known in Tanzania, so cost-benefit studies are 
needed before policies can be changed.  
In Chapter 7, we summarised the main findings in this thesis and elaborated on the 
methodological considerations, public health importance and recommendations for 
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future research. The prevalence of GDM in Tanzania is higher than expected, 
specifically in the urban area, in this case Dar es Salaam. The main modifiable risk 
factor is overweight/obesity. Healthy lifestyle, including healthy diet and exercise, 
for prevention of overweight and obesity should be advocated specifically for 
women at reproductive age. Although there is still an ongoing debate worldwide on 
the usefulness of screening and on the diagnostic criteria for GDM, this should not 
be used as an excuse to postpone GDM testing in Tanzania, especially in urban 
women where type 2 diabetes, hypertension and overweight/obesity are 
recognized as highly prevalent disorders.  
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De prevalentie van overgewicht/obesitas en type 2 diabetes neemt wereldwijd toe, 
ook in Afrika. Een veel genoemde verklaring voor deze waargenomen stijging is de 
verandering in leefstijl, zoals voeding en beweging, voornamelijk door 
verstedelijking. Zwangerschapsdiabetes is een risicofactor voor het optreden van 
type 2 diabetes op latere leeftijd, voor zowel moeder als kind. Vroegtijdige 
opsporing en behandeling verlaagt het risico op nadelige gevolgen van 
zwangerschapsdiabetes. Kennis over de omvang en de risicofactoren van 
zwangerschapsdiabetes zijn belangrijk om preventieve interventies beter te kunnen 
plannen, zodat de ‘moeder-kind-cyclus’ van type 2 diabetes doorbroken kan 
worden.  
Het doel van dit proefschrift is om de prevalentie en de determinanten van 
zwangerschapsdiabetes  in stedelijke en landelijke gebieden van Sub-Saharisch 
Afrika en specifiek voor Tanzania te bepalen.  
Als eerste onderdeel van het project hebben we de prevalentie en risicofactoren 
van zwangerschapsdiabetes in Tanzania onderzocht, waarbij we stedelijke en 
landelijke gebieden met elkaar vergeleken (Hoofdstuk 2). Dit werd gedaan door 
middel van een dwarsdoorsnede onderzoek in verschillende geboorteklinieken 
waar vrouwen die de kliniek bezochten werden gevraagd om mee te doen. We 
zagen een hogere prevalentie van zwangerschapsdiabetes in stedelijke gebieden 
(8.4%) dan in landelijke gebieden (1.0%), waarbij de totale prevalentie (5.9%) veel 
hoger was vergeleken met gerapporteerde waardes in de jaren ’90. De verschillen 
tussen landelijke en stedelijke gebieden kunnen onder andere het gevolg zijn van 
verschillen in lichamelijke beweging, aangezien de meeste vrouwen op het 
platteland betrokken zijn bij agrarisch werk, dat meer arbeidsintensief is. Een 
belaste familieanamnese voor type 2 diabetes, de aanwezigheid van 
overgewicht/obesitas gedefinieerd als bovenarmomtrek  ≥ 28 cm en een 
doodgeboorte of miskraam in de voorgeschiedenis waren significant geassocieerd 
met aanwezigheid van zwangerschapsdiabetes. Ook werd bij vrouwen met 
bloedarmoede vaker zwangerschapsdiabetes gevonden dan bij vrouwen met 
normale haemoglobin concentraties.  Belangrijk om op te merken is dat de 
prevalentie varieerde afhankelijk van de gebruikte diagnostische criteria. Wanneer 
de aanbevolen diagnostische criteria van de IADPSG werden gebruikt, met een 
lagere afkapwaarde voor nuchtere glucoseconcentratie, was de prevalentie van 
zwangerschapsdiabetes twee keer zo hoog (13.0%).   
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De prevalentie en gerapporteerde risicofactoren van zwangerschapsdiabetes in 
sub-Saharisch Afrika werden onderzocht aan de hand van een systematische 
review van de literatuur en een meta-regressie analyse van de resultaten 
(Hoofdstuk 3). Daarbij vonden we 22 studies, die waren uitgevoerd in slechts 6 van 
de 47 Afrikaanse landen beneden de Sahara, waarbij de meesten waren uitgevoerd 
in Nigeria. We vonden een hoge mate van heterogeniteit tussen de studies, die niet 
verklaard kon worden door de gebruikte variabelen in de meta-regressie analyse. 
De prevalentie was het hoogst bij vrouwen met een hoog risico, namelijk 14%. De 
risicofactoren die het meest frequent gerapporteerd werden waren: overgewicht 
en/of obesitas, een belaste familieanamnese voor type 2 diabetes, 
zwangerschapsdiabetes in een eerdere zwangerschap, een doodgeboorte in de 
voorgeschiedenis, een kind met hoog geboortegewicht (macrosomie) in een 
eerdere zwangerschap en een leeftijd boven de 30 jaar.  
Een andere risicofactor voor complicaties tijdens of na de bevalling is het hebben 
van een hoge bloeddruk tijdens de zwangerschap. In Hoofdstuk 4 hebben we de 
prevalentie van hoge bloeddruk tijdens de zwangerschap onderzocht. Tijdens de 
zwangerschap komen zwangerschapsdiabetes en hoge bloeddruk vaak tegelijk 
voor. Ondanks dat bloeddruk altijd wordt gemeten tijdens een bezoek aan een 
geboortekliniek, is er over het voorkomen van hoge bloeddruk in Tanzania weinig 
bekend. Net zoals voor zwangerschapsdiabetes kwam hoge bloeddruk relatief vaak 
voor in de bestudeerde onderzoekspopulatie. De prevalentie voor hoge bloeddruk 
was 7.7%, en was hoger in de stedelijke gebieden (8.9%) dan in de landelijke 
gebieden (5.3%). In stedelijke gebieden waren leeftijd van de moeder, een hogere 
bovenarmomtrek en een grotere variatie in voeding risicofactoren voor een hoge 
bloeddruk bij vrouwen. Ook hadden HIV-positieve vrouwen een hoger risico, 
waarbij in vrouwen die onlangs waren gediagnosticeerd vaker een hoge bloeddruk 
werd gemeten dan bij vrouwen die al antiretrovirale therapie kregen. In landelijke 
gebieden was het risico op hoge bloeddruk verhoogd met het toenemen van de 
leeftijd en de zwangerschapsduur.  
Bij de deelnemende vrouwen uit Dar es Salaam (n=466) werd een follow-up 
onderzoek uitgevoerd naar geboorte-uitkomst, deels op basis van gegevens uit de 
kliniek, deels op basis van een telefonisch afgenomen vragenlijst. Met deze 
gegevens konden risicofactoren  voor een r  hoog of laag geboortegewicht 
bestudeerd worden  (Hoofdstuk 5). Zowel een hoog (macrosomie) als een laag 
geboortegewicht kwamen voor bij vrouwen ouder dan 20 jaar; macrosomie kwam 
vaker voor (5.9%) dan een laag geboortegewicht (3.6%). Dit duidt erop dat de 
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zogenaamde ‘dubbele belasting’ van onder- en overvoeding ook terug te zien is in 
het stadium van de vroege kindertijd. Vrouwen met zwangerschapsdiabetes en 
vrouwen met een eerder zwaar kind hadden een verhoogd risico op het krijgen van 
een kind met hoog geboortegewicht, terwijl vrouwen met een hoge bloeddruk een 
verhoogd risico hadden op doodgeboorte of het krijgen van een kind met een laag 
geboortegewicht.  
In Hoofdstuk 6 hebben we de mogelijkheden en uitdagingen van diabetesscreening 
in Tanzaniaanse geboorteklinieken bestudeerd aan de hand van een 
literatuuroderzoek en een vragenlijstonderzoek bij gezondheidsinstellingen in Dar 
es Salaam. De voornaamste uitdaging voor screening bleek de beperkte 
beschikbaarheid van zowel menselijke als materiële middelen te zijn. 
Diabetesscreening wordt tijdens de zwangerschap voornamelijk gedaan door het 
testen van glucose in de urine; in de stedelijke gebieden gebeurde dit regelmatig. 
De gevoeligheid van de urine-glucose test is echter laag wanneer het gaat om het 
identificeren van vrouwen met zwangerschapsdiabetes. De bestaande begeleiding 
voor HIV en het testen daarvan biedt een mogelijkheid om het meten van 
bloedglucose eenvoudig mee te nemen. De kosten van het behandelen van 
zwangerschapsdiabetes in Tanzania zijn echter nog onbekend. Voordat het 
screeningsbeleid zou kunnen worden veranderd zijn er daarom eerst aanvullende 
economische evaluaties nodig. 
In Hoofdstuk 7 zijn de belangrijkste bevindingen van dit proefschrift samengevat en 
worden de methodologische beperkingen en de relevantie voor de 
volksgezondheid toegelicht. Ook worden er enkele aanbevelingen gegeven voor 
toekomstig onderzoek. De prevalentie van zwangerschapsdiabetes in Tanzania is 
hoger dan verwacht, met name in de stedelijke gebieden, in dit geval Dar es 
Salaam. De belangrijkste te beïnvloeden risicofactor is overgewicht/obesitas. Een 
gezonde leefstijl, waaronder gezonde voeding en voldoende beweging, en 
preventie van overgewicht en obesitas zou zeker bij vrouwen in de vruchtbare 
leeftijdsgroep moeten worden gestimuleerd. Ondanks dat er nog steeds een 
wereldwijd debat gaande is over de bruikbaarheid van screening en de 
diagnostische criteria van zwangerschapsdiabetes, zou dit geen excuus moeten zijn 
om het testen op diabetes tijdens de zwangerschap in Tanzania uit te stellen, zeker 
bij vrouwen in stedelijke gebieden waar type 2 diabetes, hoge bloeddruk en 
overgewicht/obesitas veel voorkomende aandoeningen zijn. 
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